0000056978 True FY 2022 0000056978 2021-10-03 2022-10-01 0000056978 dei:OtherAddressMember 2021-10-03 2022-10-01 0000056978 2022-04-02 iso4217:USD 0000056978 2022-11-14 xbrli:shares 0000056978 klic:BallBondingEquipmentSegmentMember 2021-10-03 2022-10-01 0000056978 klic:BallBondingEquipmentSegmentMember 2020-10-04 2021-10-02 0000056978 klic:WedgeBondingEquipmentSegmentMember 2021-10-03 2022-10-01 0000056978 klic:WedgeBondingEquipmentSegmentMember 2020-10-04 2021-10-02 0000056978 klic:AdvancedSolutionsSegmentMember 2021-10-03 2022-10-01 0000056978 klic:AdvancedSolutionsSegmentMember 2020-10-04 2021-10-02 0000056978 klic:AftermarketProductsandServicesAPSSegmentMember 2021-10-03 2022-10-01 0000056978 klic:AftermarketProductsandServicesAPSSegmentMember 2020-10-04 2021-10-02 0000056978 us-gaap:AllOtherSegmentsMember 2021-10-03 2022-10-01 0000056978 us-gaap:AllOtherSegmentsMember 2020-10-04 2021-10-02 0000056978 klic:CorporateExpensesMember 2021-10-03 2022-10-01 0000056978 klic:CorporateExpensesMember 2020-10-04 2021-10-02 0000056978 2022-10-01 0000056978 2021-10-02 0000056978 2020-10-04 2021-10-02 0000056978 2019-09-29 2020-10-03 iso4217:USD xbrli:shares 0000056978 us-gaap:CommonStockMember 2019-09-28 0000056978 us-gaap:TreasuryStockMember 2019-09-28 0000056978 us-gaap:RetainedEarningsMember 2019-09-28 0000056978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-28 0000056978 2019-09-28 0000056978 us-gaap:CommonStockMember 2019-09-29 2020-10-03 0000056978 us-gaap:TreasuryStockMember 2019-09-29 2020-10-03 0000056978 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-09-28 0000056978 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-09-28 0000056978 us-gaap:RetainedEarningsMember 2019-09-29 2020-10-03 0000056978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-29 2020-10-03 0000056978 us-gaap:CommonStockMember 2020-10-03 0000056978 us-gaap:TreasuryStockMember 2020-10-03 0000056978 us-gaap:RetainedEarningsMember 2020-10-03 0000056978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-03 0000056978 2020-10-03 0000056978 us-gaap:CommonStockMember 2020-10-04 2021-10-02 0000056978 us-gaap:TreasuryStockMember 2020-10-04 2021-10-02 0000056978 us-gaap:RetainedEarningsMember 2020-10-04 2021-10-02 0000056978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-04 2021-10-02 0000056978 us-gaap:CommonStockMember 2021-10-02 0000056978 us-gaap:TreasuryStockMember 2021-10-02 0000056978 us-gaap:RetainedEarningsMember 2021-10-02 0000056978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-02 0000056978 us-gaap:CommonStockMember 2021-10-03 2022-10-01 0000056978 us-gaap:TreasuryStockMember 2021-10-03 2022-10-01 0000056978 us-gaap:RetainedEarningsMember 2021-10-03 2022-10-01 0000056978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-03 2022-10-01 0000056978 us-gaap:CommonStockMember 2022-10-01 0000056978 us-gaap:TreasuryStockMember 2022-10-01 0000056978 us-gaap:RetainedEarningsMember 2022-10-01 0000056978 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 0000056978 us-gaap:EquipmentMember 2021-10-03 2022-10-01 0000056978 klic:SparePartsMember 2021-10-03 2022-10-01 0000056978 klic:ExpendableToolsMember 2021-10-03 2022-10-01 0000056978 us-gaap:BuildingMember 2021-10-03 2022-10-01 0000056978 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2021-10-03 2022-10-01 0000056978 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2021-10-03 2022-10-01 0000056978 us-gaap:ToolsDiesAndMoldsMember 2021-10-03 2022-10-01 0000056978 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-10-03 2022-10-01 0000056978 klic:UniqartaMember 2021-01-19 2021-01-19 0000056978 klic:UniqartaMember 2022-07-15 2022-07-15 0000056978 klic:UniqartaMember 2021-01-19 0000056978 klic:UniqartaMember us-gaap:InProcessResearchAndDevelopmentMember 2021-01-19 2021-01-19 0000056978 us-gaap:OtherIntangibleAssetsMember klic:UniqartaMember 2021-01-19 2021-01-19 0000056978 us-gaap:InProcessResearchAndDevelopmentMember 2021-10-03 2022-10-01 0000056978 klic:UniqartaMember 2020-10-04 2021-10-02 0000056978 klic:UniqartaMember 2020-10-04 2021-10-02 0000056978 klic:UniqartaMember 2019-09-29 2020-10-03 0000056978 klic:WedgeBondingEquipmentSegmentMember 2021-10-02 0000056978 klic:AftermarketProductsandServicesAPSSegmentMember 2021-10-02 0000056978 us-gaap:AllOtherSegmentsMember 2021-10-02 0000056978 klic:WedgeBondingEquipmentSegmentMember 2022-10-01 0000056978 klic:AftermarketProductsandServicesAPSSegmentMember 2022-10-01 0000056978 us-gaap:AllOtherSegmentsMember 2022-10-01 0000056978 us-gaap:DevelopedTechnologyRightsMember 2022-10-01 0000056978 us-gaap:DevelopedTechnologyRightsMember 2021-10-02 0000056978 srt:MinimumMember us-gaap:DevelopedTechnologyRightsMember 2021-10-03 2022-10-01 0000056978 srt:MaximumMember us-gaap:DevelopedTechnologyRightsMember 2021-10-03 2022-10-01 0000056978 us-gaap:CustomerRelationshipsMember 2022-10-01 0000056978 us-gaap:CustomerRelationshipsMember 2021-10-02 0000056978 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2021-10-03 2022-10-01 0000056978 us-gaap:CustomerRelationshipsMember srt:MaximumMember 2021-10-03 2022-10-01 0000056978 us-gaap:InProcessResearchAndDevelopmentMember 2022-10-01 0000056978 us-gaap:InProcessResearchAndDevelopmentMember 2021-10-02 0000056978 us-gaap:TradeNamesMember 2022-10-01 0000056978 us-gaap:TradeNamesMember 2021-10-02 0000056978 srt:MinimumMember us-gaap:TradeNamesMember 2021-10-03 2022-10-01 0000056978 srt:MaximumMember us-gaap:TradeNamesMember 2021-10-03 2022-10-01 0000056978 us-gaap:OtherIntangibleAssetsMember 2022-10-01 0000056978 us-gaap:OtherIntangibleAssetsMember 2021-10-02 0000056978 us-gaap:OtherIntangibleAssetsMember srt:MinimumMember 2021-10-03 2022-10-01 0000056978 us-gaap:OtherIntangibleAssetsMember srt:MaximumMember 2021-10-03 2022-10-01 0000056978 us-gaap:DevelopedTechnologyRightsMember 2021-10-03 2022-10-01 0000056978 us-gaap:CashMember 2022-10-01 0000056978 us-gaap:MoneyMarketFundsMember 2022-10-01 0000056978 us-gaap:BankTimeDepositsMember 2022-10-01 0000056978 us-gaap:CashMember 2021-10-02 0000056978 us-gaap:MoneyMarketFundsMember 2021-10-02 0000056978 us-gaap:BankTimeDepositsMember 2021-10-02 0000056978 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-10-03 2022-10-01 0000056978 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-10-01 0000056978 klic:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-10-01 0000056978 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-10-02 0000056978 klic:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-10-02 0000056978 klic:AccruedExpensesAndOtherCurrentLiabilitiesMember 2022-10-01 0000056978 klic:AccruedExpensesAndOtherCurrentLiabilitiesMember 2021-10-02 0000056978 us-gaap:OtherComprehensiveIncomeMember us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-10-03 2022-10-01 0000056978 us-gaap:OtherComprehensiveIncomeMember us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-10-04 2021-10-02 0000056978 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-10-03 2022-10-01 0000056978 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-10-04 2021-10-02 0000056978 srt:MinimumMember 2022-10-01 0000056978 srt:MaximumMember 2022-10-01 klic:renewal_option xbrli:pure 0000056978 klic:CitibankMember 2013-11-22 0000056978 klic:CitibankMember 2022-10-01 0000056978 klic:CitibankMember 2021-10-02 0000056978 klic:MUFGBankLtd.SingaporeBranchMember klic:FacilityAgreementsMember 2019-02-15 0000056978 klic:MUFGBankLtd.SingaporeBranchMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember klic:FacilityAgreementsMember 2019-02-15 2019-02-15 0000056978 klic:OverdraftFacilityMember klic:MUFGBankLtd.SingaporeBranchMember 2022-10-01 0000056978 srt:MinimumMember 2021-10-03 2022-10-01 0000056978 srt:MaximumMember 2021-10-03 2022-10-01 0000056978 klic:August2017ShareRepurchaseProgramMember 2017-08-15 0000056978 2018-07-10 0000056978 2019-01-31 0000056978 2020-07-03 0000056978 2022-03-03 2022-03-03 0000056978 2022-03-03 0000056978 2022-03-09 2022-03-09 0000056978 klic:AcceleratedShareRepurchaseASRMember 2022-03-10 2022-03-10 0000056978 klic:AcceleratedShareRepurchaseASRMember 2022-10-01 0000056978 klic:AcceleratedShareRepurchaseASRMember 2022-04-22 2022-04-22 0000056978 klic:AcceleratedShareRepurchaseASRMember 2022-03-10 2022-04-22 0000056978 2022-06-08 2022-06-08 0000056978 2022-08-30 2022-08-30 0000056978 2021-10-18 2021-10-18 0000056978 klic:OmnibusIncentivePlan2021Member 2022-10-01 0000056978 klic:RelativeTSRPSUMember 2021-10-03 2022-10-01 0000056978 srt:MinimumMember klic:RelativeTSRPSUMember 2022-10-01 0000056978 srt:MaximumMember klic:RelativeTSRPSUMember 2022-10-01 0000056978 klic:RevenueGrowthPerformanceShareUnitsMember 2021-10-03 2022-10-01 0000056978 srt:MinimumMember klic:RevenueGrowthPerformanceShareUnitsMember 2022-10-01 0000056978 srt:MaximumMember klic:RevenueGrowthPerformanceShareUnitsMember 2022-10-01 0000056978 klic:ShareBasedPaymentArrangementOptionAndTimeBasedRestrictedShareUnitsMember 2021-10-03 2022-10-01 0000056978 us-gaap:CostOfSalesMember 2021-10-03 2022-10-01 0000056978 us-gaap:CostOfSalesMember 2020-10-04 2021-10-02 0000056978 us-gaap:CostOfSalesMember 2019-09-29 2020-10-03 0000056978 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-10-03 2022-10-01 0000056978 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-10-04 2021-10-02 0000056978 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-09-29 2020-10-03 0000056978 us-gaap:ResearchAndDevelopmentExpenseMember 2021-10-03 2022-10-01 0000056978 us-gaap:ResearchAndDevelopmentExpenseMember 2020-10-04 2021-10-02 0000056978 us-gaap:ResearchAndDevelopmentExpenseMember 2019-09-29 2020-10-03 0000056978 klic:RelativeTSRPSUMember 2020-10-04 2021-10-02 0000056978 klic:RelativeTSRPSUMember 2019-09-29 2020-10-03 0000056978 klic:TimeBasedRestrictedStockMember 2021-10-03 2022-10-01 0000056978 klic:TimeBasedRestrictedStockMember 2020-10-04 2021-10-02 0000056978 klic:TimeBasedRestrictedStockMember 2019-09-29 2020-10-03 0000056978 us-gaap:EmployeeStockOptionMember 2021-10-03 2022-10-01 0000056978 us-gaap:EmployeeStockOptionMember 2020-10-04 2021-10-02 0000056978 us-gaap:EmployeeStockOptionMember 2019-09-29 2020-10-03 0000056978 us-gaap:CommonStockMember 2021-10-03 2022-10-01 0000056978 us-gaap:CommonStockMember 2020-10-04 2021-10-02 0000056978 us-gaap:CommonStockMember 2019-09-29 2020-10-03 0000056978 klic:RelativeTSRPSUMember 2019-09-28 0000056978 klic:RelativeTSRPSUMember 2018-09-30 2019-09-28 0000056978 klic:RelativeTSRPSUMember 2020-10-03 0000056978 klic:RelativeTSRPSUMember 2021-10-02 0000056978 klic:RelativeTSRPSUMember 2022-10-01 0000056978 klic:TimeBasedRestrictedStockMember 2019-09-28 0000056978 klic:TimeBasedRestrictedStockMember 2018-09-30 2019-09-28 0000056978 klic:TimeBasedRestrictedStockMember 2020-10-03 0000056978 klic:TimeBasedRestrictedStockMember 2021-10-02 0000056978 klic:TimeBasedRestrictedStockMember 2022-10-01 0000056978 klic:SpecialGrowthPSUMember 2019-09-28 0000056978 klic:SpecialGrowthPSUMember 2018-09-30 2019-09-28 0000056978 klic:SpecialGrowthPSUMember 2019-09-29 2020-10-03 0000056978 klic:SpecialGrowthPSUMember 2020-10-03 0000056978 klic:SpecialGrowthPSUMember 2020-10-04 2021-10-02 0000056978 klic:SpecialGrowthPSUMember 2021-10-02 0000056978 klic:SpecialGrowthPSUMember 2021-10-03 2022-10-01 0000056978 klic:SpecialGrowthPSUMember 2022-10-01 0000056978 us-gaap:EmployeeStockOptionMember 2022-10-01 0000056978 klic:NonEmployeeDirectorMember 2021-10-03 2022-10-01 0000056978 klic:NonEmployeeDirectorMember 2020-10-04 2021-10-02 0000056978 klic:NonEmployeeDirectorMember 2019-09-29 2020-10-03 0000056978 country:CH 2022-10-01 0000056978 country:CH 2021-10-02 0000056978 country:TW 2022-10-01 0000056978 country:TW 2021-10-02 klic:segment 0000056978 klic:BallBondingEquipmentSegmentMember 2019-09-29 2020-10-03 0000056978 klic:WedgeBondingEquipmentSegmentMember 2019-09-29 2020-10-03 0000056978 klic:AdvancedSolutionsSegmentMember 2019-09-29 2020-10-03 0000056978 klic:AftermarketProductsandServicesAPSSegmentMember 2019-09-29 2020-10-03 0000056978 us-gaap:AllOtherSegmentsMember 2019-09-29 2020-10-03 0000056978 klic:CorporateExpensesMember 2019-09-29 2020-10-03 0000056978 klic:CapitalEquipmentSegmentMember klic:GeneralSemiconductorMember 2021-10-03 2022-10-01 0000056978 klic:CapitalEquipmentSegmentMember klic:GeneralSemiconductorMember 2020-10-04 2021-10-02 0000056978 klic:CapitalEquipmentSegmentMember klic:GeneralSemiconductorMember 2019-09-29 2020-10-03 0000056978 klic:AutomotiveAndIndustrialMember klic:CapitalEquipmentSegmentMember 2021-10-03 2022-10-01 0000056978 klic:AutomotiveAndIndustrialMember klic:CapitalEquipmentSegmentMember 2020-10-04 2021-10-02 0000056978 klic:AutomotiveAndIndustrialMember klic:CapitalEquipmentSegmentMember 2019-09-29 2020-10-03 0000056978 klic:CapitalEquipmentSegmentMember klic:LEDMember 2021-10-03 2022-10-01 0000056978 klic:CapitalEquipmentSegmentMember klic:LEDMember 2020-10-04 2021-10-02 0000056978 klic:CapitalEquipmentSegmentMember klic:LEDMember 2019-09-29 2020-10-03 0000056978 klic:CapitalEquipmentSegmentMember klic:MemoryMember 2021-10-03 2022-10-01 0000056978 klic:CapitalEquipmentSegmentMember klic:MemoryMember 2020-10-04 2021-10-02 0000056978 klic:CapitalEquipmentSegmentMember klic:MemoryMember 2019-09-29 2020-10-03 0000056978 klic:AdvancedPackagingMember klic:CapitalEquipmentSegmentMember 2021-10-03 2022-10-01 0000056978 klic:AdvancedPackagingMember klic:CapitalEquipmentSegmentMember 2020-10-04 2021-10-02 0000056978 klic:AdvancedPackagingMember klic:CapitalEquipmentSegmentMember 2019-09-29 2020-10-03 0000056978 klic:CapitalEquipmentSegmentMember 2021-10-03 2022-10-01 0000056978 klic:CapitalEquipmentSegmentMember 2020-10-04 2021-10-02 0000056978 klic:CapitalEquipmentSegmentMember 2019-09-29 2020-10-03 0000056978 country:CN 2021-10-03 2022-10-01 0000056978 country:CN 2020-10-04 2021-10-02 0000056978 country:CN 2019-09-29 2020-10-03 0000056978 country:MY 2021-10-03 2022-10-01 0000056978 country:MY 2020-10-04 2021-10-02 0000056978 country:MY 2019-09-29 2020-10-03 0000056978 country:TW 2021-10-03 2022-10-01 0000056978 country:TW 2020-10-04 2021-10-02 0000056978 country:TW 2019-09-29 2020-10-03 0000056978 country:KR 2021-10-03 2022-10-01 0000056978 country:KR 2020-10-04 2021-10-02 0000056978 country:KR 2019-09-29 2020-10-03 0000056978 country:US 2021-10-03 2022-10-01 0000056978 country:US 2020-10-04 2021-10-02 0000056978 country:US 2019-09-29 2020-10-03 0000056978 country:HK 2021-10-03 2022-10-01 0000056978 country:HK 2020-10-04 2021-10-02 0000056978 country:HK 2019-09-29 2020-10-03 0000056978 us-gaap:AllOtherSegmentsMember 2021-10-03 2022-10-01 0000056978 us-gaap:AllOtherSegmentsMember 2020-10-04 2021-10-02 0000056978 us-gaap:AllOtherSegmentsMember 2019-09-29 2020-10-03 0000056978 country:SG 2022-10-01 0000056978 country:SG 2021-10-02 0000056978 country:US 2022-10-01 0000056978 country:US 2021-10-02 0000056978 country:CN 2022-10-01 0000056978 country:CN 2021-10-02 0000056978 country:IL 2022-10-01 0000056978 country:IL 2021-10-02 0000056978 us-gaap:AllOtherSegmentsMember 2022-10-01 0000056978 us-gaap:AllOtherSegmentsMember 2021-10-02 0000056978 klic:UnfundedCapitalCommitmentsMember 2022-10-01 0000056978 klic:ASETechnologyHoldingMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-10-04 2021-10-02 0000056978 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember klic:TianshuiHuatianTechnologyCoLtdMember 2021-10-03 2022-10-01 0000056978 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember klic:TianshuiHuatianTechnologyCoLtdMember 2020-10-04 2021-10-02 0000056978 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember klic:HaosengIndustrialCoLtdMember 2021-10-03 2022-10-01 0000056978 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember klic:HaosengIndustrialCoLtdMember 2020-10-04 2021-10-02 0000056978 us-gaap:AllowanceForCreditLossMember 2021-10-02 0000056978 us-gaap:AllowanceForCreditLossMember 2021-10-03 2022-10-01 0000056978 us-gaap:AllowanceForCreditLossMember 2022-10-01 0000056978 us-gaap:InventoryValuationReserveMember 2021-10-02 0000056978 us-gaap:InventoryValuationReserveMember 2021-10-03 2022-10-01 0000056978 us-gaap:InventoryValuationReserveMember 2022-10-01 0000056978 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-10-02 0000056978 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-10-03 2022-10-01 0000056978 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-10-01 0000056978 us-gaap:AllowanceForCreditLossMember 2020-10-03 0000056978 us-gaap:AllowanceForCreditLossMember 2020-10-04 2021-10-02 0000056978 us-gaap:InventoryValuationReserveMember 2020-10-03 0000056978 us-gaap:InventoryValuationReserveMember 2020-10-04 2021-10-02 0000056978 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-10-03 0000056978 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-10-04 2021-10-02 0000056978 us-gaap:AllowanceForCreditLossMember 2019-09-28 0000056978 us-gaap:AllowanceForCreditLossMember 2019-09-29 2020-10-03 0000056978 us-gaap:InventoryValuationReserveMember 2019-09-28 0000056978 us-gaap:InventoryValuationReserveMember 2019-09-29 2020-10-03 0000056978 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-09-28 0000056978 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-09-29 2020-10-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
Amendment No. 1
(Mark One)

☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
| EXCHANGE ACT OF 1934

For the fiscal year ended October 1, 2022
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
| EXCHANGE ACT OF 1934

For the transition period from to .
Commission File No. 000-00121
KULICKE AND SOFFA INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)

Pennsylvania | 23-1498399
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.)

23A Serangoon North Avenue 5, #01-01, Singapore 554369
1005 Virginia Dr., Fort Washington, PA 19034
(Address of Principal Executive Offices and Zip Code)
Registrant’s telephone number, including area code: (215) 784-6000

N/A
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, Without Par Value | KLIC | The Nasdaq Global Market

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes ☐ No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ | Accelerated filer | ☐
Non-accelerated filer | ☐ | Smaller reporting company | ☐
Emerging growth company | ☐ |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of April 2, 2022, the aggregate market value of the registrant's common stock held by non-affiliates of the registrant was approximately $3,279.6 million based on the closing sale price as reported on The Nasdaq Global Market (reference is made to Part II, Item 5 herein for a statement of assumptions upon which this calculation is based).
As of November 14, 2022, there were 57,018,988 shares of the registrant's common stock, without par value, outstanding.
Documents Incorporated by Reference
The information required by Part III of this Annual Report, to the extent not set forth herein, is incorporated herein by reference from the registrant’s definitive proxy statement relating to the Annual Meeting of Shareholders to be held in 2023, which definitive proxy statement shall be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this Report relates.

EXPLANATORY NOTE
Kulicke and Soffa Industries, Inc. (the “Company”, “we”, “us”, “our” or “K&S”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment” or “Form 10-K/A”) to our Annual Report on Form 10-K for the fiscal year ended October 1, 2022, which was filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 17, 2022 (the “Original Form 10-K”) to make certain changes as described below.
During the third quarter of fiscal year 2023, in response to comment letters from and ongoing discussions with the staff of the SEC, the Company reconsidered the guidance under ASC 280, Segment Reporting, and determined that certain prior period conclusions about the Company’s operating and reportable segments were erroneous. As a result, the Company had incorrectly presented certain segment-related disclosures in the notes to our previously issued consolidated financial statements, included in the Original Form 10-K.
In light of the foregoing, management reassessed the effectiveness of the Company’s internal control over financial reporting as of October 1, 2022, based on the framework established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). As a result of that reassessment, management identified a material weakness related to the Company’s segment reporting and, accordingly, concluded that our disclosure controls and procedures were not effective as of October 1, 2022 and that the Company did not maintain effective internal control over financial reporting as of October 1, 2022. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis.
The Company is filing this Amendment to the Original Form 10-K for the purpose of amending the Original Form 10-K to: (i) amend Part II, Item 8 “Financial Statements and Supplementary Data” to reissue the Report of Independent Registered Public Accounting Firm as it pertains to PricewaterhouseCoopers LLP’s (“PwC”) opinion on the effectiveness of the Company’s internal control over financial reporting (“ICFR”) as of October 1, 2022; and (ii) amend and restate Part II, Item 9A “Controls and Procedures” of the Original Form 10-K to reflect management’s conclusion that the Company’s ICFR and disclosure controls and procedures were not effective as of the October 1, 2022 due to the material weakness in ICFR, and to describe the Company’s remediation plan for addressing such material weakness.
As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company has included the entire text of Part I, Item IA, Part II, Item 7, Part II, Item 8, Part II, Item 9A of the Original Form 10-K in this Amendment. However, there have been no changes to the text of such items other than the amendments as stated in the immediately preceding paragraph, and as further discussed below.
The Company has evaluated the materiality of the incorrect presentation of its segment-related disclosures in the notes to its consolidated financial statements and has concluded that it did not result in a material misstatement of the Company’s previously issued consolidated financial statements.
Notwithstanding the above, the Company has determined that it would revise its notes to the consolidated financial statements to correct the presentation of its segment-related disclosures and will additionally: (i) amend Part II, Item 7 “Management's Discussion and Analysis of Financial Condition and Results of Operations” to revise the segment-related information within the “Results of Operations”; and (ii) revise segment-related information in Note 4: Goodwill and Intangible Assets and Note 16: Segment Information.
The Company’s principal executive officer and principal financial officer are providing new currently dated certifications. In addition, the Company is filing a new consent from PwC. Accordingly, this Amendment amends Items 15 “Exhibits, Financial Statement Schedules” in the Original Form 10-K to reflect the filing of the new certifications and consent. Except as specifically noted above, this Amendment does not reflect events that occurred subsequent to the filing of the Original Form 10-K, nor does it modify or update disclosures in the Original Form 10-K in any way. Among other things, risk factors and forward-looking statements made in the Original Form 10-K have not been revised to reflect events that occurred or facts that became known to the Company after the filing of the Original Form 10-K, and any such forward looking statements should be read in their historical context.
Accordingly, this Amendment should be read in conjunction with the Company’s other filings made with the SEC subsequent to the filing of the Original Form 10-K.

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
2022 Annual Report on Form 10-K/A
October 1, 2022
Index

|  | Page Number
| Explanatory Note |
| Part I |
Item 1A. | Risk Factors | 2
| Part II |
Item 7. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 15
Item 8. | Financial Statements and Supplementary Data | 28
Item 9A. | Controls and Procedures | 67
| Part IV |
Item 15. | Exhibits and Financial Statement Schedules | 69
| Signatures | 73

Table of Contents
PART I
Forward-Looking Statements
In addition to historical information, this filing contains statements relating to future events or our future results. These statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the safe harbor provisions created by statute. Such forward-looking statements include, but are not limited to, statements with respect to our future revenue increasing, continuing or strengthening, or decreasing or weakening; our capital allocation strategies, including any share repurchases; demand for our products, including replacement demand; our research and development efforts; our ability to identify and realize new growth opportunities, our ability to control costs; and our operational flexibility as a result of (among other factors):
•our expectations regarding the potential impacts on our business of the novel coronavirus (“COVID-19”) pandemic, including supply chain disruptions, the economic and public health effects, and governmental and other responses to these impacts;
•our expectations regarding the potential impacts on our business of actual or potential inflationary pressures, interest rate and risk premium adjustments, falling consumer sentiment, or economic recession caused, directly or indirectly, by the prolonged Ukraine/Russia conflict, the COVID-19 pandemic, geopolitical tensions, catastrophic events including as a result of climate change and other macroeconomic factors;
•our expectations regarding our effective tax rate and our unrecognized tax benefit;
•our ability to operate our business in accordance with our business plan;
•risks inherent in doing business on an international level, including currency risks, regulatory requirements, political risks, export restrictions and other trade barriers;
•projected growth rates in the overall semiconductor industry, the semiconductor assembly equipment market, and the market for semiconductor packaging materials; and
•projected demand for our products and services.
Generally, words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” “goal” and “believe,” or the negative of or other variations on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this filing. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
Forward-looking statements are based on current expectations and involve risks and uncertainties. Our future results could differ significantly from those expressed or implied by our forward-looking statements. These risks and uncertainties include, without limitation, those described below and under the heading “Risk Factors” in the Original Form 10-K and our other reports and registration statements filed from time to time with the Securities and Exchange Commission. This discussion should be read in conjunction with our audited financial statements included in this Form 10-K/A.
We operate in a rapidly changing and competitive environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. Future events and actual results, performance and achievements could differ materially from those set forth in, contemplated by or underlying the forward-looking statements, which speak only as of the date on which they were made. Except as required by law, we assume no obligation to update or revise any forward-looking statement to reflect actual results or changes in, or additions to, the factors affecting such forward-looking statement. Given those risks and uncertainties, investors should not place undue reliance on forward-looking statements as predictions of actual results.
1

Table of Contents
Item 1A. RISK FACTORS
Semiconductor Industry and Macroeconomic Risks
Our operating results and financial condition could be adversely impacted by volatile worldwide economic conditions and unpredictable spending by our customers due to uncertainties in the macroeconomic environment.
Though the semiconductor industry’s cycle can be independent of the general economy, global economic conditions may have a direct impact on demand for semiconductor units and ultimately demand for semiconductor capital equipment and tools. Accordingly, our business and financial performance is impacted, both positively and negatively, by fluctuations in the macroeconomic environment. Expenditures by our customers depend on the current and anticipated market demand for semiconductors and products that use semiconductors, LEDs and batteries, including mobile devices, personal computers, consumer electronics, telecommunications equipment, automotive components, electric vehicles and other industrial products. Reductions or other fluctuations in our customers' spending as a result of uncertain conditions and volatility in the macroeconomic environment, including from government, economic or fiscal instability, economic recession, actual or potential inflation, rising interest rates, slower growth in certain geographic regions, global health crises and pandemics, restricted global credit conditions, reduced demand, excess inventory, higher energy prices, or other conditions, could adversely affect our business, financial condition and operating results. Further, our profitability can be affected by volatility because we incur a certain amount of fixed costs that we cannot modulate up and down to meet increases or decreases in demand. The impact of broad-based weakening in the global macroeconomic environment could make our customers cautious and delay orders until the economic outlook becomes clearer. Significant downturns in the market for semiconductor devices or in general economic conditions reduce demand for our products and can materially and adversely affect our business, financial condition and operating results. Our visibility into future demand is generally limited and forecasting is difficult, and we believe historic, industry-wide volatility will persist.
The COVID-19 pandemic has adversely affected our business, and may in the future materially and adversely affect our results of operations and financial condition.
The ongoing COVID-19 pandemic and resulting containment measures have significantly impacted the global economy, disrupted global supply chains, created significant volatility and disruption in financial markets, and affected unemployment levels. The global responses to the COVID-19 pandemic remain dynamic. Some countries continue to impose quarantines, containment measures or travel restrictions, and certain countries, such as China, continue to impose periodic lockdowns in response to rising case numbers. In certain jurisdictions, there has been a resurgence of illnesses or threat of emerging new variants of the virus, potentially leading to more severe restrictions in the future.
While we continue our normal operations in all of our manufacturing locations, work-from-home practices have been instituted or permitted from time-to-time across our offices worldwide, which have in some cases impacted our non-manufacturing productivity. We could experience further productivity disruptions in the event of an outage to systems and technologies critical to effect remote work, or from the increased data security and technology risks arising therefrom.
The COVID-19 pandemic continues to disrupt our supply chain, including materials, equipment, engineering support and services, especially to, from and within China. In addition, the costs of logistics have increased as a result of general inflationary pressures, and labor shortages have further contributed to rising costs across the supply chain, further exacerbating the impact the pandemic has had on the supply chain.
Other effects of the COVID-19 pandemic on our business will depend on future developments that cannot be accurately predicted at this time, but may include the following:
•a decrease in short-term and/or long-term demand for our products resulting from widespread business shutdowns and slowdowns, quarantines, travel and logistics restrictions and other actions taken by governments, businesses, and the general public in an effort to limit exposure to and spread of COVID-19;
•negative impacts to our operations, technology development, new product introduction and customer qualifications resulting from our efforts to mitigate the impact of COVID-19 through execution of our BCP;
•increased volatility in the semiconductor and electric vehicle industries due to heightened uncertainty, including our inability to keep pace relative to our competitors during a post-COVID-19 market recovery should that occur; and
•reduced sales volume to or loss of customers, or cancellation, delay or reduction of backlogged customer orders.
2

Table of Contents
The ultimate impact of COVID-19 on our business will depend on, among other things:
•the extent and duration of the pandemic, the severity of the disease;
•the emergence of new variants of the virus;
•the distribution and effectiveness of available vaccines and boosters and the rates at which they are administered;
•the effects on the economy of the pandemic and of the measures taken by governmental authorities and other third parties restricting day-to-day life,
•international travel and border crossings, and the length of time that such measures remain in place; and
•governmental programs implemented to assist businesses impacted by the COVID-19 pandemic.
To the extent the COVID-19 pandemic adversely affects our business, results of operations and financial conditions, it may also exacerbate the other risks discussed in this section on “Risk Factors”.
We depend on our suppliers, including sole source suppliers, for raw materials, components and subassemblies. If our suppliers do not deliver their products to us, or deliver non-compliant or defective products, we would be unable to deliver our products to our customers.
Our products are complex and require raw materials, components and subassemblies having a high degree of reliability, accuracy and performance. We rely on subcontractors to manufacture many of these components and subassemblies and we rely on sole source suppliers for certain key technology parts and raw materials. As a result, we are exposed to a number of significant risks, including:
•decreased control over the manufacturing process for components and subassemblies;
•changes in our manufacturing processes in response to changes in the market, which may delay our shipments;
•our inadvertent use of defective or contaminated raw materials;
•the relatively small operations and limited manufacturing resources of some of our suppliers, which may limit their ability to manufacture and sell subassemblies, components or parts in the volumes we require and at acceptable quality levels and prices;
•restrictions on our ability to rely on suppliers due to changes in trade regulation as well as laws and regulations enacted in response to concerns related to climate change, conflict minerals, or responsible sourcing practices;
•the inability of suppliers to meet our or other customer demand requirements;
•reliability or quality issues with certain key subassemblies provided by single source suppliers as to which we may not have any short-term alternative;
•shortages caused by disruptions at our suppliers and subcontractors for a variety of reasons, including public health emergencies and associated containment measures (such as the COVID-19 pandemic), geopolitical tensions (such as the Ukraine/Russia conflict), significant natural disasters (including as a result of climate change) or significant price changes (including as a result of inflationary pressures);
•delays in the delivery of raw materials or subassemblies, which, in turn, may delay shipments to our customers;
•loss of suppliers as a result of consolidation of suppliers in the industry; and
•loss of suppliers because of their bankruptcy or insolvency.
If any of these risks were to materialize, we might be unable to deliver our products to our customers on time and at expected cost, or at all. While we observed some easing of the industry-wide supply constraints towards the end of fiscal 2022, we expect constraints to continue and the duration of such constraints or their long-term impact on our business cannot be predicted at this time.
3

Table of Contents
As part of our supply chain management, we have increased our inventory levels in an effort to mitigate component shortages. These increases in our inventory levels may lead to an excess of materials in the future in the event that the demand for our products is lower than our expectations or if we otherwise fail to anticipate future customer demand properly. Excess inventory levels could result in inventory write-downs at discounted prices, which could adversely affect our cash flows or gross margins. As a result, our business, financial condition and operating results would be materially and adversely affected.
The semiconductor industry is volatile with sharp periodic downturns and slowdowns. Cyclical industry downturns are made worse by volatile global economic conditions.
The semiconductor industry is volatile, with periods of rapid growth followed by industry-wide retrenchment. These periodic downturns and slowdowns have in the past adversely affected our business, financial condition and operating results. Downturns have been characterized by, among other things, diminished product demand, excess production capacity, and accelerated erosion of selling prices. Historically these downturns have severely and negatively affected the industry’s demand for capital equipment, including assembly equipment and, to a lesser extent, tools. In any case, we believe the historical volatility of our business, both upward and downward, will persist. Consequently, our revenues may decline, and our results of operations and financial condition may be adversely affected.
Difficulties in forecasting demand for our product lines may lead to periodic inventory shortages or excesses.
We typically operate our business with limited visibility of future demand. We do not have long-term contracts with many of our customers. As a result, demand for our products in future periods is difficult to predict and we sometimes experience inventory shortages or excesses. We generally order supplies and otherwise plan our production based on internal forecasts for demand. We have in the past failed, and may again in the future fail, to accurately forecast demand for our products. This has led to, and may in the future lead to, delays in product shipments or, alternatively, an increased risk of inventory obsolescence. As part of our supply chain management, we have increased our inventory levels in an effort to mitigate component shortages, which may increase the risk of inventory obsolescence. If we fail to accurately forecast demand for our products, our business, financial condition and operating results may be materially and adversely affected.
Our quarterly operating results fluctuate significantly and may continue to do so in the future.
In the past, our quarterly operating results have fluctuated significantly. We expect that our quarterly results will continue to fluctuate. Although these fluctuations are partly due to the cyclical and volatile nature of the semiconductor industry, they also reflect other factors, many of which are outside of our control.
Some of the factors that may cause our net revenue and operating margins to fluctuate significantly from period to period are:
•market downturns;
•industry inventory levels;
•the mix of products we sell because, for example:
◦certain lines of equipment or certain aftermarket tools within our business segments are more profitable than others; and
◦some sales arrangements have higher gross margins than others;
•canceled or deferred orders;
•variations in sales channel or mix of direct sales and indirect sales;
•seasonality;
•competitive pricing pressures may force us to reduce prices;
•higher than anticipated costs of development, achieving customer acceptance or production of new products;
•the availability and cost of the components for our products;
•delays in the development and manufacture of our new products and upgraded versions of our products and market acceptance of these products when introduced;
•customers’ delay in purchasing our products due to anticipation that we or our competitors may introduce new or upgraded products; and
•our competitors’ introduction of new products.
4

Table of Contents
Many of our expenses, such as research and development, selling, general and administrative expenses, and interest expense, do not vary directly with our net revenue. Our research and development efforts include long-term projects lasting a year or more, which require significant investments. In order to realize the benefits of these projects, we believe that we must continue to fund them even during periods when our revenue has declined. As a result, a decline in our net revenue would adversely affect our operating results as we continue to make these expenditures. In addition, if we were to incur additional expenses in a quarter in which we did not experience comparable increased net revenue, our operating results would decline. In a downturn, we may have excess inventory, which could be written off. Some of the other factors that may cause our expenses to fluctuate from period-to-period include:
•timing and extent of our research and development efforts;
•severance, restructuring, and other costs of relocating facilities;
•inventory write-offs due to obsolescence or other causes; and
•an increase in the cost of labor or materials.
Because our net revenue and operating results are volatile and difficult to predict, we believe consecutive period-to-period or year-over-year comparisons of our operating results may not be a good indication of our future performance.
Competitive Risks
Our average selling prices usually decline over time and may continue to do so.
Typically, our average selling prices have declined over time due to continuous price pressure from our customers and competitive cost reductions in our industry’s supply chains. We seek to offset this decline by continually reducing our cost structure by consolidating operations in lower cost areas, reducing other operating costs, by pursuing product strategies focused on product performance and customer service, and developing new products for which we are able to charge higher prices. These efforts may not enable us to fully offset price declines, and if they do not, our financial condition and operating results may be materially and adversely affected.
We may not be able to rapidly develop, manufacture and gain market acceptance of new and enhanced products required to maintain or expand our business.
We believe our continued success depends on our ability to continuously develop and manufacture new products and product enhancements on a timely and cost-effective basis. We must introduce these products and product enhancements into the market in a timely manner in response to customers’ demands for higher performance assembly equipment and leading-edge materials customized to address rapid technological advances in integrated circuits, and capital equipment designs. Our competitors may develop new products or enhancements to their products that offer improved performance and features, or lower prices which may render our products less competitive. The development and commercialization of new products require significant capital expenditures over an extended period of time, and some products we seek to develop may never become profitable. In addition, we may not be able to develop and introduce products incorporating new technologies in a timely manner that will satisfy our customers’ future needs or achieve market acceptance. If we are not able to develop and sell our products that meet the demands of our customers, it would result in lower net revenues and our operating results would be adversely affected.
We may be unable to continue to compete successfully in the highly competitive semiconductor equipment and packaging materials industries.
The semiconductor equipment and packaging materials industries are very competitive. In the semiconductor equipment industry, significant competitive factors include price, speed/throughput, production yield, process control, delivery time, innovation, quality and customer support. In the semiconductor packaging materials industry, significant competitive factors include price, delivery and quality.
In each of our markets, we face competition and the threat of competition from established competitors and potential new entrants. In addition, established competitors may combine to form larger, better-capitalized companies. Some of our competitors have or may have significantly greater financial, engineering, manufacturing and marketing resources than we do. Some of these competitors are Asian and European companies that have had, and may continue to have, an advantage over us in supplying products to local customers who appear to prefer to purchase from local suppliers. Some of these competitors compete across many of our product lines, while others are primarily focused in a specific product area, sometimes with government assistance or through the support of strategic alliances, all of which could result in lowering the barriers to entry.
5

Table of Contents
We expect our competitors to improve their current products’ performance, and to introduce new products and materials with improved price and performance characteristics. Our competitors may independently develop technology similar to or better than ours. They may also appropriate our technology and our intellectual property to compete against us and we may not have adequate legal recourse. New product and material introductions by existing competitors or by new market entrants could hurt our sales. If a semiconductor manufacturer or subcontract assembler selects a competitor’s product or materials for a particular assembly operation, we may not be able to sell products or materials to that manufacturer or assembler for a significant period of time. Manufacturers and assemblers sometimes develop lasting relationships with suppliers and assembly equipment providers in our industry and often go years without requiring replacement. In addition, we may have to lower our prices in response to price cuts by our competitors, which may materially and adversely affect our business, financial condition and operating results. If we cannot compete successfully, we could lose customers and experience reduced margins and profitability.
Geographic, Trade and Customer Risks
Substantially all of our sales, distribution channels and manufacturing operations are located outside of the U.S., which subjects us to risks, including risks from changes in trade regulations, currency fluctuations, political instability and conflicts.
Over 90% of our net revenue is derived from shipments to customers located outside of the U.S., primarily in the Asia/Pacific region. In the Asia/Pacific region, our customer base remains more geographically concentrated in China as a result of economic and industry conditions. Approximately 56.9%, 55.6% and 51.6% of our net revenue for fiscal 2022, 2021, and 2020, respectively, was derived from shipments to customers located in China.
We expect our future performance to depend on our ability to continue to compete in foreign markets, particularly in the Asia/Pacific region. Some of these economies have been highly volatile, resulting in significant fluctuation in local currencies, and political and economic instability. Some of these economies may also increase trade protectionism, thereby increasing barriers to entry, amplifying supply chain risks and adversely affecting the demand for our products. These conditions may continue or worsen, which may materially and adversely affect our business, financial condition and operating results.
We also rely on non-U.S. suppliers for materials and components used in our products, and substantially all of our manufacturing operations are located in countries other than the U.S. We manufacture our ball, wedge and APAMA bonders in Singapore, our Hybrid and Electronic Assembly solutions in the Netherlands, our dicing blades, capillaries and bonding wedges in China, and our capillary blanks in Israel and China. We also rely on independent foreign distribution channels for certain of our product lines. As a result, a major portion of our business is subject to the risks associated with international, and particularly Asia/Pacific, commerce, such as:
•stringent and frequently changing trade compliance regulations;
•less protective foreign intellectual property laws, and the enforcement of patent and other intellectual property rights;
•longer payment cycles in foreign markets;
•foreign exchange restrictions and capital controls, monetary policies and regulatory requirements;
•restrictions or significant taxes on the repatriation of our assets, including cash;
•tariff and currency fluctuations;
•difficulties of staffing and managing dispersed international operations, including labor work stoppages and strikes in our factories or the factories of our suppliers;
•changes in our structure or tax incentive arrangements;
•possible disagreements with tax authorities;
•episodic events outside our control such as, for example, outbreaks of coronaviruses, influenza or other illnesses;
•natural disasters such as earthquakes, fires or floods, including as a result of climate change;
•risks of war and civil disturbances, including the Ukraine/Russia conflict, or other events that may limit or disrupt manufacturing, markets and international trade;
•act of terrorism that impact our operations, customers or supply chain or that target U.S. interests or U.S. companies;
6

Table of Contents
•seizure of our foreign assets, including cash;
•the imposition of sanctions of countries in which we do business;
•changing political conditions and rising geopolitical tensions; and
•legal systems which are less developed and may be less predictable than those in the U.S.
In addition, there is a potential risk of conflict and instability in the relationship between Taiwan and China which could disrupt the operations of our customers and/or suppliers in both Taiwan and China, our manufacturing operations in China, and our future plans in the region.
Our international operations also depend on favorable trade relations between the U.S. and those foreign countries in which our customers, subcontractors and materials suppliers have operations. A protectionist trade environment in either the U.S. or those foreign countries in which we do business, such as a change in the current tariff structures, export compliance or other trade policies, may materially and adversely affect our ability to sell our products in foreign markets.
Catastrophic events, such as pandemics and extreme weather events as a result of climate change, can have a material adverse effect on our operations and financial results.
Our operations and business, and those of our customers and suppliers, can be disrupted by natural disasters, public health issues (including the COVID-19 pandemic), cybersecurity incidents, interruptions of service from utilities, or other catastrophic events including as a result of climate change. For example, we have at times experienced temporary disruptions in our manufacturing processes as a result of power outages. In addition, global climate change can result in natural disasters occurring more frequently, with greater intensity and with less predictability. For example, in August 2022, China’s Sichuan province ordered all factories to shut down for an extended period to ease a power shortage in the region resulting from an unprecedented heat wave crossing 104-degree Fahrenheit in dozens of Chinese cities. As Sichuan is a key manufacturing location for the semiconductor and solar panel industries, such power rationing measures impacted factories and suppliers who operate there. The long-term effects of climate change on the global economy and the semiconductor industry in particular are unclear but could be severe, and could exacerbate the other risk factors described herein. Catastrophic events could make it difficult or impossible to manufacture or deliver products to our customers, receive materials from our suppliers, or perform critical functions, whether on a timely basis or at all, which could adversely affect our revenue and operations. Some of the systems we maintain as part of our business recovery plans cannot guarantee us protection from such disruptions. Furthermore, even if our operations are unaffected or recover quickly, if our customers or suppliers cannot timely resume their own operations due to a catastrophic event, we may be unable to fulfil our customers’ orders, and may experience reduced or cancelled orders or other disruptions to our supply chain that may adversely affect our results of operations.
We are subject to export restrictions that may limit our ability to sell to certain customers, and trade wars, in particular the U.S.-China trade war, could adversely affect our business.
The U.S. and several other countries levy tariffs on certain goods and impose other trade restrictions that may impact our customers’ investment in manufacturing equipment, reduce the competitiveness of our products, or inhibit our ability to sell products or purchase necessary equipment and supplies. In particular, trade tensions between the U.S. and China have been escalating since 2018, with U.S. tariffs on Chinese goods and retaliatory Chinese tariffs on U.S. goods. We cannot predict what further actions may ultimately be taken with respect to tariffs or trade relations between the U.S. and other countries, what products may be subject to such actions, or what actions may be taken by other countries in response. Further changes in trade policy, tariffs, additional taxes, restrictions on exports or other trade barriers, or restrictions on supplies, equipment, and raw materials, may limit our ability to produce products, increase our selling and/or manufacturing costs, reduce the competitiveness of our products, or inhibit our ability to sell products or purchase necessary equipment and supplies, which could have a material adverse effect on our business, results of operations, or financial condition.
Though nearly all of our manufacturing activities take place outside of the U.S., certain of our advanced packaging products are subject to the EAR because they are based on U.S. technology or contain more than a de minimis amount of controlled U.S. content. The EAR require licenses for, and sometimes prohibit, the export of certain products. The CCL sets forth the types of goods and services controlled by the EAR, including civilian science, technology, and engineering dual-use items. For products listed on the CCL, a license may be required as a condition to export depending on the end destination, end use or end user and any applicable license exceptions.
7

Table of Contents
In 2020, the U.S. Department of Commerce Bureau of Industry and Security (“BIS”) amended the EAR to expand controls on certain foreign products based on U.S. technology and sold to Huawei and certain other companies. In October 2022, the BIS amended the EAR again to extend those foreign controls to numerous companies on BIS’ so-called Entity List. The 2020 and 2022 amendments impact some of our advanced packaging products, which are based on U.S. technology and are within the scope of the expanded EAR controls on Huawei and other Entity List companies. Therefore, these products cannot be sold to Huawei and other Entity List companies, and are subject to certain end-use restrictions. To date, these amendments to the EAR have not had a material direct impact on our business, financial condition or results of operations and we do not expect that they will, although they could have indirect impacts, including increasing tensions in U.S. and Chinese trade relations, potentially leading to negative sentiments towards U.S.-based companies among Chinese consumers. Additionally, some end users may prefer to avoid the U.S. supply chain to avoid the application of these regulations.
Future changes in, and responses to, U.S. trade policy could reduce the competitiveness of our products and cause our sales to decline, and therefore could have a material adverse effect on our business, financial condition or results of operations.
Because a small number of customers account for most of our sales, our net revenue could decline if we lose a significant customer.
The semiconductor manufacturing industry is highly concentrated, with a relatively small number of large semiconductor manufacturers and their subcontract assemblers and vertically integrated manufacturers of electronic systems purchasing a substantial portion of our semiconductor assembly equipment and packaging materials. Sales to a relatively small number of customers have historically accounted for a significant percentage of our net revenue. There was no customer with sales representing more than 10% of net revenue in fiscal 2022. Sales to our ten largest customers comprised 49.1% and 62.0% of our net revenue for fiscal 2022 and fiscal 2021, respectively.
We expect a small number of customers will continue to account for a high percentage of our net revenue for the foreseeable future. Thus, our business success depends on our ability to maintain strong relationships with our customers. Any one of a number of factors could adversely affect these relationships. If, for example, during periods of escalating demand for our equipment, we were unable to add inventory and production capacity quickly enough to meet the needs of our customers, or if because of supply chain constraints we are not able to fulfil our customers' orders, they may turn to other suppliers making it more difficult for us to retain their business. We may also make commitments from time-to-time to our customers regarding minimum volumes and performance standards, and if we are unable to meet those commitments, we may incur liabilities to our customers. If we lose orders from a significant customer that we are not able to replace, if a significant customer reduces its orders substantially, or if we incur liabilities for not meeting customer commitments, these losses, reductions or liabilities may materially and adversely affect our business, financial condition and operating results.
We maintain a backlog of customer orders that is subject to cancellation, reduction or delay in delivery schedules, which may result in lower than expected revenues.
We manufacture products primarily pursuant to purchase orders for current delivery or to forecast, rather than pursuant to long-term supply contracts. As a result, we must commit resources to the manufacture of products without binding purchase commitments from customers. The semiconductor industry is occasionally subject to double-booking and rapid changes in customer outlooks or unexpected build ups of inventory in the supply channel as a result of shifts in end market demand and macro-economic conditions. Accordingly, many of these purchase orders or forecasts may be revised or canceled without penalty. Even in cases where our standard terms and conditions of sale or other contractual arrangements do not permit a customer to cancel an order without penalty, we may from time to time accept cancellations to maintain customer relationships or because of industry practice, custom or other factors. The broad-based weakening in the global macroeconomic environment may result in lower than expected demand for our products, and our inability to sell products after we devote significant resources to them could have a material adverse effect on our levels of inventory, revenues and profitability.
Human Capital Risks
Increased labor costs and competition for qualified personnel may reduce the efficiency of our flexible manufacturing model and adversely impact our operating results.
The labor costs in the various countries in which we operate are rising. There is substantial competition in China and Singapore for qualified and capable manufacturing personnel, which may make it difficult for us to recruit and retain qualified employees. In addition, current or future immigration laws, policies or regulations may limit our ability to attract, hire and retain qualified employees in Singapore. If we are unable to staff sufficient personnel at our China, Singapore, Israel and the Netherlands facilities or if there are increases in labor costs that we are unable to recover in our pricing to our customers, we may experience increased manufacturing costs, which would adversely affect our operating results.
8

Table of Contents
Our business depends on attracting and retaining management, sales and technical employees as well as on the succession of senior management.
Our future success depends on our ability to hire and retain qualified management, sales, finance, accounting and technical employees, including senior management. Experienced personnel with the relevant and necessary skill sets in our industry are in high demand and competition for their talents is intense, especially in Asia, where most of the Company’s key personnel are located. If we are unable to continue to attract and retain the managerial, marketing, finance, accounting and technical personnel we require, our business, financial condition and operating results may be materially and adversely affected.
Effective succession planning is also important to our long-term success. Failure to ensure effective transfer of knowledge and smooth transitions involving senior management could hinder our strategic planning and execution. From time to time, senior management or other key employees may leave our company, and the loss of any key employee could result in significant disruptions to our operations, including adversely affecting the timeliness of product releases, the successful implementation and completion of company initiatives, the effectiveness of our disclosure controls and procedures and our internal control over financial reporting, and the results of our operations. Changes in immigration policies may also impair our ability to recruit and hire technical and professional talent. In addition, hiring, training, and successfully integrating replacement critical personnel could be time consuming, may cause additional disruptions to our operations, and may be unsuccessful, which could negatively impact future revenues.
Product Risks
Alternative packaging technologies may render some of our products obsolete and materially and adversely affect our overall business and financial results.
Alternative packaging technologies have emerged that may improve device performance or reduce the size of an integrated circuit package, as compared to traditional wire bonding. These technologies include flip chip and wafer-level packaging. Some of these alternative technologies eliminate the need for wires to establish the electrical connection between a die and its package. The semiconductor industry may, in the future, shift a significant part of its volume into alternative packaging technologies which do not employ our products. If a significant shift to alternative packaging technologies or to another technology not offered by us were to occur, demand for our equipment and related packaging materials may be materially and adversely affected. Given that a majority of our revenue comes from wire bonding, a reduced demand for our wire bonding equipment could materially and adversely affect our financial results.
We may send products and equipment to customers or potential customers for trial, evaluation or other purposes which may result in retrofit charges, impairments or write-down of inventory value if the products and equipment are not subsequently purchased by the customers.
From time to time we send certain products and equipment to customers or potential customers for testing, evaluation or other purposes in advance of receiving any confirmation of purchase or purchase orders. Such equipment may be at the customer location for an extended period of time per the agreements with these customers and potential customers. The customer or potential customer may refuse to buy all or partial quantities of such product or equipment and return this back to us. As a result, we may incur charges to retrofit the machines or sell the machines as second hand at a lower price, and accordingly may have to record impairments on the returned inventory, all of which would adversely affect our operating results.
Undetected problems in our products could directly impair our financial results.
If errata (deviations from product specifications) or flaws in design, production, assembly or testing of our products (by us or our suppliers) were to occur, we could experience a rate of failure in our products that would result in materially adverse consequences, including:
•incurring warranty expenses;
•writing off the value of inventory;
•disposing of products that cannot be fixed;
•retrofitting products that have been shipped;
•providing product replacements or modifications; and
•defending against litigation.
9

Table of Contents
Continued improvement in manufacturing capabilities, control of material and manufacturing quality and costs and product testing are critical factors in our future growth. Our efforts to monitor, develop, modify and implement appropriate tests and manufacturing processes for our products may not be sufficient to permit us to avoid a rate of failure in our products that results in substantial delays in shipment, significant repair or replacement costs, potential damage to our reputation or general customer dissatisfaction with our products. We may also not be able to obtain product liability or other insurance to fully cover such risks. Any of the foregoing risks, if they were to materialize, could have a material adverse effect on our business, results of operations or financial condition.
Operations and Supply Chain Risks
We may not be able to continue to consolidate manufacturing and other facilities or entities without incurring unanticipated costs and disruptions to our business.
As part of our ongoing efforts to drive further efficiency, we may consolidate our manufacturing and other facilities or entities. Should we consolidate, we may experience unanticipated events, including the actions of governments, suppliers, employees or customers, which may result in unanticipated costs and disruptions to our business. We may also incur restructuring charges, severance costs, asset impairments, loss of accumulated knowledge, inefficiency during transitional periods, employee attrition and other effects that could negatively impact our financial condition and results of operations.
We may be materially and adversely affected by environmental and safety laws and regulations, including laws and regulations implemented in response to climate change.
We are subject to various federal, state, local and foreign laws and regulations governing, among other things, the generation, storage, use, emission, discharge, transportation and disposal of hazardous material, investigation and remediation of contaminated sites and the health and safety of our employees. Public attention continues to focus on the environmental impact of manufacturing operations and the risk to neighbors of waste and chemical releases from such operations.
Proper waste disposal plays an important role in the operation of our manufacturing plants. In many of our facilities we maintain wastewater treatment systems that remove metals and other contaminants from process wastewater. These facilities operate under permits that must be renewed periodically. A violation of those permits may lead to revocation of the permits, fines, penalties or the incurrence of capital or other costs to comply with the permits, including the potential shutdown of operations.
Compliance with existing or future land use, environmental, climate-related and health and safety laws and regulations may: (1) result in significant costs to us for additional capital equipment or other process requirements; (2) restrict our ability to expand our operations, and/or (3) cause us to curtail our operations. We also could incur significant costs, including cleanup costs, fines or other sanctions and third-party claims for property damage or personal injury, as a result of violations of or liabilities under such laws and regulations.
Increasingly, various agencies and governmental bodies have expressed interest in promulgating rules relating to climate change. For example, in March 2022, the SEC published a proposed rule that would require companies to provide significantly expanded climate-related disclosures in their Form 10-K, which may require us to incur significant additional costs to comply and impose increased oversight obligations on our management and Board of Directors. The cost of complying, or of failing to comply, with these and other regulatory requirements or contractual obligations could adversely affect our operating results, financial condition and ability to conduct our business.
To the extent that higher costs result in higher prices for our products, we may experience a reduction in the demand for those products, which could negatively affect our results of operations. Conversely, we may not be able to pass these increased costs onto our customers in the form of higher prices, as a result of which our results of operations may also be adversely affected.
We may acquire or divest businesses or enter into joint ventures or strategic alliances, which may materially affect our business, financial condition and operating results.
10

Table of Contents
We continually evaluate our portfolio of businesses and may decide to buy or sell businesses or enter into joint ventures or other strategic alliances. We may not find suitable acquisition candidates, we may not be able to close such acquisitions, and the acquisitions we complete may not be successful. We may be unable to successfully integrate acquired businesses with our existing businesses and successfully implement, improve and expand our systems, procedures and controls to accommodate these acquisitions. If we are not able to successfully integrate any acquired businesses with ours, the anticipated benefits of the acquisitions may not be realized fully or may take longer than expected to be realized. We may also incur higher than expected costs as a result of any acquisitions or experience an overall post-completion process that takes longer than originally anticipated.
These transactions place additional demands on our management, our various functional teams and our current labor force. The combination of businesses may result in the loss of key personnel or an interruption of, or loss of momentum in, our existing businesses and/or the acquired business. In addition, we may need to divest existing businesses, which would cause a decline in revenue or profitability and may make our financial results more volatile. If we fail to integrate and manage acquired businesses successfully or to mitigate the risks associated with divestitures, joint ventures or other alliances, or if the time and costs associated with integration exceeds our expectations, or if our acquired business were to perform poorly, our business, financial condition and operating results may be materially and adversely affected.
Increasing attention to ESG matters, including any targets or other ESG initiatives, could result in additional costs or risks or adversely impact our business
Certain investors, shareholder advocacy groups, other market participants, customers and other stakeholder groups have focused increasingly on companies' environmental, social and governance (“ESG”) initiatives, including those concerning climate change, human rights, diversity and inclusion, and shareholder proxy access. This may result in increased costs, enhanced compliance or disclosure obligations and costs, or other adverse impacts on our business, financial condition or results of operations.
From time to time, we create and publish voluntary disclosures regarding ESG matters. Our sustainability report, currently in its sixth edition, continues to outline our Company’s strategies, initiatives and performance of ESG topics identified through a materiality assessment to be most relevant to the operations and stakeholders of our Company. The identification, assessment, and disclosure of such matters is complex. Many of the statements in such voluntary disclosures are based on our expectations and assumptions, which may require substantial discretion and forecasts about costs and future circumstances.
Additionally, ESG matters continue to evolve rapidly. Organizations that provide information to investors on ESG matters may develop more discrete rating matrices, benchmarks and processes on evaluating companies on their ESG approach. This may create opportunities for misalignment or perceived failure resulting in unfavorable ESG ratings. This could foster negative investor sentiment toward us, our customers, or our industry, which could negatively impact our business and operations. To the extent ESG matters negatively impact our reputation, it may also impede our ability to compete as effectively to recruit or retain employees, which may adversely affect our operations.
Intellectual Property Risks
Our success depends in part on our intellectual property, which we may be unable to protect.
Our success depends in part on our proprietary technology. To protect this technology, we rely principally on contractual restrictions (such as nondisclosure and confidentiality provisions) in our agreements with employees, subcontractors, vendors, consultants and customers and on the common law of trade secrets and proprietary “know-how”. We also rely, in some cases, on patent and copyright protection, although this protection may in some cases be insufficient due to the rapid development of technology in our industry. We may not be successful in protecting our technology for a number of reasons, including the following:
•employees, subcontractors, vendors, consultants and customers may violate their contractual agreements, and the cost of enforcing those agreements may be prohibitive, or those agreements may be unenforceable or more limited than we anticipate;
•foreign intellectual property laws may not adequately protect our intellectual property rights; and
•our patent and copyright claims may not be sufficiently broad to effectively protect our technology; our patents or copyrights may be challenged, invalidated or circumvented; or we may otherwise be unable to obtain adequate protection for our technology.
11

Table of Contents
Also, competitors may copy or misappropriate our trade secrets, products or designs either through lawful means of reverse engineering or through unlawful means that we are unable to prove, in either case eroding our market share. In addition, our partners and alliances may have rights to technology developed by us. We may incur significant expense to protect or enforce our intellectual property rights. If we are unable to protect our intellectual property rights, our competitive position may be weakened.
Third parties may claim we are infringing on their intellectual property, which could cause us to incur significant litigation costs or other expenses, or prevent us from selling some of our products.
The semiconductor industry is characterized by rapid technological change, with frequent introductions of new products and technologies. Industry participants often develop products and features similar to those introduced by others, creating a risk that their products and processes may give rise to claims they infringe on the intellectual property of others. We may unknowingly infringe on the intellectual property rights of others and incur significant liability for that infringement. If we are found to have infringed on the intellectual property rights of others, we could be enjoined from continuing to manufacture, market or use the affected product, or be required to obtain a license to continue manufacturing or using the affected product. A license could be very expensive to obtain or may not be available at all. Similarly, changing or re-engineering our products or processes to avoid infringing the rights of others may be costly, impractical or time consuming.
Occasionally, third parties assert that we are, or may be, infringing on or misappropriating their intellectual property rights. In these cases, we defend, and will continue to defend, against claims or negotiate licenses where we consider these actions appropriate. Intellectual property cases are uncertain and involve complex legal and factual questions. If we become involved in this type of litigation, it could consume significant resources and divert our attention from our business.
Information Technology and Enterprise System Risks
We may be subject to disruptions or failures in our information technology systems and network infrastructures that could have a material adverse effect on us.
We maintain and rely extensively on information technology systems and network infrastructures for the effective operation of our business. We also hold large amounts of data in data center facilities around the world, primarily in Singapore and the U.S., on which our business depends. A disruption, infiltration or failure of our information technology systems or any of our data centers as a result of software or hardware malfunctions, computer viruses, cyber-attacks, employee theft or misuse, power disruptions, natural disasters or accidents could cause breaches of data security and loss of critical data, which in turn could materially adversely affect our business. Our security procedures, such as virus protection software, data loss protection and our business continuity planning, such as our disaster recovery policies and back-up systems, may not be adequate or implemented properly to fully address the adverse effect of such events, which could adversely impact our operations. In addition, our business could be adversely affected to the extent we do not make the appropriate level of investment in our technology systems as our technology systems become out-of-date or obsolete and are not able to deliver the type of data integrity and reporting we need to run our business. Furthermore, when we implement new systems and/or upgrade existing systems, we could be faced with temporary or prolonged disruptions that could adversely affect our business.
We have experienced, and expect to continue to be subject to, cybersecurity threats and incidents, ranging from employee error or misuse, to individual attempts to gain unauthorized access to information systems, to sophisticated and targeted measures known as advanced persistent threats, none of which have been material to the Company to date. We devote significant resources to network security and other measures to protect our systems and data from unauthorized access or misuse. However, depending on the nature and scope, cybersecurity incidents could result in business disruption; the misappropriation, corruption or loss of confidential information and critical data (of the Company or that belonging to third parties); reputational damage; litigation with third parties; diminution in the value of our investment in research, development and engineering; data privacy issues; and increased cybersecurity protection and remediation costs.
We are implementing a new enterprise resource planning system. Our failure to implement it successfully, on time and on budget could have a material adverse effect on us.
In 2020 we began implementing a new enterprise resource planning (“ERP”) system, and will continue to implement the new system in phases across our various entities over the next two years. ERP implementations are complex, time-consuming, labor intensive, and involve substantial expenditures on system software and implementation activities. The ERP system is critical to our ability to provide important information to our management, obtain and deliver products, provide services and customer support, send invoices and track payments, fulfill contractual obligations, accurately maintain books and records, provide accurate, timely and reliable reports on our financial and operating results, and otherwise operate our business. ERP implementations also require transformation of business and financial processes in order to reap the benefits of the ERP system.
12

Table of Contents
Any such implementation involves risks inherent in the conversion to a new computer system, including loss of information and potential disruption to our normal operations. The implementation and maintenance of the new ERP system has required, and will continue to require, the investment of significant financial and human resources and the implementation may be subject to delays and cost overruns. In addition, we may not be able to successfully complete the implementation of the new ERP system without experiencing difficulties.
Any disruptions, delays or deficiencies in the design and implementation or the ongoing maintenance of the new ERP system could adversely affect our ability to process orders, ship products, provide services and customer support, send invoices and track payments, fulfill contractual obligations, accurately maintain books and records, provide accurate, timely and reliable reports on our financial and operating results, including reports required by the SEC such as the evaluation of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, and otherwise operate our business. Additionally, if we do not effectively implement the ERP system as planned or the system does not operate as intended, the effectiveness of our internal control over financial reporting could be adversely affected or our ability to assess it adequately could be delayed.
Currency and Tax Risks
We are exposed to fluctuations in currency exchange rates that could negatively impact our financial results and cash flows.
Because most of our foreign sales are denominated in U.S. dollar, an increase in value of the U.S. dollar against foreign currencies will make our products more expensive than those offered by some of our foreign competitors. In addition, a weakening of the U.S. dollar against other currencies could make our costs in non-U.S. locations more expensive to fund. Our ability to compete overseas may therefore be materially and adversely affected by the fluctuations of the U.S. dollar against other currencies.
Because nearly all of our business is conducted outside the U.S., we face exposure to adverse movements in foreign currency exchange rates which could have a material adverse impact on our financial results and cash flows. Historically, our primary exposures have related to net working capital exposures denominated in currencies other than the foreign subsidiaries’ functional currency, and remeasurement of our foreign subsidiaries’ net monetary assets from the subsidiaries’ local currency into the subsidiaries’ functional currency. In general, an increase in the value of the U.S. dollar could require certain of our foreign subsidiaries to record translation and remeasurement gains. Conversely, a decrease in the value of the U.S. dollar could require certain of our foreign subsidiaries to record losses on translation and remeasurement. An increase in the value of the U.S. dollar could increase the cost to our customers of our products in those markets outside the U.S. where we sell in U.S. dollars, and a weakened U.S. dollar could increase the cost of local operating expenses and procurement of raw materials, both of which could have an adverse effect on our cash flows. Our primary exposures include the Singapore Dollar, Chinese Yuan, Japanese Yen, Swiss Franc, Philippine Peso, Thai Baht, Taiwan Dollar, South Korean Won, Israeli Shekel, Malaysian Ringgit and Euro. Although we from time to time have entered into foreign exchange forward contracts to hedge certain foreign currency exposure of our operating expenses, our attempts to hedge against these risks may not be successful and may result in a material adverse impact on our financial results and cash flows.
Changes to our existing tax incentive in Singapore may materially reduce our reported results of operations in future periods.
Our existing tax incentive, scheduled to expire in our fiscal 2025, allows certain classes of income to be subject to reduced income tax rates in Singapore provided we meet certain employment and investment conditions. If we cannot, or elect not to, comply with these conditions, we could be required to refund material tax benefits previously realized with respect to this tax incentive. Subsequent renewals are at the discretion of the Singapore government and we may not be able to extend the tax incentive arrangement beyond its expiration date or we may also elect not to renew this tax incentive arrangement. In the absence of the tax incentive, the income tax rate in Singapore that would otherwise apply is 17%, which would result in a significant increase in our provision for (benefit from) income taxes in future periods.
Changes in tax legislation could adversely impact our future profitability.
We are subject to income taxes in the U.S. and many foreign jurisdictions. Tax laws and regulations are continuously evolving with corporate tax reform, base-erosion efforts, global minimum tax, and increased transparency continuing to be high priorities in many tax jurisdictions in which we operate. Although the timing and methods of implementation may vary, many countries, including those in the Asia/Pacific region in which we have significant operations, have implemented, or are in the process of implementing, legislation or practices inspired by the base erosion and profit shifting project undertaken by the Organization for Economic Co-operation and Development (“OECD”). Unless repealed or otherwise modified, beginning in our fiscal 2023, the U.S. Tax Cuts and Jobs Act of 2017 (“TCJA”) enactment of IRC Section 174 will require the capitalization and amortization of
13

Table of Contents
R&D expenditures which will increase our effective tax rate and reduce our operating cash flows. Further, the increased scrutiny on international tax and continuous changes to countries’ tax legislation may also affect the policies and decisions of tax authorities with respect to certain income tax and transfer pricing positions taken by the Company in prior or future periods. We continue to monitor new tax legislation or other developments since significant changes in tax legislation, or in the interpretation of existing legislation, could materially and adversely affect our financial condition and operating results.
Other changes in taxation could materially impact our future effective tax rate.
Additionally, our future effective tax rate could be affected by numerous other factors including higher or lower than anticipated foreign earnings in various jurisdictions where we are subjected to tax rates that differ from the U.S. federal statutory tax rate, by changes in the valuation allowances recorded against certain deferred tax balances, or by changes in accounting principles and reporting requirements, or interpretations and application thereof. Changes in our assertion for foreign earnings permanently or non-permanently reinvested as a result of changes in facts and circumstances and challenges by tax authorities to our historic or future tax positions and transfer pricing policies could also significantly adversely impact our future effective tax rate.
Risks Related to Our Shares and Corporate Law
We have the ability to issue additional equity securities, which would lead to dilution of our issued and outstanding common shares.
We may from time to time issue additional equity securities or securities convertible into equity securities, which would result in dilution of our existing shareholders’ equity interests in us. Our board of directors has the authority to issue, without vote or action of shareholders, preferred shares in one or more series, and has the ability to fix the rights, preferences, privileges and restrictions of any such series. Any such series of preferred shares could contain dividend rights, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences or other rights superior to the rights of holders of our common shares. In addition, we are authorized to issue, without shareholder approval, up to an aggregate of 200 million common shares, of which approximately 57.1 million shares were outstanding as of October 1, 2022. We are also authorized to issue, without shareholder approval (except as required by the rules of the Nasdaq stock market), securities convertible into either common shares or preferred shares. We may issue such shares in connection with financing transactions, joint ventures, mergers and acquisitions or other purposes. In addition, our shareholders will experience additional dilution when performance or restricted share units vest and settle, when we issue equity awards to our employees under our equity incentive plans, or when we otherwise issue additional equity.
Anti-takeover provisions in our articles of incorporation and bylaws and under Pennsylvania law may discourage other companies from attempting to acquire us.
Some provisions of our articles of incorporation and bylaws as well as Pennsylvania law may discourage some transactions where we would otherwise experience a fundamental change. For example, our articles of incorporation and bylaws contain provisions that:
•classify our board of directors into four classes, with one class being elected each year;
•permit our board to issue “blank check” preferred shares without shareholder approval; and
•prohibit us from engaging in some types of business combinations with a holder of 20% or more of our voting securities without super-majority board or shareholder approval.
Further, under the Pennsylvania Business Corporation Law, because our shareholders approved bylaw provisions that provide for a classified board of directors, shareholders may remove directors only for cause. These provisions and some other provisions of the Pennsylvania Business Corporation Law could delay, defer or prevent us from experiencing a fundamental change and may adversely affect our common shareholders' voting and other rights.
14

Table of Contents
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
In addition to historical information, this filing contains statements relating to future events or our future results. These statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the safe harbor provisions created by statute. Such forward-looking statements include, but are not limited to, statements with respect to our future revenue increasing, continuing or strengthening, or decreasing or weakening; our capital allocation strategies, including any share repurchases; demand for our products, including replacement demand; our research and development efforts; our ability to identify and realize new growth opportunities; our ability to control costs; and our operational flexibility as a result of (among other factors):
•our expectations regarding the potential impacts on our business of the novel coronavirus (“COVID-19”) pandemic, including supply chain disruptions, the economic and public health effects, and governmental and other responses to these impacts;
•our expectations regarding the potential impacts on our business of actual or potential inflationary pressures, interest rate and risk premium adjustments, falling consumer sentiment, or economic recession caused, directly or indirectly, by the prolonged Ukraine/Russia conflict, the COVID-19 pandemic, geopolitical tensions, catastrophic events including as a result of climate change and other macroeconomic factors;
•our expectations regarding our effective tax rate and our unrecognized tax benefit;
•our ability to operate our business in accordance with our business plan;
•risks inherent in doing business on an international level, including currency risks, regulatory requirements, political risks, export restrictions and other trade barriers;
•projected growth rates in the overall semiconductor industry, the semiconductor assembly equipment market, and the market for semiconductor packaging materials; and
•projected demand for our products and services.
Generally, words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” “goal” and “believe,” or the negative of or other variations on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this filing. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
Forward-looking statements are based on current expectations and involve risks and uncertainties. Our future results could differ significantly from those expressed or implied by our forward-looking statements. These risks and uncertainties include, without limitation, those described below and under the heading “Risk Factors” in the Original Form 10-K and our other reports and registration statements filed from time to time with the Securities and Exchange Commission. This discussion should be read in conjunction with our audited financial statements included in this Form 10-K/A.
We operate in a rapidly changing and competitive environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. Future events and actual results, performance and achievements could differ materially from those set forth in, contemplated by or underlying the forward-looking statements, which speak only as of the date on which they were made. Except as required by law, we assume no obligation to update or revise any forward-looking statement to reflect actual results or changes in, or additions to, the factors affecting such forward-looking statements. Given those risks and uncertainties, investors should not place undue reliance on forward-looking statements as predictions of actual results.
This section of this Form 10-K/A generally discusses fiscal 2022 and 2021 items and year-to-year comparisons between fiscal 2022 and 2021. Discussions of fiscal 2020 items and year-to-year comparisons between fiscal 2021 and 2020 that are not included in this Form 10-K/A can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the fiscal year ended October 2, 2021, which was filed with the SEC on November 18, 2021.
Our Management's Discussion and Analysis (“MD&A”) is provided in addition to the accompanying consolidated financial statements and notes to assist readers in understanding our results of operations, financial condition, and cash flows. The MD&A is organized as follows:
15

Table of Contents
•Overview: Introduction of our operations, key events, business environment, technology leadership, products and services
•Critical Accounting Policies and Estimates
•Recent Accounting Pronouncements
•Results of Operations
•Liquidity and Capital Resources
•Other Obligations and Contingent Payments
Overview
For an overview of our business, see “Part I – Item 1. – Business” in the Original Form 10-K.
Critical Accounting Policies and Estimates
The preparation of consolidated financial statements requires us to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. On an ongoing basis, we evaluate estimates, including, but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, income taxes, equity-based compensation expense and warranties. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable. As a result, we make judgments regarding the carrying values of our assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, we evaluate these estimates. Actual results may differ from these estimates.
We believe the following critical accounting policies, which have been reviewed with the Audit Committee of our Board of Directors, reflect our more significant judgments and estimates used in the preparation of our consolidated financial statements.
Revenue Recognition
In accordance with ASC No. 606, Revenue from Contracts with Customers, the Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay.
The Company recognizes revenue from sales of our products, including sales to our distributors, at a point in time, generally upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order. Control is considered transferred when title and risk of loss pass, when the customer becomes obligated to pay and, where applicable, when the customer has accepted the products or upon expiration of the acceptance period. For sales to distributors, payment is due on our standard commercial terms and is not contingent upon resale of the products.
Our business is subject to contingencies related to customer orders, including:
•Right of Return: A large portion of our revenue comes from the sale of equipment used in the semiconductor assembly process. Other product sales relate to consumable products, which are sold in high-volume quantities, and are generally maintained at low stock levels at the customer’s facility. Customer returns have historically represented a very small percentage of customer sales on an annual basis.
•Warranties: Our equipment is generally shipped with a one-year warranty against manufacturing defects. We establish reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management’s estimate of future expenses, including product parts replacement, freight charges and labor costs expected to be incurred to correct product failures during the warranty period.
•Conditions of Acceptance: Sales of our consumable products generally do not have customer acceptance terms. In certain cases, sales of our equipment have customer acceptance clauses which may require the equipment to perform in accordance with customer specifications or when installed at the customer’s facility. In such cases, if the terms of acceptance are satisfied at our facility prior to shipment, the revenue for the equipment will be recognized upon shipment. If the terms of acceptance are satisfied at our customers’ facilities, the revenue for the equipment will not be recognized until acceptance, which is typically obtained after installation and testing, is received from the customer.
Service revenue is generally recognized over time as the services are performed.
16

Table of Contents
The Company measures revenue based on the amount of consideration we expect to be entitled to in exchange for products or services. Any variable consideration such as sales incentives are recognized as a reduction of net revenue at the time of revenue recognition.
The length of time between invoicing and payment is not significant under our payment terms. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined our contracts generally do not include a significant financing component. Shipping and handling costs billed to customers are recognized in net revenue.
Shipping and handling costs paid by the Company are included in cost of sales.
Allowance for Doubtful Accounts
We maintain allowances for doubtful accounts for estimated losses resulting from our customers’ failure to make required payments. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We are subject to concentrations of customers and sales to a few geographic locations, which could also impact the collectability of certain receivables. If global or regional economic conditions deteriorate or political conditions were to change in some of the countries where we do business, it could have a significant impact on our results of operations, and our ability to realize the full value of our accounts receivable.
Inventories
Inventories are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. We generally provide reserves for obsolete inventory and for inventory considered to be in excess of demand. Demand is generally defined as 18 months forecasted future consumption for equipment, 24 months forecasted future consumption for spare parts, and 12 months forecasted future consumption for tools. Forecasted consumption is based upon internal projections, historical sales volumes, customer order activity and a review of consumable inventory levels at customers’ facilities. We communicate forecasts of our future consumption to our suppliers and adjust commitments to those suppliers accordingly. If required, we reserve the difference between the carrying value of our inventory and the lower of cost or net realizable value, based upon projections about future consumption, and market conditions. If actual market conditions are less favorable than projections, additional inventory reserves may be required.
Inventory reserve provision for certain subsidiaries is determined based on management’s estimate of future consumption for equipment and spare parts. This estimate is based on historical sales volumes, internal projections and market developments and trends.
Accounting for Impairment of Goodwill
ASC No. 350, Intangibles-Goodwill and Other requires goodwill and other intangible assets with indefinite lives to be reviewed for impairment annually, or more frequently if circumstances indicate a possible impairment. We assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, after assessing the qualitative factors, a company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying value, then performing the impairment test is unnecessary. However, if a company concludes otherwise, then it is required to perform the goodwill impairment test. The Company’s impairment test is performed by comparing the fair value of a reporting unit with its carrying value, and determining if the carrying amount exceeds its fair value.
As part of the annual evaluation, the Company performs an impairment test of its goodwill in the fourth quarter of each fiscal year to coincide with the completion of its annual forecasting and refreshing of its business outlook processes. On an ongoing basis, the Company monitors if a “triggering” event has occurred that may have the effect of reducing the fair value of a reporting unit below its respective carrying value. Adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment charge in the future.
Impairment assessments inherently involve judgment as to the assumptions made about the expected future cash flows and the impact of market conditions on those assumptions. Future events and changing market conditions may impact the assumptions as to prices, costs, growth rates or other factors that may result in changes in the estimates of future cash flows. Although the Company believes the assumptions that it has used in testing for impairment are reasonable, significant changes in any one of the assumptions could produce a significantly different result. Indicators of potential impairment, including significant and unforeseen customer losses, a significant adverse change in legal factors or in the business climate, a significant adverse action or assessment by a regulator, a significant stock price decline or unanticipated competition, may lead the Company to perform interim goodwill impairment assessments.
For further information on goodwill and other intangible assets, see Note 4 to our consolidated financial statements in Item 8.
17

Table of Contents
Income Taxes
In accordance with ASC No. 740, Income Taxes, deferred income taxes are determined using the balance sheet method. The Company records a valuation allowance to reduce its deferred tax assets to the amount expected, on a more likely than not basis, to be realized. While the Company has considered future taxable income and ongoing tax planning strategies in assessing the need for the valuation allowance, if it were to determine that it would be able to realize its deferred tax assets in the future in excess of its net recorded amount, an adjustment to deferred tax assets would increase income in the period when such determination is made. Likewise, should the Company determine that it would not be able to realize all or part of its deferred tax assets in the future, an adjustment to deferred tax assets would decrease income in the period when such determination is made.
The Company determines the amount of unrecognized tax benefit with respect to uncertain tax positions taken or expected to be taken on its income tax returns in accordance with ASC No. 740 Topic 10, Income Taxes, General (“ASC 740.10”). Under ASC 740.10, the Company utilizes a two-step approach for evaluating uncertain tax positions. Step one, or recognition, requires a company to determine if the weight of available evidence indicates a tax position is more likely than not to be sustained upon examination solely based on its technical merit. Step two, or measurement, is based on the largest amount of benefit, which is more likely than not to be realized on settlement with the taxing authority, including resolution of related appeals or litigation processes, if any.
Equity-Based Compensation
The Company accounts for equity-based compensation under the provisions of ASC No. 718, Compensation - Stock Compensation (“ASC 718”). ASC 718 requires the recognition of the fair value of the equity-based compensation in net income. Compensation expense associated with Relative TSR Performance Share Units is determined using a Monte-Carlo valuation model, and compensation expense associated with time-based and Growth Performance Share Units is determined based on the number of shares granted and the fair value on the date of grant. See Note 11 to our consolidated financial statements in Item 8 for a summary of the terms of these performance-based awards. The fair value of equity-based awards is amortized over the vesting period of the award and the Company elected to use the straight-line method for awards granted after the adoption of ASC 718.
RECENT ACCOUNTING PRONOUNCEMENTS
See Note 1 to our consolidated financial statements in Item 8 for a description of certain recent accounting pronouncements, including the expected dates of adoption and effects on our consolidated results of operations and financial condition.
RESULTS OF OPERATIONS
Results of Operations for fiscal 2022 and 2021
The following table reflects our income from operations for fiscal 2022 and 2021:

|  | Fiscal |  |  |  |
(dollar amounts in thousands) |  | 2022 |  | 2021 |  | $ Change |  | % Change
Net revenue |  | $ | 1,503,620 |  |  | $ | 1,517,664 |  |  | $ | (14,044) |  |  | (0.9) | %
Cost of sales |  | 755,300 |  |  | 820,678 |  |  | (65,378) |  |  | (8.0) | %
Gross profit |  | 748,320 |  |  | 696,986 |  |  | 51,334 |  |  | 7.4 | %
Selling, general and administrative |  | 141,396 |  |  | 147,061 |  |  | (5,665) |  |  | (3.9) | %
Research and development |  | 136,852 |  |  | 137,478 |  |  | (626) |  |  | (0.5) | %
Operating expenses |  | 278,248 |  |  | 284,539 |  |  | (6,291) |  |  | (2.2) | %
Income from operations |  | $ | 470,072 |  |  | $ | 412,447 |  |  | $ | 57,625 |  |  | 14.0 | %

18

Table of Contents
Bookings and Backlog
Our backlog consists of customer orders scheduled for shipment within the next twelve months. A booking is recorded when a customer order is reviewed and it is determined that all specifications can be met, production (or service) can be scheduled, a delivery date can be set, and the customer meets our credit requirements. We use bookings to evaluate the results of our operations, generate future operating plans and assess the performance of our Company. While we believe that this measure is useful in evaluating our business, this information should be considered as supplemental in nature and is not meant as a substitute for revenue recognized in accordance with GAAP. In addition, other companies, including companies in our industry, may calculate bookings differently or not at all, which reduces its usefulness as a comparative measure. Reconciliation of bookings to net revenue is not practicable. A majority of our orders are subject to cancellation or deferral by our customers with limited or no penalties. Also, customer demand for our products can vary dramatically without prior notice. Because of the volatility of customer demand, possibility of customer changes in delivery schedules or cancellations and potential delays in product shipments, our backlog as of any particular date may not be indicative of net revenue for any succeeding period.
The following tables reflect our bookings and backlog for fiscal 2022 and 2021:

| Fiscal
(in thousands) | 2022 |  | 2021
Bookings | $ | 1,226,524 |  |  | $ | 2,176,981 |
| As of
(in thousands) | October 1, 2022 |  | October 2, 2021
Backlog | $ | 510,145 |  |  | $ | 787,241 |

The semiconductor industry is volatile and our operating results are adversely impacted by volatile worldwide economic conditions. Though the semiconductor industry’s cycle can be independent of the general economy, global economic conditions may have a direct impact on demand for semiconductor units and ultimately demand for semiconductor capital equipment and expendable tools. Accordingly, our business and financial performance is impacted, both positively and negatively, by fluctuations in the macroeconomic environment. Our visibility into future demand is generally limited and forecasting is difficult. There can be no assurances regarding levels of demand for our products and we believe historical industry-wide volatility will persist.
The U.S. and several other countries have levied tariffs on certain goods. In particular, trade tensions between the U.S. and China have been escalating since 2018, with U.S. tariffs on Chinese goods and retaliatory Chinese tariffs on U.S. goods. These have resulted in uncertainties in the semiconductor, LED, memory and automotive markets. While the Company anticipates long-term growth in semiconductor consumption, we observed trade-related adverse impacts in demand from China from the fourth quarter of fiscal 2018 through fiscal 2022, and such impacts may increase in severity in fiscal 2023 and/or beyond.
Net Revenue
Our net revenues for fiscal 2022 decreased as compared to our net revenues for fiscal 2021. The decrease in net revenue is primarily due to lower volume in Ball Bonding Equipment, APS and All Others, partially offset by higher volume in Wedge Bonding Equipment and Advanced Solutions, as further outlined following the tables presented immediately below. Please refer to Note 16 for further information on the revision of the reportable and operating segments.
The following table reflects net revenue by reportable segments for fiscal 2022 and 2021:
19

Table of Contents

|  | Fiscal |  |  |  |
(dollar amounts in thousands) |  | 2022 |  | 2021 |  | $ Change |  | % Change
|  | Net revenue |  | % of total net revenue |  | Net revenue |  | % of total net revenue |  |  |  |
Ball Bonding Equipment |  | $ | 909,428 |  |  | 60.5 | % |  | $ | 1,016,663 |  |  | 67.0 | % |  | $ | (107,235) |  |  | (10.5) | %
Wedge Bonding Equipment |  | 194,086 |  |  | 12.9 | % |  | 138,836 |  |  | 9.2 | % |  | $ | 55,250 |  |  | 39.8 | %
Advanced Solutions |  | 94,683 |  |  | 6.3 | % |  | 35,123 |  |  | 2.3 | % |  | $ | 59,560 |  |  | 169.6 | %
APS |  | 197,152 |  |  | 13.1 | % |  | 205,088 |  |  | 13.5 | % |  | $ | (7,936) |  |  | (3.9) | %
All Others |  | 108,271 |  |  | 7.2 | % |  | 121,954 |  |  | 8.0 | % |  | $ | (13,683) |  |  | (11.2) | %
Total net revenue |  | $ | 1,503,620 |  |  | 100.0 | % |  | $ | 1,517,664 |  |  | 100.0 | % |  | $ | (14,044) |  |  | (0.9) | %

Ball Bonding Equipment
For fiscal 2022, the lower Ball Bonding Equipment net revenue as compared to fiscal 2021 was primarily due to lower volume. The lower volume was due to a decrease in customer investments as a result of uncertainties in the overall macroeconomic environment, partially offset by favorable price variance due to product mix.
Wedge Bonding Equipment
For fiscal 2022, the higher Wedge Bonding Equipment net revenue as compared to fiscal 2021 was primarily due to higher volume and favorable price variance due to product mix. The higher volume was due to an increase in customer investments mainly in the automotive and renewable energy market.
Advanced Solutions
For fiscal 2022, the higher Advanced Solutions net revenue as compared to fiscal 2021 was primarily due to higher volume mainly for thermocompression systems and solutions and the timing of revenue recognition for certain customer contracts.
APS
For fiscal 2022, the lower APS net revenue as compared to fiscal 2021 was primarily due to lower volume in spares, services and bonding tools. The lower volume was due to a decrease in customer utilization.
All Others
For fiscal 2022, the lower net revenue in the “All Others” category as compared to fiscal 2021 was primarily due to lower volume. The lower volume was due to a decrease in customer purchases primarily in mini LED transfer solutions market and the general semiconductor end markets.
Gross Profit Margin
The following table reflects gross profit as a percentage of net revenue by reportable segments for fiscal 2022 and 2021:

|  | Fiscal |  |
|  | 2022 |  | 2021 |  | Basis point change
Ball Bonding Equipment |  | 49.0 | % |  | 45.1 | % |  | 390 |
Wedge Bonding Equipment |  | 48.1 | % |  | 42.2 | % |  | 590 |
Advanced Solutions |  | 33.7 | % |  | 17.1 | % |  | 1,660 |
APS |  | 60.4 | % |  | 58.2 | % |  | 220 |
All Others |  | 54.5 | % |  | 45.4 | % |  | 910 |
Total gross margin |  | 49.8 | % |  | 45.9 | % |  | 390 |

20

Table of Contents
Ball Bonding Equipment
For fiscal 2022, the higher Ball Bonding Equipment gross profit margin as compared to fiscal 2021 was primarily driven by favorable price variance due to product mix (higher sales of higher margin products).
Wedge Bonding Equipment
For fiscal 2022, the higher Wedge Bonding Equipment gross profit margin as compared to fiscal 2021 was primarily driven by favorable price variance due to product mix (higher sales of higher margin products).
Advanced Solutions
For fiscal 2022, the higher Advanced Solutions gross profit margin as compared to fiscal 2021 was primarily driven by favorable price variance due to timing of revenue recognition for certain customer contracts.
APS
For fiscal 2022, the higher APS gross profit margin as compared to fiscal 2021 was primarily driven by favorable product mix in spares and services offset by less favorable price variance in bonding tools.
All Others
For fiscal 2022, the higher gross profit margin in the “All Others” category as compared to fiscal 2021 was primarily driven by favorable price variance due to product mix in the mini LED transfer solutions market and favorable customer mix in the general semiconductor end market.
Operating Expenses
The following table reflects operating expenses for fiscal 2022 and 2021:

|  | Fiscal |  |  |  |
(dollar amounts in thousands) |  | 2022 |  | 2021 |  | $ Change |  | % Change
Selling, general and administrative |  | $ | 141,396 |  |  | $ | 147,061 |  |  | $ | (5,665) |  |  | (3.9) | %
Research and development |  | 136,852 |  |  | 137,478 |  |  | $ | (626) |  |  | (0.5) | %
Total |  | $ | 278,248 |  |  | $ | 284,539 |  |  | $ | (6,291) |  |  | (2.2) | %

Selling, General and Administrative (“SG&A”)
For fiscal 2022, the lower SG&A expenses as compared to fiscal 2021 was primarily due to $7.1 million net favorable variance in foreign exchange. This was partially offset by a $2.0 million COVID-19 related grant received from the Singapore government in the prior year period.
Research and Development (“R&D”)
For fiscal 2022, the lower R&D expenses as compared to fiscal 2021 was primarily due to lower staff costs related to incentive compensation. This is partially offset by higher spending on prototype materials.
21

Table of Contents
Income from Operations
For fiscal 2022, total income from operations was higher as compared to fiscal 2021. This was primarily due to higher gross profit and lower operating expenses in fiscal 2022.
The following tables reflect income/(loss) from operations by reportable segments for fiscal 2022 and 2021:

|  | Fiscal |  |  |  |
(dollar amounts in thousands) |  | 2022 |  | 2021 |  | $ Change |  | % Change
Ball Bonding Equipment |  | $ | 385,276 |  |  | $ | 401,450 |  |  | $ | (16,174) |  |  | (4.0) | %
Wedge Bonding Equipment |  | 66,649 |  |  | 34,563 |  |  | 32,086 |  |  | 92.8 | %
Advanced Solutions |  | (15,389) |  |  | (40,759) |  |  | 25,370 |  |  | 62.2 | %
APS |  | 82,473 |  |  | 75,400 |  |  | 7,073 |  |  | 9.4 | %
All Others |  | 25,732 |  |  | 20,565 |  |  | 5,167 |  |  | 25.1 | %
Corporate Expenses |  | (74,669) |  |  | (78,772) |  |  | 4,103 |  |  | 5.2 | %
Total income from operations |  | $ | 470,072 |  |  | $ | 412,447 |  |  | $ | 57,625 |  |  | 14.0 | %

Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, APS and All Others
For the fiscal year 2022, the higher Wedge Bonding Equipment, All Others and APS income from operations and the lower Advanced Solutions loss from operations as compared to the prior year period was primarily due to the changes in revenue and operating expenses as explained under “Net Revenue” and “Operating Expenses” above. For Ball Bonding Equipment, the lower income from operations was primarily due to the changes in revenue as explained under “Net Revenue” above.
Interest Income and Expense
The following table reflects interest income and interest expense for fiscal 2022 and 2021:

|  | Fiscal |  |  |  |
(dollar amounts in thousands) |  | 2022 |  | 2021 |  | $ Change |  | % Change
Interest income |  | $ | 7,124 |  |  | $ | 2,321 |  |  | $ | 4,803 |  |  | 206.9 | %
Interest expense |  | $ | (208) |  |  | $ | (218) |  |  | $ | 10 |  |  | 4.6 | %

Interest income
For fiscal 2022, the higher interest income as compared to fiscal 2021 was primarily due to higher weighted average interest rates on cash, cash equivalents and short-term investments.
Interest expense
For fiscal 2022, the lower interest expense as compared to fiscal 2021 was primarily due to lower levels of average short-term debt outstanding. Please refer to Note 10: Debt and Other Obligations to our consolidated financial statements in Item 8 for a discussion of the Overdraft Facility.
Provision for Income Taxes
The following table reflects the provision for income taxes and the effective tax rate for fiscal 2022 and 2021:

|  | Fiscal |  |
(dollar amounts in thousands) |  | 2022 |  | 2021 |  | Change
Provision for income taxes |  | $ | 43,443 |  |  | $ | 47,295 |  |  | $ | (3,852) |
Effective tax rate |  | 9.1 | % |  | 11.4 | % |  | (2.3) | %

For fiscal 2022, the lower effective tax rate as compared to fiscal 2021 is primarily due to tax benefits from foreign exchange losses and increase in tax credits generated during the fiscal year.
Please refer to Note 15: Income Taxes to our consolidated financial statements in Item 8.
22

Table of Contents
LIQUIDITY AND CAPITAL RESOURCES
The following table reflects total cash, cash equivalents and short-term investments as of October 1, 2022 and October 2, 2021:

|  | As of |  |
(dollar amounts in thousands) |  | October 1, 2022 |  | October 2, 2021 |  | Change
Cash and cash equivalents |  | $ | 555,537 |  |  | $ | 362,788 |  |  | $ | 192,749 |
Short-term investments |  | 220,000 |  |  | 377,000 |  |  | (157,000) |
Total cash, cash equivalents, and short-term investments |  | $ | 775,537 |  |  | $ | 739,788 |  |  | $ | 35,749 |
Percentage of total assets |  | 48.8 | % |  | 46.2 | % |  |

The following table reflects summary Consolidated Statements of Cash Flows information for fiscal 2022 and 2021:

|  | Fiscal
(in thousands) |  | 2022 |  | 2021
Net cash provided by operating activities |  | $ | 390,188 |  |  | $ | 300,032 |
Net cash provided by / (used in) investing activities |  | 133,799 |  |  | (81,707) |
Net cash used in financing activities |  | (321,191) |  |  | (44,258) |
Effect of exchange rate changes on cash and cash equivalents |  | (10,047) |  |  | 594 |
Changes in cash, and cash equivalents |  | $ | 192,749 |  |  | $ | 174,661 |
Cash and cash equivalents, beginning of period |  | 362,788 |  |  | 188,127 |
Cash and cash equivalents, end of period |  | $ | 555,537 |  |  | $ | 362,788 |

Fiscal 2022
Net cash provided by operating activities consisted of net income of $433.5 million, non-cash adjustments of $22.6 million and a net unfavorable change in operating assets and liabilities of $65.9 million. The net change in operating assets and liabilities was primarily driven by a decrease in accounts payable and accrued expenses and other current liabilities of $128.7 million, and an increase in prepaid expenses and other current assets of $37.9 million and inventories of $14.9 million. This was partially offset by a decrease in accounts and notes receivable of $113.3 million and income tax payable of $4.9 million.
The decrease in accounts payable and accrued expenses and other current liabilities was primarily due to lower purchases in the fourth quarter of fiscal 2022, lower accrued employee compensation, accrued customer obligations and accrued commissions. The increase in prepaid expenses and other current assets was mainly due to the addition of contract assets in fiscal 2022. The increase in inventories was due to increased manufacturing activities to meet higher demand in the first half of fiscal 2022 followed by slower utilization due to lower demand in the second half of fiscal 2022. The decrease in accounts and notes receivable was due to lower sales in the fourth quarter of fiscal 2022 and a change in customer mix of different credit terms.
The net cash provided by investing activities was primarily due to net maturity of short-term investments of $157.0 million, partially offset by capital expenditures of $23.0 million.
The net cash used in financing activities was primarily due to common stock repurchases of $281.3 million and dividend payments of $39.4 million.
Fiscal 2021
Net cash provided by operating activities consisted of net income of $367.2 million, non-cash adjustments of $21.2 million and a net unfavorable change in operating assets and liabilities of $88.3 million. The net change in operating assets and liabilities was primarily driven by an increase in accounts and notes receivable of $221.9 million, inventories of $52.7 million, and prepaid expenses and other current assets of $4.6 million. This was partially offset by an increase in accounts payable and accrued expenses and other current liabilities of $182.0 million, and income tax payable of $7.7 million.
The increase in accounts payable and accrued expenses and other current liabilities was primarily due to higher purchases due to higher manufacturing activities. The increase in inventories was due to increased manufacturing activities in fiscal 2021 in response to increased sales. The increase in accounts receivable was due to higher sales.
The net cash used in investing activities was primarily due to net purchases of short-term investments of $35.0 million, the Uniqarta acquisition of $26.3 million, and capital expenditures of $22.8 million, partially offset by proceeds from the sale of an equity-method investment of $2.1 million.
23

Table of Contents
The net cash used in financing activities was primarily due to dividend payments of $33.5 million, and common stock repurchases of $10.4 million.
24

Table of Contents
Fiscal 2023 Liquidity and Capital Resource Outlook
We expect our fiscal 2023 capital expenditures to be between $70.0 million and $74.0 million. The actual amounts for fiscal 2023 will vary depending on market conditions. Expenditures are anticipated to be primarily used for research and development projects, enhancements to our manufacturing operations, improvements to our information technology security, implementation of an enterprise resource planning system and leasehold improvements for our facilities. Our ability to make these expenditures will depend, in part, on our future cash flows, which are determined by our future operating performance and, therefore, subject to prevailing macroeconomic conditions, including the impact from the COVID-19 pandemic, inflationary pressures, geopolitical tensions including the prolonged Ukraine/Russia conflict and other factors, some of which are beyond our control.
As of October 1, 2022 and October 2, 2021, approximat ely $499.8 million and $724.5 million of cash, cash equivalents, and short-term investments were held by the Company’s foreign subsidiaries, respectively, with a large portion of the cash amounts expected to be available for use in the U.S. without incurring additional U.S. income tax. The decrease is primarily due to the repatriation of cash held by the Company’s foreign subsidiaries to the U.S.
The Company’s international operations and capital requirements are funded primarily by cash generated by foreign operating activities and cash held by foreign subsidiaries. In fiscal 2022, the Company’s U.S. operations and capital requirements have been funded primarily by cash generated from U.S. operating activities, cash held by U.S. entities, and cash previously held by foreign subsidiaries that was repatriated to the U.S. entities during the fiscal year. In the future, the Company may repatriate additional cash held by foreign subsidiaries that has already been subject to U.S. income tax or drawdown cash from our existing Facility Agreements. We believe these sources of cash and liquidity are sufficient to meet our additional liquidity needs for the foreseeable future including repayment of outstanding balances under the Facility Agreements, as well as payment of dividends, share repurchases and income taxes. Should the Company’s U.S. cash needs exceed its funds generated by U.S. and foreign operations due to changing business conditions or transactions outside the ordinary course, such as acquisitions of large capital assets, businesses or any other capital appropriation in the U.S., the Company may require additional financing in the U.S. In this event, the Company could seek U.S. borrowing alternatives.
We believe that our existing cash, cash equivalents, short-term investments, existing Facility Agreements, and anticipated cash flows from operations will be sufficient to meet our liquidity and capital requirements, notwithstanding the COVID-19 pandemic and macroeconomic headwinds, for the next twelve months and beyond. Our liquidity is affected by many factors, some based on normal operations of our business and others related to macroeconomic conditions including inflationary pressures, industry-related uncertainties, effects arising from the prolonged Ukraine/Russia conflict, which we cannot predict. We also cannot predict economic conditions and industry downturns or the timing, strength or duration of recoveries. We intend to continue to use our cash for working capital needs and for general corporate purposes.
In this unprecedented environment, as a result of the COVID-19 pandemic, the prolonged Ukraine/Russia conflict or for other reasons, we may seek, as we believe appropriate, additional debt or equity financing which would provide capital for corporate purposes, working capital funding, additional liquidity needs or to fund future growth opportunities, including possible acquisitions. The timing and amount of potential capital requirements cannot be determined at this time and will depend on a number of factors, including our actual and projected demand for our products, semiconductor and semiconductor capital equipment industry conditions, competitive factors, the condition of financial markets and the global economic situation.
Share Repurchase Program
On August 15, 2017, the Company’s Board of Directors authorized a program (the “Program”) to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018, 2019 and 2020, the Board of Directors increased the share repurchase authorization under the Program to $200 million, $300 million and $400 million, respectively. On March 3, 2022, the Board of Directors increased the share repurchase authorization under the Program by an additional $400 million to $800 million, and extended its duration through August 1, 2025. The Company has entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. The Program may be suspended or discontinued at any time and is funded using the Company’s available cash, cash equivalents and short-term investments. Under the Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations.
During the fiscal year ended October 1, 2022, the Company repurchased a total of approximately 2,782.1 thousand shares of common stock at a cost of approximately $132.8 million. The stock repurchases were recorded in the periods they were delivered and accounted for as treasury stock in the Company’s Consolidated Balance Sheets. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon re-issuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If the Company reissues treasury stock at an amount
25

Table of Contents
below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings.
Accelerated Share Repurchase (“ASR”)
In addition to the 2,782.1 thousand shares of common stock repurchased under the Program during the fiscal year ended October 1, 2022, on March 9, 2022, the Company entered into an ASR agreement (the “March 2022 ASR Agreement”) with an investment bank counterparty (“Dealer”) to repurchase $150 million of the Company’s common stock. The March 2022 ASR Agreement was entered into pursuant to the Company’s current $800 million share repurchase authorization.
Under the March 2022 ASR Agreement, the Company made an up-front payment of $150 million to the Dealer and received an initial delivery of 2,449.9 thousand shares of common stock at a cost of approximately $120 million on March 10, 2022. The final number of shares to be repurchased will be based on the volume-weighted average price of the Company’s common stock during the term of the transaction, less a discount and subject to adjustments pursuant to the terms and conditions of the March 2022 ASR Agreement. For accounting purposes, the March 2022 ASR Agreement is evaluated as an unsettled forward contract indexed to the Company’s own stock, with $30 million being classified within common stock. At settlement, the Dealer may be required to deliver additional shares of common stock to the Company, or, under certain circumstances, the Company may be required to deliver shares of its common stock or may elect to make a cash payment to the Dealer.
The March 2022 ASR Agreement was settled between the Company and the Dealer on April 22, 2022 and the Company received an additional 344.5 thousand shares of common stock from the Dealer. In total, an aggregate of 2,794.4 thousand shares of common stock were delivered by the Dealer under the March 2022 ASR Agreement at an average price of $53.68 per share, which was then reclassified as treasury stock from common stock in shareholder’s equity. As of October 1, 2022, our remaining stock repurchase authorization under the Program was approximately $249.2 million.
Dividends
On August 30, 2022, June 8, 2022, March 3, 2022 and October 18, 2021, the Board of Directors declared a quarterly dividend $0.17 per share of common stock. During the fiscal year ended October 1, 2022, the Company declared dividends of $0.68 per share of common stock. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company’s financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company’s stockholders.
Other Obligations and Contingent Payments
In accordance with U.S. generally accepted accounting principles, certain obligations and commitments as of October 1, 2022 are appropriately not included in the Consolidated Balance Sheets and Statements of Operations in this Form 10-K/A. However, because these obligations and commitments are entered into in the normal course of business and because they may have a material impact on our liquidity, we have disclosed them in the table below.
Additionally, as of October 1, 2022, the Company had deferred tax liabilities of $34.0 million and unrecognized tax benefit recorded within the income tax payable for uncertain tax positions of $16.9 million, including related accrued interest of $2.0 million. These amounts are not included in the contractual obligation table below because we are unable to reasonably estimate the timing of these payments at this time.
The following table presents certain payments due by the Company under contractual obligations with minimum firm commitments as of October 1, 2022:

|  |  |  | Payments due in
(in thousands) |  | Total |  | Less than 1 year |  | 1 - 3 years |  | 3 - 5 years |  | More than 5 years
Inventory purchase obligations (1) |  | $ | 316,123 |  |  | 316,123 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
U.S. one-time transition tax payable (2) (reflected on our Balance Sheets) |  | 54,408 |  |  | 6,723 |  |  | 29,414 |  |  | 18,271 |  |  | — |
Total |  | $ | 370,531 |  |  | $ | 322,846 |  |  | $ | 29,414 |  |  | $ | 18,271 |  |  | $ | — |

(1)We order inventory components in the normal course of our business. A portion of these orders are non-cancellable and a portion may have varying penalties and charges in the event of cancellation.
(2)Associated with the U.S. one-time transition tax on certain earnings and profits of our foreign subsidiaries in relation to the TCJA.
26

Table of Contents
Credit Facilities
On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company and one of its subsidiaries with an overdraft facility of up to $150.0 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the Secured Overnight Financing Rate (“SOFR”) plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of two of its subsidiaries (the “Subsidiaries”), or encumber its assets with material security interests (including any pledge of monies in the Subsidiaries’ cash deposit account with the Bank). The Facility Agreements also contain customary events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other material indebtedness of the Company and any breach of a representation or warranty under the Facility Agreements. As of October 1, 2022, there were no outstanding amounts under the Overdraft Facility.
As of October 1, 2022, other than the bank guarantee disclosed in Note 10, we did not have any other off-balance sheet arrangements, such as contingent interests or obligations associated with variable interest entities.
27

Table of Contents
PART II
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The consolidated financial statements of Kulicke and Soffa Industries, Inc. listed in the index appearing under Item 15(a)(1) herein are filed as part of this Report under this Item 8.
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Kulicke and Soffa Industries, Inc.
Opinions on the Financial Statements and Internal Control Over Financial Reporting
We have audited the accompanying consolidated balance sheets of Kulicke and Soffa Industries, Inc. and its subsidiaries (the “Company”) as of October 1, 2022 and October 2, 2021, and the related consolidated statements of operations, of comprehensive income, of changes in shareholders’ equity and of cash flows for each of the three years in the period ended October 1, 2022, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended October 1, 2022 appearing under Item 15(a)(2) (collectively referred to as the “consolidated financial statements”). We also have audited the Company’s internal control over financial reporting as of October 1, 2022, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of October 1, 2022 and October 2, 2021, and the results of its operations and its cash flows for each of the three years in the period ended October 1, 2022 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company did not maintain, in all material respects, effective internal control over financial reporting as of October 1, 2022, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO because a material weakness in internal control over financial reporting existed as of that date related to a design gap in the existing review of the segment reporting process, which failed to (a) identify all of the key metrics used by the CODM to evaluate performance and allocate resources, (b) assess in totality the level of information provided to and utilized by the CODM to evaluate performance and allocate resources and (c) appropriately analyze every factor pertinent to whether operating segments share economic similarities that are required for aggregation under ASC 280.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness referred to above is described in Management’s Report on Internal Control Over Financial Reporting appearing under Item 9A. We considered this material weakness in determining the nature, timing, and extent of audit tests applied in our audit of the 2022 consolidated financial statements, and our opinion regarding the effectiveness of the Company’s internal control over financial reporting does not affect our opinion on those consolidated financial statements.
Restatement of Management’s Conclusion Regarding Internal Control Over Financial Reporting
Management and we previously concluded that the Company maintained effective internal control over financial reporting as of October 1, 2022. However, management has subsequently determined that a material weakness in internal control over financial reporting existed as of that date related to a design gap in the existing review of the segment reporting process, which failed to (a) identify all of the key metrics used by the CODM to evaluate performance and allocate resources, (b) assess in totality the level of information provided to and utilized by the CODM to evaluate performance and allocate resources and (c) appropriately analyze every factor pertinent to whether operating segments share economic similarities that are required for aggregation under ASC 280. Accordingly, management’s report has been restated and our present opinion on internal control over financial reporting, as presented herein, is different from that expressed in our previous report.
28

Table of Contents
Basis for Opinions
The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in management’s report referred to above. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Valuation of inventories - Reserves for excess and obsolete raw materials
As described in Notes 1 and 2 to the consolidated financial statements, the Company’s consolidated net inventory balance was $185.0 million. The Company generally provides reserves for obsolete inventory and for inventory considered to be in excess of demand. Demand is generally defined as forecasted future consumption for inventories, and is based upon internal projections, historical sales volumes, customer order activity and a review of consumable inventory levels at customers’ facilities.
29

Table of Contents
The principal considerations for our determination that performing procedures relating to the valuation of inventories, specifically the reserves for excess and obsolete raw materials, is a critical audit matter are our assessment that this is an area of significant judgment by management when developing reserves for excess and obsolete raw materials, including developing the assumption related to forecasted future consumption for raw materials. This has in turn led to significant auditor judgment, subjectivity, and effort in performing procedures and evaluating management’s assumptions over the reasonableness of the significant assumptions related to the forecasted future consumption for raw materials.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s reserves for excess and obsolete raw materials, including controls over management’s assumption related to forecasted future consumption for raw materials. These procedures also included, among others, testing management’s process for developing the reserves for excess or obsolete raw materials; evaluating the appropriateness of management’s approach; testing the completeness and accuracy of underlying data used in the approach; and evaluating the reasonableness of management’s assumption related to forecasted future consumption for raw materials. Evaluating management’s assumption related to forecasted future consumption for raw materials involved evaluating whether the assumption used by management was reasonable considering (i) current and past sales results, (ii) the consistency of sales with external market and industry data, and (iii) comparing prior year estimates of sales to actual sales results in the current year.
/s/ PricewaterhouseCoopers LLP
Singapore
November 17, 2022, except for the effects of the revision discussed in Notes 4 and 16 to the consolidated financial statements and with respect to our opinion on internal control over financial reporting insofar as it relates to the effects of the matter discussed in the fourth paragraph of Management’s Report on Internal Control Over Financial Reporting, as to which the date is August 8, 2023.
We have served as the Company’s auditor since 2011.
30

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amount)

|  | As of
|  | October 1, 2022 |  | October 2, 2021
ASSETS |  |  |  |
Current assets: |  |  |  |
Cash and cash equivalents |  | $ | 555,537 |  |  | $ | 362,788 |
Short-term investments |  | 220,000 |  |  | 377,000 |
Accounts and notes receivable, net of allowance for doubtful accounts of $0 and $687, respectively |  | 309,323 |  |  | 421,193 |
Inventories, net |  | 184,986 |  |  | 167,323 |
Prepaid expenses and other current assets |  | 62,200 |  |  | 23,586 |
Total current assets |  | 1,332,046 |  |  | 1,351,890 |
Property, plant and equipment, net |  | 80,908 |  |  | 67,982 |
Operating right-of-use assets |  | 41,767 |  |  | 41,592 |
Goodwill |  | 68,096 |  |  | 72,949 |
Intangible assets, net |  | 31,939 |  |  | 42,752 |
Deferred tax assets |  | 25,572 |  |  | 15,715 |
Equity investments |  | 5,397 |  |  | 6,388 |
Other assets |  | 2,874 |  |  | 2,363 |
TOTAL ASSETS |  | $ | 1,588,599 |  |  | $ | 1,601,631 |
LIABILITIES AND SHAREHOLDERS' EQUITY |  |  |  |
Current liabilities: |  |  |  |
Accounts payable |  | 67,311 |  |  | 154,636 |
Operating lease liabilities |  | 6,766 |  |  | 4,903 |
Accrued expenses and other current liabilities |  | 134,541 |  |  | 161,570 |
Income taxes payable |  | 40,063 |  |  | 30,766 |
Total current liabilities |  | 248,681 |  |  | 351,875 |
Deferred tax liabilities |  | 34,037 |  |  | 32,828 |
Income taxes payable |  | 64,634 |  |  | 69,422 |
Operating lease liabilities |  | 34,927 |  |  | 38,084 |
Other liabilities |  | 11,670 |  |  | 14,185 |
TOTAL LIABILITIES |  | $ | 393,949 |  |  | $ | 506,394 |
Commitments and contingent liabilities (Note 17) |  |  |  |
SHAREHOLDERS' EQUITY: |  |  |  |
Preferred stock, without par value: |  |  |  |
Authorized 5,000 shares; issued - none |  | $ | — |  |  | $ | — |
Common stock, no par value: |  |  |  |
Authorized 200,000 shares; issued 85,364 and 85,364 respectively; outstanding 57,128 and 61,931 shares, respectively |  | 561,684 |  |  | 550,117 |
Treasury stock, at cost, 28,237 and 23,433 shares, respectively |  | (675,800) |  |  | (400,412) |
Retained earnings |  | 1,341,666 |  |  | 948,554 |
Accumulated other comprehensive loss |  | (32,900) |  |  | (3,022) |
TOTAL SHAREHOLDERS' EQUITY |  | $ | 1,194,650 |  |  | $ | 1,095,237 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |  | $ | 1,588,599 |  |  | $ | 1,601,631 |

The accompanying notes are an integral part of these consolidated financial statements.
31

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)

|  |  |  | Fiscal
|  |  |  |  |  | 2022 |  | 2021 |  | 2020
Net revenue |  |  |  |  |  | $ | 1,503,620 |  |  | $ | 1,517,664 |  |  | $ | 623,176 |
Cost of sales |  |  |  |  |  | 755,300 |  |  | 820,678 |  |  | 325,201 |
Gross profit |  |  |  |  |  | 748,320 |  |  | 696,986 |  |  | 297,975 |
Selling, general and administrative |  |  |  |  |  | 141,396 |  |  | 147,061 |  |  | 116,007 |
Research and development |  |  |  |  |  | 136,852 |  |  | 137,478 |  |  | 123,459 |
Operating expenses |  |  |  |  |  | 278,248 |  |  | 284,539 |  |  | 239,466 |
Income from operations |  |  |  |  |  | 470,072 |  |  | 412,447 |  |  | 58,509 |
Interest income |  |  |  |  |  | 7,124 |  |  | 2,321 |  |  | 7,541 |
Interest expense |  |  |  |  |  | (208) |  |  | (218) |  |  | (1,716) |
Income before income taxes |  |  |  |  |  | 476,988 |  |  | 414,550 |  |  | 64,334 |
Provision for income taxes |  |  |  |  |  | 43,443 |  |  | 47,295 |  |  | 11,998 |
Share of results of equity-method investee, net of tax |  |  |  |  |  | — |  |  | 94 |  |  | 36 |
Net income |  |  |  |  |  | $ | 433,545 |  |  | $ | 367,161 |  |  | $ | 52,300 |
Net income per share: |  |  |  |  |  |  |  |  |  |
Basic |  |  |  |  |  | $ | 7.21 |  |  | $ | 5.92 |  |  | $ | 0.83 |
Diluted |  |  |  |  |  | $ | 7.09 |  |  | $ | 5.78 |  |  | $ | 0.83 |
Weighted average shares outstanding: |  |  |  |  |  |  |  |  |  |
Basic |  |  |  |  |  | 60,164 |  |  | 62,009 |  |  | 62,828 |
Diluted |  |  |  |  |  | 61,182 |  |  | 63,515 |  |  | 63,359 |

The accompanying notes are an integral part of these consolidated financial statements.
32

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)

|  |  | Fiscal
|  |  |  |  | 2022 |  | 2021 |  | 2020
Net income |  |  |  |  | $ | 433,545 |  |  | $ | 367,161 |  |  | $ | 52,300 |
Other comprehensive income / (loss): |  |  |  |  |  |  |  |  |
Foreign currency translation adjustment |  |  |  |  | (30,536) |  |  | 672 |  |  | 7,755 |
Unrecognized actuarial gain / (loss) on pension plan, net of tax |  |  |  |  | 2,276 |  |  | — |  |  | (1,490) |
|  |  |  |  | (28,260) |  |  | 672 |  |  | 6,265 |
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |  |
Unrealized (loss) / gain on derivative instruments, net of tax |  |  |  |  | (2,694) |  |  | 24 |  |  | 358 |
Reclassification adjustment for loss / (gain) on derivative instruments recognized, net of tax |  |  |  |  | 1,076 |  |  | (1,197) |  |  | 796 |
Net (decrease) / increase from derivatives designated as hedging instruments, net of tax |  |  |  |  | (1,618) |  |  | (1,173) |  |  | 1,154 |
Total other comprehensive (loss) / income |  |  |  |  | (29,878) |  |  | (501) |  |  | 7,419 |
Comprehensive income |  |  |  |  | $ | 403,667 |  |  | $ | 366,660 |  |  | $ | 59,719 |

The accompanying notes are an integral part of these consolidated financial statements.
33

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(in thousands)

| Common Stock |  | Treasury Stock |  | Retained earnings |  | Accumulated Other Comprehensive (loss) / income |  | Shareholders' Equity
| Shares |  | Amount |  |  |  |
Balances as of September 28, 2019 | 63,173 |  |  | $ | 533,590 |  |  | $ | (349,212) |  |  | $ | 594,625 |  |  | $ | (9,940) |  |  | $ | 769,063 |
Issuance of stock for services rendered | 37 |  |  | 491 |  |  | 359 |  |  | — |  |  | — |  |  | 850 |
Repurchase of common stock | (2,486) |  |  | — |  |  | (55,001) |  |  | — |  |  | — |  |  | (55,001) |
Issuance of shares for equity-based compensation | 834 |  |  | (9,037) |  |  | 9,037 |  |  | — |  |  | — |  |  | — |
Equity-based compensation | — |  |  | 14,169 |  |  | — |  |  | — |  |  | — |  |  | 14,169 |
Cumulative effect of accounting changes | — |  |  | — |  |  | — |  |  | (769) |  |  | — |  |  | (769) |
Cash dividend declared | — |  |  | — |  |  | — |  |  | (30,037) |  |  | — |  |  | (30,037) |
Components of comprehensive income: |  |  |  |  |  |  |  |  |  |  |
Net income | — |  |  | — |  |  | — |  |  | 52,300 |  |  | — |  |  | 52,300 |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 7,419 |  |  | 7,419 |
Total comprehensive income | — |  |  | — |  |  | — |  |  | 52,300 |  |  | 7,419 |  |  | 59,719 |
Balances as of October 3, 2020 | 61,558 |  |  | $ | 539,213 |  |  | $ | (394,817) |  |  | $ | 616,119 |  |  | $ | (2,521) |  |  | $ | 757,994 |
Issuance of stock for services rendered | 23 |  |  | 616 |  |  | 202 |  |  | — |  |  | — |  |  | 818 |
Repurchase of common stock | (215) |  |  | — |  |  | (10,182) |  |  | — |  |  | — |  |  | (10,182) |
Issuance of shares for equity-based compensation | 565 |  |  | (4,385) |  |  | 4,385 |  |  | — |  |  | — |  |  | — |
Equity-based compensation | — |  |  | 14,673 |  |  | — |  |  | — |  |  | — |  |  | 14,673 |
Cash dividend declared | — |  |  | — |  |  | — |  |  | (34,726) |  |  | — |  |  | (34,726) |
Components of comprehensive income: |  |  |  |  |  |  |  |  |  |  |
Net income | — |  |  | — |  |  | — |  |  | 367,161 |  |  | — |  |  | 367,161 |
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (501) |  |  | (501) |
Total comprehensive income/(loss) | — |  |  | — |  |  | — |  |  | 367,161 |  |  | (501) |  |  | 366,660 |
Balances as of October 2, 2021 | 61,931 |  |  | $ | 550,117 |  |  | $ | (400,412) |  |  | $ | 948,554 |  |  | $ | (3,022) |  |  | $ | 1,095,237 |
Issuance of stock for services rendered | 18 |  |  | 774 |  |  | 175 |  |  | — |  |  | — |  |  | 949 |
Repurchase of common stock | (5,576) |  |  | — |  |  | (282,807) |  |  | — |  |  | — |  |  | (282,807) |
Issuance of shares for equity-based compensation | 755 |  |  | (7,244) |  |  | 7,244 |  |  | — |  |  | — |  |  | — |
Equity-based compensation | — |  |  | 18,037 |  |  |  |  | — |  |  | — |  |  | 18,037 |
Cash dividend declared | — |  |  | — |  |  | — |  |  | (40,433) |  |  | — |  |  | (40,433) |
Components of comprehensive income: |  |  |  |  |  |  |  |  |  |  |
Net income | — |  |  | — |  |  | — |  |  | 433,545 |  |  | — |  |  | 433,545 |
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (29,878) |  |  | (29,878) |
Total comprehensive income / (loss) | — |  |  | — |  |  | — |  |  | 433,545 |  |  | (29,878) |  |  | 403,667 |
Balances as of October 1, 2022 | 57,128 |  |  | $ | 561,684 |  |  | $ | (675,800) |  |  | $ | 1,341,666 |  |  | $ | (32,900) |  |  | $ | 1,194,650 |

The accompanying notes are an integral part of these consolidated financial statements.
34

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

|  | Fiscal
|  | 2022 |  | 2021 |  | 2020
CASH FLOWS FROM OPERATING ACTIVITIES: |  |  |  |  |  |
Net income |  | $ | 433,545 |  |  | $ | 367,161 |  |  | $ | 52,300 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |  |  |
Depreciation and amortization |  | 21,293 |  |  | 19,810 |  |  | 19,739 |
Impairment charges |  | 1,346 |  |  | — |  |  | — |
Equity-based compensation and employee benefits |  | 18,986 |  |  | 15,491 |  |  | 15,019 |
Adjustment for doubtful accounts |  | (245) |  |  | (248) |  |  | 371 |
Adjustment for inventory valuation |  | (2,613) |  |  | (2,965) |  |  | 4,170 |
Change in the estimation of warranty reserve |  | — |  |  | — |  |  | (5,417) |
Deferred taxes |  | (8,648) |  |  | (9,818) |  |  | (827) |
(Gain) / loss on disposal of property, plant and equipment |  | (253) |  |  | 259 |  |  | 953 |
Gain on disposal of equity-method investments |  | — |  |  | (1,046) |  |  | — |
Unrealized foreign currency translation |  | (7,278) |  |  | (378) |  |  | 874 |
Share of results of equity-method investee |  | — |  |  | 94 |  |  | 36 |
Changes in operating assets and liabilities: |  |  |  |  |  |
Accounts and notes receivable |  | 113,340 |  |  | (221,924) |  |  | (1,928) |
Inventory |  | (14,924) |  |  | (52,719) |  |  | (26,194) |
Prepaid expenses and other current assets |  | (37,907) |  |  | (4,573) |  |  | (3,561) |
Accounts payable, accrued expenses and other current liabilities |  | (128,734) |  |  | 181,960 |  |  | 38,148 |
Income taxes payable |  | 4,946 |  |  | 7,686 |  |  | (291) |
Other, net |  | (2,666) |  |  | 1,242 |  |  | 1,020 |
Net cash provided by operating activities |  | 390,188 |  |  | 300,032 |  |  | 94,412 |
CASH FLOWS FROM INVESTING ACTIVITIES: |  |  |  |  |  |
Acquisition of business, net of cash acquired |  | — |  |  | (26,338) |  |  | — |
Purchases of property, plant and equipment |  | (22,985) |  |  | (22,775) |  |  | (11,719) |
Proceeds from sales of property, plant and equipment |  | 181 |  |  | 291 |  |  | 50 |
Purchase of equity investments |  | (397) |  |  | — |  |  | (1,288) |
Purchase of short term investments |  | (469,000) |  |  | (507,000) |  |  | (442,000) |
Maturity of short term investments |  | 626,000 |  |  | 472,000 |  |  | 329,000 |
Disposal of equity-method investments |  | — |  |  | 2,115 |  |  | — |
Net cash provided by / (used in) investing activities |  | 133,799 |  |  | (81,707) |  |  | (125,957) |
CASH FLOWS FROM FINANCING ACTIVITIES: |  |  |  |  |  |
Payment on short term debt |  | (54,500) |  |  | (22,750) |  |  | (147,143) |
Payment for finance leases |  | (509) |  |  | (379) |  |  | (123) |
Repurchase of common stock |  | (281,319) |  |  | (10,426) |  |  | (54,549) |
Proceeds from short term debt |  | 54,500 |  |  | 22,750 |  |  | 86,239 |
Common stock cash dividends paid |  | (39,363) |  |  | (33,453) |  |  | (30,233) |
Net cash used in financing activities |  | (321,191) |  |  | (44,258) |  |  | (145,809) |
Effect of exchange rate changes on cash and cash equivalents |  | (10,047) |  |  | 594 |  |  | 1,297 |
Changes in cash and cash equivalents |  | 192,749 |  |  | 174,661 |  |  | (176,057) |
Cash and cash equivalents at beginning of period |  | 362,788 |  |  | 188,127 |  |  | 364,184 |
Cash and cash equivalents at end of period |  | $ | 555,537 |  |  | $ | 362,788 |  |  | $ | 188,127 |
CASH PAID FOR: |  |  |  |  |  |
Interest |  | $ | 208 |  |  | $ | 218 |  |  | $ | 1,716 |
Income taxes |  | $ | 50,309 |  |  | $ | 51,856 |  |  | $ | 13,271 |

The accompanying notes are an integral part of these consolidated financial statements.
35

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1: BASIS OF PRESENTATION
These consolidated financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (the “Company”), with appropriate elimination of intercompany balances and transactions.
Fiscal Year
Each of the Company’s first three fiscal quarters ends on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. The 2022, 2021, and 2020 fiscal years ended on October 1, 2022, October 2, 2021 and October 3, 2020, respectively.
Nature of Business
The Company designs, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company’s operating results depend upon the capital and operating expenditures of semiconductor device manufacturers, integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), and other electronics manufacturers, including automotive electronics suppliers, worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry’s demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, including those sold by the Company. These downturns and slowdowns have in the past adversely affected the Company’s operating results. The Company believes such volatility will continue to characterize the industry and the Company’s operations in the future.
Use of Estimates
The preparation of consolidated financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.
Due to the coronavirus (“COVID-19”) pandemic and macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of October 1, 2022. While there was no material impact to our consolidated financial statements as of and for the year ended October 1, 2022, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 and macroeconomic headwinds that could materially impact our consolidated financial statements in future reporting periods.
The Company reviews its warranty reserve balances as part of its ongoing policy review. At the start of fiscal 2020, the Company determined there was a need to obtain granular data given uncertainty in sales demand. Accordingly, the Company commenced the collection of granular data over the four fiscal quarters in 2020 to establish a more precise estimate of its warranty reserve. This collection was finalized and the information incorporated in the fourth quarter of fiscal 2020. This resulted in a decrease to the reserve for warranty and an increase in net income by $5.4 million for the fiscal year 2020, as well as an increase to net income per share, basic and diluted, by $0.09 and $0.09, respectively. For further information on warranty reserve, see Notes 14 and 17 below.
36

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Vulnerability to Certain Concentrations
Financial instruments which may subject the Company to concentrations of credit risk as of October 1, 2022 and October 2, 2021 consisted primarily of trade receivables. The Company manages credit risk associated with investments by investing its excess cash in highly rated debt instruments of the U.S. government and its agencies, financial institutions, and corporations. The Company has established investment guidelines relative to diversification and maturities designed to maintain safety and liquidity. These guidelines are periodically reviewed and modified as appropriate.
The Company’s trade receivables result primarily from the sale of semiconductor equipment, related accessories and replacement parts, and tools to a relatively small number of large manufacturers in a highly concentrated industry. Write-offs of uncollectible accounts have historically not been material. The Company actively monitors its customers’ financial strength to reduce the risk of loss, including as a result of COVID-19 and macroeconomic headwinds.
The Company’s products are complex and require raw materials, components and subassemblies having a high degree of reliability, accuracy and performance. The Company relies on subcontractors to manufacture many of these components and subassemblies and it relies on sole source suppliers for some important components and raw material inventory.
Foreign Currency Translation and Remeasurement
The majority of the Company’s business is transacted in U.S. dollars; however, the functional currencies of some of the Company’s subsidiaries are their local currencies. In accordance with ASC No. 830, Foreign Currency Matters (“ASC 830”), for a subsidiary of the Company that has a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net income, but are accumulated in the cumulative translation adjustment account as a separate component of shareholders’ equity (accumulated other comprehensive income / (loss)). The tax effect of currency translation adjustments related to unremitted foreign earnings no longer deemed to be indefinitely reinvested outside the U.S. is reflected in the determination of the Company's net income or other comprehensive income (“OCI”). Gains and losses resulting from foreign currency transactions are included in the determination of net income.
The Company’s operations are exposed to changes in foreign currency exchange rates due to transactions denominated in currencies other than the location’s functional currency. The Company is also exposed to foreign currency fluctuations that impact the remeasurement of net monetary assets of those operations whose functional currency, the U.S. dollar, differs from their respective local currencies, most notably in Israel, Singapore and Switzerland. In addition to net monetary remeasurement, the Company has exposures related to the translation of subsidiary financial statements from their functional currency, the local currency, into its reporting currency, the U.S. dollar, most notably in the Netherlands, China, Taiwan, Japan and Germany. The Company’s U.S. operations also have foreign currency exposure due to net monetary assets denominated in currencies other than the U.S. dollar.
Derivative Financial Instruments
The Company’s primary objective for holding derivative financial instruments is to manage the fluctuation in foreign exchange rates and accordingly is not speculative in nature. The Company’s international operations are exposed to changes in foreign exchange rates as described above. The Company has established a program to monitor the forecasted transaction currency risk to protect against foreign exchange rate volatility. Generally, the Company uses foreign exchange forward contracts in these hedging programs. These instruments, which have maturities of up to twelve months, are recorded at fair value and are included in prepaid expenses and other current assets, or accrued expenses and other current liabilities.
Our accounting policy for derivative financial instruments is based on whether they meet the criteria for designation as a cash flow hedge. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction is referred to as a cash flow hedge. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain / (loss) from the effective portion of the hedge as a component of accumulated other comprehensive income / (loss) and reclassify it into earnings in the same period in which the hedged transaction affects earnings and in the same line item on the consolidated statement of operations as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the consolidated statement of cash flows in the same section as the underlying item, primarily within cash flows from operating activities.
The hedge effectiveness of these derivative instruments is evaluated by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item.
37

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
If a cash flow hedge is discontinued because it is no longer probable that the original hedged transaction will occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income / (loss) into earnings. Subsequent gain / (loss) on the related derivative instrument is recognized into earnings in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings.
Cash Equivalents
The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash equivalents. Cash equivalents are measured at fair value based on Level 1 measurement, or quoted market prices, as defined by ASC No. 820, Fair Value Measurements and Disclosures.
Equity Investments
The Company invests in equity securities in companies to promote business and strategic objectives. Equity investments are measured and recorded as follows:
•Non-marketable equity securities are equity securities without readily determinable fair value that are measured and recorded using a measurement alternative that measures the securities at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.
Allowance for Doubtful Accounts
The Company maintains allowances for doubtful accounts for estimated losses resulting from its customers’ failure to make required payments. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, including as a result of COVID-19 and macroeconomic headwinds, additional allowances may be required. If global or regional economic conditions deteriorate or political conditions were to change in some of the countries where the Company does business, it could have a significant impact on the results of operations, and the Company’s ability to realize the full value of its accounts receivable.
Inventories
Inventories are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. The Company generally provides reserves for obsolete inventory and for inventory considered to be in excess of demand. Demand is generally defined as 18 months forecasted future consumption for equipment, 24 months forecasted future consumption for spare parts, and 12 months forecasted future consumption for tools. Forecasted consumption is based upon internal projections, historical sales volumes, customer order activity and a review of consumable inventory levels at customers’ facilities. The Company communicates forecasts of its future consumption to its suppliers and adjusts commitments to those suppliers accordingly. If required, the Company reserves the difference between the carrying value of its inventory and the lower of cost or net realizable value, based upon projections about future consumption, and market conditions. If actual market conditions are less favorable than projections, additional inventory reserves may be required.
Inventory reserve provision for certain subsidiaries is determined based on management’s estimate of future consumption for equipment and spare parts. This estimate is based on historical sales volumes, internal projections and market developments and trends.
Property, Plant and Equipment
Property, plant and equipment are carried at cost. The cost of additions and those improvements which increase the capacity or lengthen the useful lives of assets are capitalized while repair and maintenance costs are expensed as incurred. Depreciation and amortization are provided on a straight-line basis over the estimated useful lives as follows: buildings 25 years; machinery, equipment, furniture and fittings 3 to 10 years; toolings 1 year; and leasehold improvements are based on the shorter of the life of lease or life of asset. Purchased computer software costs related to business and financial systems are amortized over a five-year period on a straight-line basis. Land is not depreciated.
38

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Valuation of Long-Lived Assets
In accordance with ASC No. 360, Property, Plant & Equipment (“ASC 360”), the Company’s definite lived intangible assets and property, plant and equipment are tested for impairment based on undiscounted cash flows when triggering events occur, and if impaired, written-down to fair value based on either discounted cash flows or appraised values. ASC 360 also provides a single accounting model for long-lived assets to be disposed of by sale and establishes additional criteria that would have to be met to classify an asset as held for sale. The carrying amount of an asset or asset group is not recoverable to the extent it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. Estimates of future cash flows used to test the recoverability of a long-lived asset or asset group must incorporate the entity’s own assumptions about its use of the asset or asset group and must factor in all available evidence.
ASC 360 requires that long-lived assets be tested for recoverability whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Such events include significant under-performance relative to historical internal forecasts or projected future operating results; significant changes in the manner of use of the assets; significant negative industry or economic trends; or significant changes in market capitalization. During the fiscal years ended October 1, 2022 and October 2, 2021, no “triggering” events occurred.
Accounting for Impairment of Goodwill
ASC No. 350, Intangibles - Goodwill and Other requires goodwill and other intangible assets with indefinite lives to be reviewed for impairment annually, or more frequently if circumstances indicate a possible impairment. We assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, after assessing the qualitative factors, a company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying value, then performing the impairment test is unnecessary. However, if a company concludes otherwise, then it is required to perform the goodwill impairment test. The Company’s impairment test is performed by comparing the fair value of a reporting unit with its carrying value, and determining if the carrying amount exceeds its fair value.
As part of the annual evaluation, the Company performs an impairment test of its goodwill in the fourth quarter of each fiscal year to coincide with the completion of its annual forecasting and refreshing of its business outlook processes. On an ongoing basis, the Company monitors if a “triggering” event has occurred that may have the effect of reducing the fair value of a reporting unit below its respective carrying value. Adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment charge in the future.
Impairment assessments inherently involve judgment as to the assumptions made about the expected future cash flows and the impact of market conditions on those assumptions. Future events and changing market conditions may impact the assumptions as to prices, costs, growth rates or other factors that may result in changes in the estimates of future cash flows. Although the Company believes the assumptions that it has used in testing for impairment are reasonable, significant changes in any one of the assumptions could produce a significantly different result. Indicators of potential impairment, including significant and unforeseen customer losses, a significant adverse change in legal factors or in the business climate, a significant adverse action or assessment by a regulator, a significant stock price decline or unanticipated competition may lead the Company to perform interim goodwill impairment assessments.
For further information on goodwill and other intangible assets, see Note 4 below.
Revenue Recognition
In accordance with ASC No. 606, Revenue from Contracts with Customers, the Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay.
The Company recognizes revenue from sales of our products, including sales to our distributors, at a point in time, generally upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order. Control is considered transferred when title and risk of loss pass, when the customer becomes obligated to pay and, where applicable, when the customer has accepted the products or upon expiration of the acceptance period. For sales to distributors, payment is due on our standard commercial terms and is not contingent upon the distributors’ resale of the products.
39

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Our business is subject to contingencies related to customer orders, including:
•Right of Return: A large portion of our revenue comes from the sale of equipment used in the semiconductor assembly process. Other product sales relate to consumable products, which are sold in high-volume quantities, and are generally maintained at low stock levels at the customers’ facility. Customer returns have historically represented a very small percentage of customer sales on an annual basis.
•Warranties: Our equipment is generally shipped with a one-year warranty against manufacturing defects. We establish reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management’s estimate of future expenses, including product parts replacement, freight charges and labor costs expected to be incurred to correct manufacturing defects during the warranty period.
•Conditions of Acceptance: Sales of our consumable products generally do not have customer acceptance terms. In certain cases, sales of our equipment have customer acceptance clauses which may require the equipment to perform in accordance with agreed specifications, customer specifications or subject to satisfactory installation at the customer’s facility. In such cases, if the terms of acceptance are satisfied at our facility prior to shipment, the revenue for the equipment will be recognized upon shipment. If the terms of acceptance are satisfied at our customers’ facilities, the revenue for the equipment will not be recognized until acceptance, which is typically obtained after installation and testing, is received from the customer.
Service revenue is generally recognized over time as the services are performed. For fiscal 2022 and 2021, the service revenue is not material.
The Company measures revenue based on the amount of consideration we expect to be entitled to in exchange for products or services. Any variable consideration such as sales incentives are recognized as a reduction of net revenue at the time of revenue recognition.
The length of time between invoicing and payment is not significant under our payment terms. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined our contracts generally do not include a significant financing component. Shipping and handling costs billed to customers are recognized in net revenue.
Shipping and handling costs paid by the Company are included in cost of sales.
Contract Assets
A contract asset is the Company’s right to consideration in exchange for goods or services that the Company has transferred to a customer. ASC 606, Revenue from Contracts with Customers, distinguishes between a contract asset and a receivable based on whether receipt of the consideration is conditional on something other than the passage of time. When the Company transfers control of goods or services to a customer before the customer pays consideration, the Company records either a contract asset or a receivable depending on the nature of the Company’s right to consideration for its performance. The point at which a contract asset becomes an account receivable may be earlier than the point at which an invoice is issued. The Company assesses a contract asset for impairment in accordance with ASC 310, Receivables.
Research and Development
The Company charges research and development costs associated with the development of new products to expense when incurred. In certain circumstances, pre-production machines that the Company intends to sell are carried as inventory until sold.
40

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Income Taxes
In accordance with ASC No. 740, Income Taxes, deferred income taxes are determined using the balance sheet method. The Company records a valuation allowance to reduce its deferred tax assets to the amount expected, on a more likely than not basis, to be realized. While the Company has considered future taxable income and ongoing tax planning strategies in assessing the need for the valuation allowance, if it were to determine that it would be able to realize its deferred tax assets in the future in excess of its net recorded amount, an adjustment to deferred tax assets would increase income in the period when such determination is made. Likewise, should the Company determine it would not be able to realize all or part of its deferred tax assets in the future, an adjustment to deferred tax assets would decrease income in the period when such determination is made.
The Company determines the amount of unrecognized tax benefit with respect to uncertain tax positions taken or expected to be taken on its income tax returns in accordance with ASC No. 740 Topic 10, Income Taxes, General (“ASC 740.10”). Under ASC 740.10, the Company utilizes a two-step approach for evaluating uncertain tax positions. Step one, or recognition, requires a company to determine if the weight of available evidence indicates a tax position is more likely than not to be sustained upon examination solely based on its technical merit. Step two, or measurement, is based on the largest amount of benefit, which is more likely than not to be realized on settlement with the taxing authority, including resolution of related appeals or litigation processes, if any.
Equity-Based Compensation
The Company accounts for equity-based compensation under the provisions of ASC No. 718, Compensation - Stock Compensation (“ASC 718”). ASC 718 requires the recognition of the fair value of the equity-based compensation in net income. Compensation expense associated with Relative TSR Performance Share Units is determined using a Monte-Carlo valuation model, and compensation expense associated with time-based and Growth Performance Share Units is determined based on the number of shares granted and the fair value on the date of grant. See Note 11 for a summary of the terms of these performance-based awards. The fair value of equity-based awards is amortized over the vesting period of the award, and the Company elected to use the straight-line method for awards granted after the adoption of ASC 718.
Earnings per Share
Earnings per share (“EPS”) are calculated in accordance with ASC No. 260, Earnings per Share. Basic EPS include only the weighted average number of common shares outstanding during the period. Diluted EPS include the weighted average number of common shares and the dilutive effect of stock options, restricted stock awards, performance share units and restricted share units outstanding during the period, when such instruments are dilutive.
Accelerated Share Repurchase
From time to time, the Company may enter into accelerated share repurchase (“ASR”) agreements with third-party financial institutions to repurchase shares of the Company’s common stock. Under an ASR agreement, in exchange for an up-front payment, the counterparty makes an initial delivery of shares of the Company’s common stock during the purchase period of the relevant ASR. This initial delivery of shares represents the minimum number of shares that the Company may receive under an ASR agreement. Upon settlement of an ASR agreement, the counterparty may deliver additional shares, with the final number of shares delivered determined based on the volume-weighted average price of the Company’s common stock over the term of such ASR agreement, less an agreed-upon discount. The transactions are accounted for as equity transactions and are included in Treasury Stock when the shares are received, at which time there is an immediate reduction in the weighted-average common shares calculation for basic and diluted earnings per share.
Accounting for Business Acquisitions
The Company accounts for business acquisitions in accordance with ASC No. 805, Business Combinations. The fair value of the net assets acquired and the results of operations of the acquired businesses are included in the consolidated financial statements from the acquisition date forward. The Company is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and results of operations during the reporting period. Estimates are used in accounting for, among other things, the fair value of acquired net operating assets, property, plant and equipment, deferred revenue, intangible assets and related deferred income taxes, useful lives of property, plant and equipment, and amortizable lives of acquired intangible assets. Any excess of the purchase consideration over the identified fair value of the assets and liabilities assumed is recognized as goodwill. The valuation of these tangible and identifiable intangible assets and liabilities is subject to further management review and may change materially between the preliminary allocation and end of the purchase price allocation period.
41

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Restructuring Charges
Restructuring charges may consist of voluntary or involuntary severance-related charges, asset-related charges and other costs due to exit activities. We recognize voluntary termination benefits when an employee accepts the offered benefit arrangement. We recognize involuntary severance-related charges depending on whether the termination benefits are provided under an ongoing benefit arrangement or under a one-time benefit arrangement. If the former, we recognize the charges once they are probable and the amounts are estimable. If the latter, we recognize the charges once the benefits have been communicated to employees.
Recent Accounting Pronouncements
Income Taxes
In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes (Topic 740). The amendments in this ASU, among other changes, simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, clarify and amend the existing guidance. We adopted this ASU in the first quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated financial statements.
Contracts in Entity’s Own Equity
In August 2020, the FASB issued ASU 2020-06, Derivatives and Hedging - Contracts in Entity’s Own Equity (Topic 815). The amendments in this ASU, among other changes, remove current guidance that allows an entity to rebut the presumption that potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares if the entity has a history or policy of cash settlement. These amendments affect any instrument that may be settled in cash or shares and, therefore, affects the diluted earnings per share calculation for both convertible instruments and contracts in an entity's own equity. We elected to early adopt this ASU in the second quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated financial statements.
Codification Improvements
In October 2020, the FASB issued ASU 2020-10, Codification Improvements. The amendments in this ASU affect a wide variety of topics in the Codification and improve the consistency of the Codification by including all disclosure guidance in the appropriate disclosure sections (Section 50). We adopted this ASU in the first quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated financial statements.
Government Assistance
In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosure by Business Entities about Government Assistance which aims at increasing the transparency of government assistance received by most business entities. The standard requires business entities to make annual disclosures about the nature of the transactions and the related accounting policy used to account for the transactions, the line items and applicable amounts on the balance sheet and income statement that are affected by the transactions, and significant terms and conditions of the transactions, including commitments and contingencies. If an entity omits any required disclosures because it is legally prohibited, it must disclose that fact. This ASU is effective for fiscal years (and interim periods within those fiscal years) beginning after December 15, 2021, which for the Company is the first quarter of fiscal 2023. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
42

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
NOTE 2: BALANCE SHEET COMPONENTS
The following tables reflect the components of significant balance sheet accounts as of October 1, 2022 and October 2, 2021:

|  | As of
(in thousands) |  | October 1, 2022 |  | October 2, 2021
Short term investments, available-for-sale(1) |  | $ | 220,000 |  |  | $ | 377,000 |
Inventories, net: |  |  |  |
Raw materials and supplies |  | $ | 118,833 |  |  | $ | 94,493 |
Work in process |  | 40,114 |  |  | 55,866 |
Finished goods |  | 45,277 |  |  | 40,006 |
|  | 204,224 |  |  | 190,365 |
Inventory reserves |  | (19,238) |  |  | (23,042) |
|  | $ | 184,986 |  |  | $ | 167,323 |
Property, plant and equipment, net: |  |  |  |
Land |  | $ | 2,182 |  |  | $ | 2,182 |
Buildings and building improvements |  | 22,783 |  |  | 23,314 |
Leasehold improvements |  | 32,400 |  |  | 30,054 |
Data processing equipment and software |  | 38,223 |  |  | 40,945 |
Machinery, equipment, furniture and fixtures |  | 90,151 |  |  | 87,994 |
Construction in progress |  | 25,004 |  |  | 9,562 |
|  | 210,743 |  |  | 194,051 |
Accumulated depreciation |  | (129,835) |  |  | (126,069) |
|  | $ | 80,908 |  |  | $ | 67,982 |
Accrued expenses and other current liabilities: |  |  |  |
Accrued customer obligations (2) |  | $ | 58,916 |  |  | $ | 72,478 |
Wages and benefits |  | 50,279 |  |  | 66,531 |
Commissions and professional fees |  | 5,019 |  |  | 6,190 |
Dividends payable |  | 9,743 |  |  | 8,673 |
Severance |  | 19 |  |  | 31 |
Other |  | 10,565 |  |  | 7,667 |
|  | $ | 134,541 |  |  | $ | 161,570 |

(1)All short-term investments were classified as available-for-sale and the fair value approximates cost basis. The Company did not recognize any realized gains or losses on the sale of investments during the fiscal years ended 2022 and 2021.
(2)Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.
43

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
NOTE 3: BUSINESS COMBINATIONS
Acquisition of Uniqarta
On January 19, 2021, Kulicke and Soffa Industries, Inc. entered into a Stock Purchase Agreement with Uniqarta, Inc. (“Uniqarta”) and its equity holders to purchase all of Uniqarta’s outstanding equity interests. Upon the closing of the acquisition, Uniqarta became a wholly-owned subsidiary of the Company. Uniqarta is a developer of laser transfer technology and the acquisition expands the Company’s presence in the LED end market.
The purchase price consisted of $26.5 million in cash paid at closing. The acquisition of Uniqarta was accounted for in accordance with ASC No. 805, Business Combinations, using the acquisition method.
On January 19, 2022, the Company finalized the valuation of the tangible and identifiable intangible assets and liabilities in connection with the acquisition of Uniqarta and no further adjustment was recorded. On July 15, 2022, the Company released the escrow amount of $3.5 million to the seller in respect of Uniqarta’s completion of its post-closing obligations under the Agreement.
The following table summarizes the allocation of the assets acquired and liabilities assumed based on the fair values as of the acquisition date:

(in thousands) | January 19, 2021
Accounts and other receivable | $ | 7 |
Prepaid expenses and other current assets | 6 |
Property, plant and equipment, net | 539 |
Goodwill | 16,799 |
Intangible assets | 11,200 |
Accounts payable | (77) |
Accrued expenses and other current liabilities | (98) |
Deferred tax liabilities | (2,038) |
Total purchase price, net of cash acquired | $ | 26,338 |

Tangible net assets (liabilities) were valued at their respective carrying amounts, which the Company believes approximate their current fair values at the acquisition date.
The valuation of identifiable intangible assets acquired, representing in-process research and development (“IPR&D”) and others, reflects management’s estimates based on, among other factors, the use of an established valuation method. The intangible assets are valued using a cost replacement method. As of October 2, 2021, the IPR&D intangible asset of $9.0 million is not amortized, but rather is reviewed for impairment on an annual basis or more frequently if indicators of impairment are present, until the project is completed, abandoned, or transferred to a third party. As of October 1, 2022, the IPR&D were transferred to developed technology (definite-lived intangible assets) as the research and development process was completed. The other intangible assets acquired of $2.2 million and the IPR&D are amortized over the period of estimated benefit using the straight-line method and the estimated useful life of six years. The straight-line method of amortization represents the Company’s best estimate of the distribution of the economic value of the identifiable intangible assets. Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired and includes the value of expected future cash flows of Uniqarta from expected synergies with our other affiliates and other unidentifiable intangible assets. None of the goodwill recorded as part of the acquisition will be deductible for income tax purposes.
In connection with the acquisition of Uniqarta, the Company recorded deferred tax liabilities primarily relating to the acquired intangible assets, which are partially offset by the acquired tax attributes. The acquired tax attributes are comprised of net operating losses and research and development credits.
For the year ended October 2, 2021, the acquired business contributed a net loss of $0.2 million.
During fiscal 2021, the Company incurred $1.7 million of expenses related to the acquisition, which is included within selling, general and administrative expense in the Consolidated Statements of Operations.
44

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
The following unaudited pro forma information presents the combined results of operations as if the acquisition had been completed on September 29, 2019, the beginning of the comparable prior annual reporting period. The unaudited pro forma results include: (i) amortization associated with preliminary estimates for the acquired intangible assets; and (ii) the associated tax impact on the unaudited pro forma adjustments.
The unaudited pro forma results do not reflect any cost saving synergies from operating efficiencies or the effect of the incremental costs incurred in integrating the two companies. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the periods presented, nor are they indicative of future results of operations:

|  | Fiscal
(in thousands) |  | 2021 |  | 2020
Net revenue |  | $ | 1,517,664 |  |  | $ | 623,176 |
Net income |  | 368,546 |  |  | 49,766 |

NOTE 4: GOODWILL AND INTANGIBLE ASSETS
Goodwill
Intangible assets classified as goodwill are not amortized. The goodwill established in connection with our acquisitions represents the estimated future economic benefits arising from the assets we acquired that did not qualify to be identified and recognized individually. The goodwill also includes the value of expected future cash flows from the acquisitions, expected synergies with our other affiliates and other unidentifiable intangible assets.
The Company performs an annual impairment test of its goodwill during the fourth quarter of each fiscal year, which coincides with the completion of its annual forecasting and refreshing of business outlook process.
The Company performed its annual impairment test in the fourth quarter of fiscal 2022 and concluded that no impairment charge was required. Any future adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a noncash impairment in the future.
During the fiscal year ended October 1, 2022, the Company reviewed qualitative factors to ascertain if a “triggering” event may have taken place that may have the effect of reducing the fair value of the reporting unit below its carrying value and concluded that no triggering event had occurred. While we have concluded that a triggering event did not occur during the fiscal year ended October 1, 2022, the prolonged COVID-19 pandemic and macroeconomic headwinds could impact the results of operations due to changes to assumptions utilized in the determination of the estimated fair values of the reporting units that could be significant enough to trigger an impairment. Net sales and earnings growth rates could be negatively impacted by reductions or changes in demand for our products. The discount rate utilized in our valuation model could also be impacted by changes in the underlying interest rates and risk premiums included in the determination of the cost of capital.
During the third quarter of fiscal year 2023, the Company reconsidered its reportable segments and has revised the segment-related presentation in the Original Form 10-K. As a result, its four reportable segments are (1) Ball Bonding Equipment, (2) Wedge Bonding Equipment, (3) Advanced Solutions, and (4) Aftermarket Products and Services (“APS”). All other operating segments that do not meet the quantitative threshold to be disclosed as a separate reportable segment have been grouped within an “All Others” category. Please refer to Note 16 for further information on the revision of the reportable and operating segments.
Accordingly, the Company’s goodwill as previously reported under “Capital Equipment” in the Original Form 10-K has been disaggregated and presented separately into the Wedge Bonding Equipment reportable segment and the “All Others” category. There are no changes to the goodwill reported under the APS reportable segment. While there were no changes in the methodology and level at which the Company performs its goodwill impairment tests, and no resulting amendments to the total carrying amount of the goodwill, the following table shows the allocation of goodwill based on these revised segments.
45

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
The following table summarizes the Company’s recorded goodwill, where applicable, by reportable segments and the “All Others” category, as of October 1, 2022 and October 2, 2021:

(in thousands) |  | Wedge Bonding Equipment |  | APS |  | All Others |  | Total
Balance at October 2, 2021 |  | 18,280 |  |  | 26,388 |  |  | 28,281 |  |  | 72,949
Other |  | — |  |  | (481) |  |  | (4,372) |  |  | (4,853) |
Balance at October 1, 2022 |  | 18,280 |  |  | 25,907 |  |  | 23,909 |  |  | 68,096 |

Intangible Assets
Intangible assets with determinable lives are amortized over their estimated useful lives. The Company’s intangible assets consist primarily of developed technology, customer relationships, in-process research and development, and trade and brand names.
The following table reflects net intangible assets as of October 1, 2022 and October 2, 2021:

|  | As of |  | Average estimated
(dollar amounts in thousands) |  | October 1, 2022 |  | October 2, 2021 |  | useful lives (in years)
Developed technology |  | $ | 89,017 |  |  | $ | 90,427 |  |  | 6.0 to 15.0
Accumulated amortization |  | $ | (58,636) |  |  | $ | (58,494) |  |  |
Net developed technology |  | $ | 30,381 |  |  | $ | 31,933 |  |  |
Customer relationships |  | $ | 33,515 |  |  | $ | 36,114 |  |  | 5.0 to 6.0
Accumulated amortization |  | $ | (33,515) |  |  | $ | (36,114) |  |  |
Net customer relationships |  | $ | — |  |  | $ | — |  |  |
In-process research and development(1) |  | $ | — |  |  | $ | 8,795 |  |  | N.A.
Accumulated amortization |  | $ | — |  |  | $ | — |  |  |
Net in-process research and development |  | $ | — |  |  | $ | 8,795 |  |  |
Trade and brand name |  | $ | 6,945 |  |  | $ | 7,374 |  |  | 7.0 to 8.0
Accumulated amortization |  | $ | (6,945) |  |  | $ | (7,275) |  |  |
Net trade and brand name |  | $ | — |  |  | $ | 99 |  |  |
Other intangible assets |  | $ | 4,700 |  |  | $ | 4,700 |  |  | 1.9 to 6.0
Accumulated amortization |  | $ | (3,142) |  |  | $ | (2,775) |  |  |
Net other intangible assets |  | $ | 1,558 |  |  | $ | 1,925 |  |  |
Net intangible assets |  | $ | 31,939 |  |  | $ | 42,752 |  |  |

(1) During the year ended October 1, 2022, $7.9 million of in-process research and development assets were transferred to developed technology (definite-lived intangible assets) as the research and development process was completed, and are being amortized over the period of estimated benefit using the straight-line method and the estimated useful life of six years.
46

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
The following table reflects estimated annual amortization expense related to intangible assets as of October 1, 2022:

| As of
(in thousands) | October 1, 2022
Fiscal 2023 | $ | 5,348 |
Fiscal 2024 | $ | 5,348 |
Fiscal 2025 | $ | 5,348 |
Fiscal 2026 | $ | 5,348 |
Fiscal 2027 | $ | 4,685 |
Fiscal 2028 and thereafter | $ | 5,862 |
Total amortization expense | $ | 31,939 |

47

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
NOTE 5: CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS
Cash equivalents consist of instruments with remaining maturities of three months or less at the date of purchase. In general, these investments are free of trading restrictions.
Cash, cash equivalents and short-term investments consisted of the following as of October 1, 2022:

(dollar amounts in thousands) | Amortized Cost |  | Unrealized Gains |  | Unrealized Losses |  | Estimated Fair Value
Current assets: |  |  |  |  |  |  |
Cash | $ | 173,402 |  |  | $ | — |  |  | $ | — |  |  | $ | 173,402 |
Cash equivalents: |  |  |  |  |  |  |
Money market funds (1) | 157,145 |  |  | — |  |  | (20) |  |  | 157,125 |
Time deposits (2) | 225,010 |  |  | — |  |  | — |  |  | 225,010 |
Total cash and cash equivalents | $ | 555,557 |  |  | $ | — |  |  | $ | (20) |  |  | $ | 555,537 |
Short-term investments: |  |  |  |  |  |  |
Time deposits (2) | $ | 220,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 220,000 |
Total short-term investments | $ | 220,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 220,000 |
Total cash, cash equivalents, and short-term investments | $ | 775,557 |  |  | $ | — |  |  | $ | (20) |  |  | $ | 775,537 |

(1)The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.
(2)Fair value approximates cost basis.
Cash, cash equivalents, restricted cash and short-term investments consisted of the following as of October 2, 2021:

(dollar amounts in thousands) | Amortized Cost |  | Unrealized Gains |  | Unrealized Losses |  | Estimated Fair Value
Current assets: |  |  |  |  |  |  |
Cash | $ | 269,201 |  |  | $ | — |  |  | $ | — |  |  | $ | 269,201 |
Cash equivalents: |  |  |  |  |  |  |
Money market funds (1) | 93,598 |  |  | — |  |  | (18) |  |  | 93,580 |
Time deposits (2) | 7 |  |  | — |  |  | — |  |  | 7 |
Total cash and cash equivalents | $ | 362,806 |  |  | $ | — |  |  | $ | (18) |  |  | $ | 362,788 |
Short-term investments: |  |  |  |  |  |  |
Time deposits (2) | 377,000 |  |  | — |  |  | — |  |  | 377,000 |
Total short-term investments | $ | 377,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 377,000 |
Total cash, cash equivalents, restricted cash and short-term investments | $ | 739,806 |  |  | $ | — |  |  | $ | (18) |  |  | $ | 739,788 |

(1)The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.
(2)Fair value approximates cost basis.
48

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
NOTE 6: EQUITY INVESTMENTS
Equity investments consisted of the following as of October 1, 2022 and October 2, 2021:

| As of
(in thousands) | October 1, 2022 |  | October 2, 2021
Non-marketable equity securities | $ | 5,397 |  |  | $ | 6,388 |

During the year ended October 1, 2022, the Company recorded an impairment of $1.3 million on a non-marketable equity security without a readily determinable fair value. The entire amount of the investment in the non-marketable equity security was impaired due to a significant deterioration in the earnings performance of the equity investee. The impairment amount is recorded within “Selling, general and administrative expense” in the Consolidated Statement of Operations.
NOTE 7: FAIR VALUE MEASUREMENTS
Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3).
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
We measure certain financial assets and liabilities at fair value on a recurring basis. There were no transfers between fair value measurement levels during the fiscal year ended October 1, 2022.
Fair Value Measurements on a Nonrecurring Basis
Our non-financial assets such as intangible assets and property, plant and equipment are carried at cost unless impairment is deemed to have occurred.
Fair Value of Financial Instruments
Amounts reported as accounts receivables, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value.
NOTE 8: DERIVATIVE FINANCIAL INSTRUMENTS
The Company’s international operations are exposed to changes in foreign exchange rates due to transactions denominated in currencies other than U.S. dollars. Most of the Company’s revenue and cost of materials are transacted in U.S. dollars. However, a significant amount of the Company’s operating expenses is denominated in foreign currencies, primarily in Singapore.
The foreign currency exposure of our operating expenses is generally hedged with foreign exchange forward contracts. The Company’s foreign exchange risk management programs include using foreign exchange forward contracts with cash flow hedge accounting designation to hedge exposures to the variability in the U.S. dollar equivalent of forecasted non-U.S. dollar-denominated operating expenses. These instruments generally mature within twelve months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and in the same line item on the Consolidated Statements of Operations as the impact of the hedged transaction.
49

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
The fair value of derivative instruments on our Consolidated Balance Sheets as of October 1, 2022 and October 2, 2021 is as follows:

| As of |  |
(in thousands) | October 1, 2022 |  | October 2, 2021
| Notional Amount |  |  |  | Fair Value Liability Derivatives(1) |  | Notional Amount |  | Fair Value Liability Derivatives(1) |  |
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forward contracts (2) | $ | 57,570 |  |  |  |  | $ | (2,234) |  |  | $ | 57,682 |  |  | $ | (616) |  |  |
Total derivatives | $ | 57,570 |  |  |  |  | $ | (2,234) |  |  | $ | 57,682 |  |  | $ | (616) |  |  |

(1)The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Balance Sheets.
(2)Hedged amounts expected to be recognized into earnings within the next twelve months.
The effect of derivative instruments designated as cash flow hedges in our Consolidated Statements of Operations for the fiscal years ended October 1, 2022 and October 2, 2021 was as follows:

(in thousands) | Fiscal
| 2022 |  | 2021
Foreign exchange forward contract in cash flow hedging relationships: |  |  |
Net (loss)/gain recognized in OCI, net of tax(1) | $ | (2,694) |  |  | $ | 24 |
Net (loss)/gain reclassified from accumulated OCI into earnings, net of tax(2) | $ | (1,076) |  |  | $ | 1,197 |

(1)Net change in the fair value of the effective portion classified in OCI.
(2)Effective portion classified as selling, general and administrative expense.
NOTE 9: LEASES
We have entered into various non-cancellable operating and finance lease agreements for certain of our offices, manufacturing, technology, sales support and service centers, equipment, and vehicles. We determine if an arrangement is a lease, or contains a lease, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor. Our lease terms may include one or more options to extend the lease terms, for periods from one year to 20 years, when it is reasonably certain that we will exercise that option. As of October 1, 2022, one option to extend the lease were recognized as right-of-use (“ROU”) assets and lease liabilities. We have lease agreements with lease and non-lease components, and non-lease components are accounted for separately and not included in our leased assets and corresponding liabilities. We have elected not to present short-term leases on the Consolidated Balance Sheets as these leases have a lease term of 12 months or less at lease inception.
Operating leases are included in operating ROU assets, current and non-current operating lease liabilities, and finance leases are included in property, plant and equipment, accrued expenses and other current liabilities, and other liabilities on the Consolidated Balance Sheets. As of October 1, 2022, our finance leases are not material.
The following table shows the components of lease expense:

(in thousands) | Fiscal
| 2022 |  | 2021
Operating lease expense (1) | $ | 8,625 |  |  | 7,629 |

(1) Operating lease expense includes short-term lease expense, which is immaterial for the fiscal year ended October 1, 2022.
50

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
The following table shows the cash flows arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of operating and finance lease liabilities, and, as such, are excluded from the amounts below:

(in thousands) | Fiscal
| 2022 |  | 2021
Cash paid for amounts included in the measurement of lease liabilities: |  |  |
Operating cash outflows from operating leases | $ | 7,908 |  |  | $ | 7,211 |

The following table shows the weighted-average lease terms and discount rates for operating leases:

| Fiscal
| 2022 |  | 2021
Operating leases: |  |  |
Weighted-average remaining lease term (in years): | 8.0 |  | 9.6
Weighted-average discount rate: | 5.8 | % |  | 5.8 | %

Future lease payments, excluding short-term leases, as of October 1, 2022, are detailed as follows:

(in thousands) | Operating leases
Fiscal 2023 | $ | 8,748 |
Fiscal 2024 | 8,354 |
Fiscal 2025 | 7,649 |
Fiscal 2026 | 4,954 |
Fiscal 2027 | 3,195 |
Fiscal 2028 and thereafter | 20,193 |
Total minimum lease payments | 53,093 |
Less: Interest | 11,400 |
Present value of lease obligations | 41,693 |
Less: Current portion | 6,766 |
Long-term portion of lease obligations | $ | 34,927 |

51

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

NOTE 10: DEBT AND OTHER OBLIGATIONS
Bank Guarantees
On November 22, 2013, the Company obtained a $5.0 million credit facility with Citibank in connection with the issuance of bank guarantees for operational purposes. As of October 1, 2022 and October 2, 2021, the outstanding amount was $2.9 million and $3.0 million respectively.
Credit Facilities
On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company and one of its subsidiaries with an overdraft facility of up to $150 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days’ written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the secured overnight financing rate (“SOFR”) plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of two of its subsidiaries (the “Subsidiaries”), or encumber its assets with material security interests (including any pledge of monies in the Subsidiaries’ cash deposit account with the Bank). The Facility Agreements also contain customary events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other material indebtedness of the Company and any breach of a representation or warranty under the Facility Agreements. As of October 1, 2022, there were no outstanding amounts under the Overdraft Facility.
NOTE 11: SHAREHOLDERS’ EQUITY AND EMPLOYEE BENEFIT PLANS
401(k) Retirement Income Plans
The Company has a 401(k) retirement plan (the “401(k) Plan”) for eligible U.S. employees. The 401(k) Plan allows for employee contributions and matching Company contributions from 4% to 6% based upon terms and conditions of the 401(k) Plan.
The following table reflects the Company’s contributions to the 401(k) Plan during fiscal 2022 and 2021:

|  | Fiscal
(in thousands) |  | 2022 |  | 2021
Cash |  | $ | 1,973 |  |  | $ | 1,780 |

Share Repurchase Program
On August 15, 2017, the Company's Board of Directors authorized a program (the "Program") to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018, 2019 and 2020, the Board of Directors increased the share repurchase authorization under the Program to $200 million, $300 million and $400 million, respectively. On March 3, 2022, the Board of Directors increased the share repurchase authorization under the Program by an additional $400 million to $800 million, and extended its duration through August 1, 2025. The Company has entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. The Program may be suspended or discontinued at any time and is funded using the Company’s available cash, cash equivalents and short-term investments. Under the Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations.
During the fiscal year ended October 1, 2022, the Company repurchased a total of approximately 2,782.1 thousand shares of common stock at a cost of approximately $132.8 million. The stock repurchases were recorded in the periods they were delivered and accounted for as treasury stock in the Company’s Consolidated Balance Sheets. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If the Company reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings.
52

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Accelerated Share Repurchase (“ASR”)
In addition to the 2,782.1 thousand shares of common stock repurchased under the Program during the fiscal year ended October 1, 2022, on March 9, 2022, the Company entered into an ASR agreement (the “March 2022 ASR Agreement”) with an investment bank counterparty (“Dealer”) to repurchase $150 million of the Company’s common stock. The March 2022 ASR Agreement was entered into pursuant to the Company’s current $800 million share repurchase authorization.
Under the March 2022 ASR Agreement, the Company made an up-front payment of $150 million to the Dealer and received an initial delivery of 2,449.9 thousand shares of common stock at a cost of approximately $120 million on March 10, 2022. The final number of shares to be repurchased will be based on the volume-weighted average price of the Company’s common stock during the term of the transaction, less a discount and subject to adjustments pursuant to the terms and conditions of the March 2022 ASR Agreement. For accounting purposes, the March 2022 ASR Agreement is evaluated as an unsettled forward contract indexed to the Company’s own stock, with $30 million being classified within common stock. At settlement, the Dealer may be required to deliver additional shares of common stock to the Company, or, under certain circumstances, the Company may be required to deliver shares of its common stock or may elect to make a cash payment to the Dealer.
The March 2022 ASR Agreement was settled between the Company and the Dealer on April 22, 2022 and the Company received an additional 344.5 thousand shares of common stock from the Dealer. In total, an aggregate of 2,794.4 thousand shares of common stock were delivered by the Dealer under the March 2022 ASR Agreement at an average price of $53.68 per share, which was then reclassified as treasury stock from common stock in shareholder’s equity. As of October 1, 2022, our remaining stock repurchase authorization under the Program was approximately $249.2 million.
Dividends
On August 30, 2022, June 8, 2022, March 3, 2022 and October 18, 2021, the Board of Directors declared a quarterly dividend $0.17 per share of common stock. During the fiscal year ended October 1, 2022, the Company declared dividends of $0.68 per share of common stock. The declaration of any future cash dividend is at the discretion of the Board of Directors, subject to applicable laws, and will depend on the Company’s financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company’s stockholders.
Accumulated Other Comprehensive Income
The following table reflects accumulated other comprehensive loss reflected on the Consolidated Balance Sheets as of October 1, 2022 and October 2, 2021:

|  | As of
(in thousands) |  | October 1, 2022 |  | October 2, 2021
(Loss) / gain from foreign currency translation adjustments |  | $ | (29,854) |  |  | $ | 682 |
Unrecognized actuarial loss on pension plan, net of tax |  | (812) |  |  | (3,088) |
Unrealized loss on hedging |  | (2,234) |  |  | (616) |
Accumulated other comprehensive loss |  | $ | (32,900) |  |  | $ | (3,022) |

53

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Equity-Based Compensation
The Company has a stockholder-approved equity-based compensation plan, the 2021 Omnibus Incentive Plan (the “Plan”) from which employees and directors receive grants. As of October 1, 2022, 3.3 million shares of common stock are available for grant to the Company’s employees and directors under the Plan.
•Relative TSR Performance Share Units (“Relative TSR PSUs”) entitle the employee to receive common shares of the Company on the award vesting date, typically the third anniversary of the grant date (or as soon as administratively practicable if later), if market performance objectives which measure relative total shareholder return (“TSR”) are attained. Relative TSR is calculated based upon the 90-calendar day average price at the end of the performance period of the Company’s stock as compared to specific peer companies that comprise the GICS (45301020) Semiconductor Index. TSR is measured for the Company and each peer company over a performance period, which is generally three years. Vesting percentages range from 0% to 200% of awards granted. The provisions of the Relative TSR PSUs are reflected in the grant date fair value of the award; therefore, compensation expense is recognized regardless of whether the market condition is ultimately satisfied. Compensation expense is reversed if the award is forfeited prior to the vesting date.
•Revenue Growth Performance Share Units (“Growth PSUs”) entitle the employee to receive common shares of the Company on the award vesting date, typically the third anniversary of the grant date (or as soon as administratively practicable if later), based on organic revenue growth objectives and relative growth performance against named competitors as set by the Management Development and Compensation Committee (“MDCC”) of the Company’s Board of Directors. Organic revenue growth is calculated by averaging revenue growth (net of revenues from acquisitions) over a performance period, which is generally three years. Revenues from acquisitions will be included in the calculation after four fiscal quarters after acquisition. Any portion of the grant that does not meet the revenue growth objectives and relative growth performance is forfeited. Vesting percentages range from 0% to 200% of awards granted.
•In general, stock options and Time-based Restricted Share Units (“Time-based RSUs”) awarded to employees vest ratably over a three-year period on the anniversary of the grant date provided the employee remains employed by the Company. The Company follows the non-substantive vesting method for stock options and recognizes compensation expense immediately for awards granted to retirement eligible employees, or over the period from the grant date to the date retirement eligibility is achieved.
Equity-based compensation expense recognized in the Consolidated Statements of Operations for fiscal 2022, 2021, and 2020 was based upon awards ultimately expected to vest, with forfeiture accounted for when they occur.
The following table reflects total equity-based compensation expense, which includes Relative TSR PSUs, Time-based RSUs, Growth PSUs, and common stock, included in the Consolidated Statements of Operations for fiscal 2022, 2021, and 2020:

|  | Fiscal
(in thousands) |  | 2022 |  | 2021 |  | 2020
Cost of sales |  | $ | 960 |  |  | $ | 828 |  |  | $ | 744 |
Selling, general and administrative |  | 13,911 |  |  | 10,998 |  |  | 11,071 |
Research and development |  | 4,115 |  |  | 3,676 |  |  | 3,204 |
Total equity-based compensation expense |  | $ | 18,986 |  |  | $ | 15,502 |  |  | $ | 15,019 |

The following table reflects equity-based compensation expense, by type of award, for fiscal 2022, 2021, and 2020:

|  | Fiscal
(in thousands) |  | 2022 |  | 2021 |  | 2020
Relative TSR PSUs |  | 4,255 |  |  | 3,916 |  |  | $ | 3,266 |
Time-based RSUs |  | 11,655 |  |  | 10,314 |  |  | 9,519 |
Growth PSUs |  | 2,127 |  |  | 444 |  |  | 1,384 |
Common stock |  | 949 |  |  | 828 |  |  | 850 |
Total equity-based compensation expense |  | $ | 18,986 |  |  | $ | 15,502 |  |  | $ | 15,019 |

54

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Equity-Based Compensation: Relative TSR PSUs
The following table reflects Relative TSR PSUs activity for fiscal 2022, 2021, and 2020:

| Number of shares (in thousands) |  | Unrecognized compensation expense (in thousands) |  | Average remaining service period (in years) |  | Weighted average grant date fair value per share
Relative TSR PSUs outstanding as of September 28, 2019 | 561 |  |  | $ | 4,136 |  |  | 0.9 |  |
Granted | 162 |  |  |  |  |  |  | $ | 28.80 |
Forfeited or expired | (52) |  |  |  |  |  |  |
Vested | (268) |  |  |  |  |  |  |
Relative TSR PSUs outstanding as of October 3, 2020 | 403 |  |  | $ | 4,198 |  |  | 1.1 |  |
Granted | 155 |  |  |  |  |  |  | $ | 28.21 |
Forfeited or expired | (6) |  |  |  |  |  |  |
Vested | (108) |  |  |  |  |  |  |
Relative TSR PSUs outstanding as of October 2, 2021 | 444 |  |  | $ | 4,455 |  |  | 1.1 |  |
Granted | 152 |  |  |  |  |  |  | $ | 52.18 |
Forfeited or expired | (11) |  |  |  |  |  |  |
Vested | (205) |  |  |  |  |  |  |
Relative TSR PSUs outstanding as of October 1, 2022 | 380 |  |  | $ | 4,619 |  |  | 0.9 |  |

55

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
The following table reflects the assumptions used to calculate compensation expense related to the Company’s Relative TSR PSUs issued during fiscal 2022, 2021, and 2020:

| Fiscal
| 2022 |  | 2021 |  | 2020
Grant price | $ | 49.20 |  |  | $ | 23.88 |  |  | $ | 22.95 |
Expected dividend yield | 1.14 | % |  | 2.01 | % |  | 2.09 | %
Expected stock price volatility | 48.50 | % |  | 45.15 | % |  | 36.29 | %
Risk-free interest rate | 0.68 | % |  | 0.21 | % |  | 1.49 | %

Equity-Based Compensation: Time-based RSUs
The following table reflects Time-based RSUs activity for fiscal 2022, 2021, and 2020:

| Number of shares (in thousands) |  | Unrecognized compensation expense (in thousands) |  | Average remaining service period (in years) |  | Weighted average grant date fair value per share
Time-based RSUs outstanding as of September 28, 2019 | 947 |  |  | $ | 10,555 |  |  | 1.4 |  |
Granted | 490 |  |  |  |  |  |  | $ | 22.93 |
Forfeited or expired | (80) |  |  |  |  |  |  |
Vested | (569) |  |  |  |  |  |  |
Time-based RSUs outstanding as of October 3, 2020 | 788 |  |  | $ | 10,480 |  |  | 1.6 |  |
Granted | 486 |  |  |  |  |  |  | $ | 24.34 |
Forfeited or expired | (24) |  |  |  |  |  |  |
Vested | (333) |  |  |  |  |  |  |
Time-based RSUs outstanding as of October 2, 2021 | 917 |  |  | $ | 11,420 |  |  | 1.4 |  |
Granted | 301 |  |  |  |  |  |  | $ | 49.47 |
Forfeited or expired | (29) |  |  |  |  |  |  |
Vested | (453) |  |  |  |  |  |  |
Time-based RSUs outstanding as of October 1, 2022 | 736 |  |  | $ | 13,752 |  |  | 1.2 |  |

56

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Equity-Based Compensation: Growth PSUs
The following table reflects Growth PSUs activity for fiscal 2022, 2021, and 2020:

| Number of shares (in thousands) |  | Unrecognized compensation expense (in thousands) |  | Average remaining service period (in years) |  | Weighted average grant date fair value per share
Special/Growth PSUs outstanding as of September 28, 2019 | 97 |  |  | $ | 1,128 |  |  | 1.6 |  |
Granted | 80 |  |  |  |  |  |  | $ | 23.65 |
Forfeited or expired | (22) |  |  |  |  |  |  |
Vested | (4) |  |  |  |  |  |  |
Special/Growth PSUs outstanding as of October 3, 2020 | 151 |  |  | $ | 1,252 |  |  | 1.1 |  |
Granted | 52 |  |  |  |  |  |  | $ | 24.01 |
Forfeited or expired | (34) |  |  |  |  |  |  |
Vested | (17) |  |  |  |  |  |  |
Special/Growth PSUs outstanding as of October 2, 2021 | 152 |  |  | $ | 1,247 |  |  | 1.0 |  |
Granted | 79 |  |  |  |  |  |  | $ | 49.26 |
Forfeited or expired | (4) |  |  |  |  |  |  |
Vested | (100) |  |  |  |  |  |  |
Special/Growth PSUs outstanding as of October 1, 2022 | 127 |  |  | $ | 1,405 |  |  | 0.9 |  |

As of October 1, 2022, there were no employee stock options.
Equity-Based Compensation: Non-Employee Directors
The 2021 Equity Plan provides for the grant of common shares to each non-employee director upon initial election to the board and on the first business day of each calendar quarter while serving on the board. The grant to a non-employee director upon initial election to the board is that number of common shares closest in value to, without exceeding, $120,000. The quarterly grant to a non-employee director upon the first business day of each calendar quarter is that number of common shares closest in value to, without exceeding, $39,500.
The following table reflects shares of common stock issued to non-employee directors and the corresponding fair value for fiscal 2022, 2021, and 2020:

| Fiscal
(in thousands) | 2022 |  | 2021 |  | 2020
Number of common shares issued | 18 |  |  | 22 |  |  | 37 |
Fair value based upon market price at time of issue | $ | 949 |  |  | $ | 828 |  |  | $ | 850 |

Pension Plan
The following table reflects the Company’s defined benefits pension obligations, mainly in Switzerland and Taiwan, as of October 1, 2022 and October 2, 2021:

|  | As of
(in thousands) | October 1, 2022 |  | October 2, 2021
Switzerland pension obligation | $ | 1,038 |  |  | $ | 3,534 |
Taiwan pension obligation | 1,189 |  |  | 1,443 |

57

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Other Plans
Some of the Company’s other foreign subsidiaries have retirement plans that are integrated with and supplement the benefits provided by laws of the various countries. These other plans are not required to report nor do they determine the actuarial present value of accumulated benefits or net assets available for plan benefits as they are defined contribution plans.
NOTE 12: REVENUE AND CONTRACT BALANCES
The Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay. Service revenue is generally recognized over time as the services are performed. For the fiscal years ended October 1, 2022, and October 2, 2021, service revenue is not material. Please refer to Note 1: Basis of Presentation- Revenue Recognition, for additional disclosure on the Company’s revenue recognition policy.
The Company reports revenue based on our reportable segments. The Company believes that reporting revenue on this basis provides information about how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Please refer to Note 16: Segment Information, for disclosure of revenue by segment.
Contract Balances
Our contract assets relate to our rights to consideration for revenue with collection dependent on events other than the passage of time, such as the achievement of specified payment milestones. The contract assets will be transferred to net account receivables as our right to consideration for these contract assets become unconditional. Contracts assets are reported in the accompanying Consolidated Balance Sheets within prepaid expenses and other current assets.
Our contract liabilities are primarily related to payments received in advance of satisfying performance obligations, and are reported in the accompanying Consolidated Balance Sheets within accrued expenses and other current liabilities.
Contract liabilities increase as a result of receiving new advance payments from customers and decrease as revenue is recognized from product sales under advance payment arrangements upon satisfying the performance obligations.
The following table shows the changes in contract asset balances during the fiscal years ended October 1, 2022 and October 2, 2021:

|  | Fiscal
(in thousands) |  | 2022 |  | 2021
Contract assets, beginning of period |  | $ | — |  |  | $ | — |
Additions |  | 51,774 |  |  | — |
Transferred to accounts receivable or collected |  | (25,457) |  |  | — |
Contract assets, end of period |  | $ | 26,317 |  |  | $ | — |

The following table shows the changes in contract liability balances during the fiscal years ended October 1, 2022 and October 2, 2021:

|  | Fiscal
(in thousands) |  | 2022 |  | 2021
Contract liabilities, beginning of period |  | $ | 15,596 |  |  | $ | 2,958 |
Revenue recognized |  | (116,399) |  |  | (59,368) |
Additions |  | 103,963 |  |  | 72,006 |
Contract liabilities, end of period |  | $ | 3,160 |  |  | $ | 15,596 |

58

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
NOTE 13: EARNINGS PER SHARE
Basic income per share is calculated using the weighted average number of shares of common stock outstanding during the period. Stock options and restricted stock are included in the calculation of diluted earnings per share, except when their effect would be anti-dilutive.
The following table reflects a reconciliation of the shares used in the basic and diluted net income per share computation for fiscal 2022, 2021, and 2020:

|  | Fiscal
(in thousands, except per share) |  | 2022 |  | 2021 |  | 2020
|  | Basic |  | Diluted |  | Basic |  | Diluted |  | Basic |  | Diluted
NUMERATOR: |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | $ | 433,545 |  |  | $ | 433,545 |  |  | $ | 367,161 |  |  | $ | 367,161 |  |  | $ | 52,300 |  |  | $ | 52,300 |
DENOMINATOR: |  |  |  |  |  |  |  |  |  |  |  |
Weighted average shares outstanding - Basic |  | 60,164 |  |  | 60,164 |  |  | 62,009 |  |  | 62,009 |  |  | 62,828 |  |  | 62,828 |
Dilutive effect of Equity Plans |  |  |  | 1,018 |  |  |  |  | 1,506 |  |  |  |  | 531 |
Weighted average shares outstanding - Diluted |  |  |  | 61,182 |  |  |  |  | 63,515 |  |  |  |  | 63,359 |
EPS: |  |  |  |  |  |  |  |  |  |  |  |
Net income per share - Basic |  | $ | 7.21 |  |  | $ | 7.21 |  |  | $ | 5.92 |  |  | $ | 5.92 |  |  | $ | 0.83 |  |  | $ | 0.83 |
Effect of dilutive shares |  |  |  | $ | (0.12) |  |  |  |  | $ | (0.14) |  |  |  |  | $ | — |
Net income per share - Diluted |  |  |  | $ | 7.09 |  |  |  |  | $ | 5.78 |  |  |  |  | $ | 0.83 |
Anti-dilutive shares(1) |  |  |  | 1 |  |  |  | 2 |  |  |  | 40

(1) Represents the Relative TSR PSUs and Growth PSUs that are excluded from the calculation of diluted earnings per share for fiscal 2022, 2021, and 2020 as the effect would have been anti-dilutive.
NOTE 14: OTHER FINANCIAL DATA
The following table reflects other financial data for fiscal 2022, 2021, and 2020:

| Fiscal
(in thousands) | 2022 |  | 2021 |  | 2020
Incentive compensation expense | $ | 27,011 |  |  | $ | 39,779 |  |  | $ | 18,524 |
Warranty and retrofit expense | 16,349 |  |  | 22,068 |  |  | 8,692 |

NOTE 15: INCOME TAXES
The following table reflects U.S. and foreign income (loss) before income taxes for fiscal 2022, 2021, and 2020:

| Fiscal
(in thousands) | 2022 |  | 2021 |  | 2020
United States | $ | (11,415) |  |  | $ | (8,853) |  |  | $ | (14,909) |
Foreign | 488,403 |  |  | 423,403 |  |  | 79,243 |
Income before income taxes | $ | 476,988 |  |  | $ | 414,550 |  |  | $ | 64,334 |

59

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
The following table reflects the current and deferred components of provision for (benefit from) income taxes for fiscal 2022, 2021, and 2020:

| Fiscal
(in thousands) | 2022 |  | 2021 |  | 2020
Current: |  |  |  |  |
Federal | $ | 14,975 |  |  | $ | 26,563 |  |  | $ | 5,129 |
State | 246 |  |  | 261 |  |  | 89 |
Foreign | 37,448 |  |  | 30,771 |  |  | 6,508 |
Deferred: |  |  |  |  |
Federal | (5,809) |  |  | (2,979) |  |  | (690) |
State | — |  |  | — |  |  | — |
Foreign | (3,417) |  |  | (7,321) |  |  | 962 |
Provision for income taxes | $ | 43,443 |  |  | $ | 47,295 |  |  | $ | 11,998 |

The following table reconciles the provision for (benefit from) income taxes with the expected income tax provision computed based on the applicable U.S. federal statutory tax rate for fiscal 2022, 2021, and 2020:

| Fiscal |
(dollar amounts in thousands) | 2022 |  | 2021 |  | 2020 |
Expected income tax provision based on the U.S. federal statutory tax rate | $ | 100,212 |  |  | $ | 86,915 |  |  | $ | 13,510 |  |
Effect of earnings of foreign subsidiaries subject to different tax rates | (17,936) |  |  | (15,028) |  |  | (1,634) |  |
Benefit from tax incentives | (50,113) |  |  | (45,501) |  |  | (6,781) |  |
Benefit from research and development tax credits | (2,995) |  |  | (2,705) |  |  | (2,915) |  |
Benefit from foreign tax credits | (26,021) |  |  | (20,281) |  |  | (1,701) |  |
Valuation allowance | (5,830) |  |  | (11,620) |  |  | 1,224 |  |
Foreign operations (Deemed income, taxes on undistributed foreign earnings, and withholding taxes) | 45,421 |  |  | 52,414 |  |  | 8,886 |  |
Non-deductible items | 267 |  |  | 113 |  |  | 1,232 |  |
Other, net (1) | 438 |  |  | 2,988 |  |  | 177 |  |
Provision for income taxes | $ | 43,443 |  |  | $ | 47,295 |  |  | $ | 11,998 |  |
Effective tax rate | 9.1 | % |  | 11.4 | % |  | 18.6 | % |

(1) Certain balances in fiscal 2021 and 2020 have been reclassified to conform to the current period presentation. These reclassifications have no impact to the consolidated financial statements in fiscal 2021 and 2020.
For fiscal 2022 and 2021, the effective tax rate differed from the U.S. federal statutory tax rate primarily due to tax benefits from tax incentives, foreign earnings subject to a lower statutory tax rate than the U.S. federal statutory tax rate, tax credits generated during the fiscal year, and the net release of valuation allowances recorded against certain loss and credit carryforwards, partially offset by tax expense related to deemed income and undistributed foreign earnings.
As of October 2, 2022, a large portion of the Company’s undistributed foreign earnings are not considered to be indefinitely reinvested outside the U.S. and are expected to be available for use in the U.S. without incurring additional U.S. income tax.
Further, we operate in a number of foreign jurisdictions, including Singapore, where we have a tax incentive that allows for a reduced tax rate on certain classes of income, provided the Company meets certain employment and investment conditions through the expiration date in fiscal 2025. In fiscal 2022, 2021, and 2020, the tax incentive arrangement helped to reduce the Company’s provision for income taxes by $50.1 million or $0.82 per share, $45.5 million or $0.72 per share and $6.8 million or $0.11 per share, respectively.
60

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
The following table reflects deferred tax balances based on the tax effects of cumulative temporary differences for fiscal 2022 and 2021:

| Fiscal
(in thousands) | 2022 |  | 2021
Accruals and reserves | $ | 14,168 |  |  | $ | 11,890 |
Tax credit carryforwards | 3,893 |  |  | 4,230 |
Fixed and intangible assets | 5,963 |  |  | 465 |
Net operating loss carryforwards | 15,329 |  |  | 28,913 |
Gross deferred tax assets | $ | 39,353 |  |  | $ | 45,498 |
Valuation allowance | $ | (21,750) |  |  | $ | (34,095) |
Deferred tax assets, net of valuation allowance | $ | 17,603 |  |  | $ | 11,403 |
Taxes on undistributed foreign earnings | $ | (26,068) |  |  | $ | (28,516) |
Deferred tax liabilities | $ | (26,068) |  |  | $ | (28,516) |
Net deferred tax liabilities | $ | (8,465) |  |  | $ | (17,113) |
Reported as |  |  |
Deferred tax assets | $ | 25,572 |  |  | $ | 15,715 |
Deferred tax liabilities | (34,037) |  |  | (32,828) |
Net deferred tax liabilities | $ | (8,465) |  |  | $ | (17,113) |

As of October 1, 2022, the Company has foreign net operating loss carryforwards of $37.9 million, state net operating loss carryforwards of $54.6 million, and U.S. federal and state tax credit carryforwards of $6.5 million that can be used to offset future income tax obligations. These net operating loss and tax credit carryforwards can be utilized prior to their expiration dates in fiscal years 2023 through 2041, except for certain credits and foreign net operating losses that can be carried forward indefinitely. The Company has recorded valuation allowances against certain foreign and state net operating loss carryforwards and state tax credits which are expected to expire unutilized.
The following table reconciles the beginning and ending balances of the Company’s unrecognized tax benefit, excluding related accrued interest and penalties, for fiscal 2022, 2021, and 2020:

|  | Fiscal
(in thousands) |  | 2022 |  | 2021 |  | 2020
Unrecognized tax benefit, beginning of year |  | $ | 14,922 |  |  | $ | 13,064 |  |  | $ | 12,925 |
Additions for tax positions, current year |  | 2,288 |  |  | 4,003 |  |  | 537 |
Reductions for tax positions, prior year |  | (587) |  |  | (2,145) |  |  | (398) |
Unrecognized tax benefit, end of year |  | $ | 16,623 |  |  | $ | 14,922 |  |  | $ | 13,064 |

The Company recognizes interest and penalties related to potential income tax liabilities as a component of unrecognized tax benefit and in provision for income taxes. The amount of interest and penalties related to unrecognized tax benefit recorded in fiscal 2022 provision for income taxes is not material. As of October 1, 2022, the Company has recognized $2.0 million of accrued interest and penalties related to unrecognized tax benefit within the income tax payable for uncertain tax positions and approximately $17.1 million of unrecognized tax benefit, including related interest and penalties, that if recognized, would impact the Company’s effective tax rate.
It is reasonably possible that the amount of the unrecognized tax benefit with respect to certain uncertain tax positions will increase or decrease during the next 12 months due to the expected lapse of statutes of limitation and/or settlements of tax examinations. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, we cannot practicably estimate the financial outcomes of these examinations.
61

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
The Company files a U.S. federal income tax return, as well as income tax returns in various state and foreign jurisdictions. For U.S. federal income tax returns purposes, tax years from fiscal 2019 remain subject to examination. For most state tax returns, tax years following fiscal 2003 remain subject to examination as a result of the generation of net operating loss carryforwards. In the foreign jurisdictions where the Company files income tax returns, the statutes of limitations with respect to these jurisdictions vary from jurisdiction to jurisdiction and range from 4 to 6 years. The Company’s tax returns are currently under examination by tax authorities in multiple state and foreign jurisdictions. The Company believes that adequate provisions have been made for any adjustments that may result from the examination.
NOTE 16: SEGMENT INFORMATION
Reportable segments are defined as components of an enterprise that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker (the “CODM”) in deciding how to allocate resources and assess performance. The Company’s Chief Executive Officer is the CODM. The CODM does not review discrete asset information.
During the third quarter of fiscal year 2023, the Company reconsidered the guidance under ASC 280, Segment Reporting, and determined that certain prior period conclusions about the Company’s operating and reportable segments were erroneous. As a result, the Company had incorrectly presented certain segment-related disclosures in the notes to our previously issued consolidated financial statements, included in the Original Form 10-K. The Company has evaluated the materiality of the incorrect presentation of its segment-related disclosures and has concluded that it did not result in a material misstatement of the Company’s previously issued consolidated financial statements. However, the Company determined it would revise its notes to the consolidated financial statements to correct the presentation of its segment-related disclosures.
The Company has revised the prior period presentation to reflect its four reportable segments as follows: (1) Ball Bonding Equipment, (2) Wedge Bonding Equipment, (3) Advanced Solutions, and (4) Aftermarket Products and Services (“APS”). The four reportable segments are disclosed below:
Ball Bonding Equipment: Reflects the results of the Company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment.
Wedge Bonding Equipment: Reflects the results of the Company from the design, development, manufacture and sale of wedge bonding equipment.
Advanced Solutions: Reflects the results of the Company from the design, development, manufacture and sale of certain advanced display, die-attach and thermocompression systems and solutions.
APS: Reflects the results of the Company from the design, development, manufacture and sale of a variety of tools, spares and services for our equipment.
Any other operating segments that have not been aggregated within the reportable segments described above which do not meet the quantitative threshold to be disclosed as a separate reportable segment have been grouped within an “All Others” category. This group is reflective of the results of the Company from the design, development, manufacture and sale of certain advanced display, advanced dispense, electronics assembly, die-attach and lithography systems and solutions. Results for the “All Others” category and other corporate expenses are included as a reconciling item between the Company’s reportable segments and its consolidated results of operations.
62

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
The following table reflects operating information by segment for fiscal 2022, 2021, and 2020:

|  | Fiscal
(in thousands) |  | 2022 |  | 2021 |  | 2020
Net revenue: |  |  |  |  |  |
Ball Bonding Equipment |  | $ | 909,428 |  |  | $ | 1,016,663 |  |  | $ | 312,611 |
Wedge Bonding Equipment |  | 194,086 |  |  | 138,836 |  |  | 67,088 |
Advanced Solutions |  | 94,683 |  |  | 35,123 |  |  | 5,186 |
APS |  | 197,152 |  |  | 205,088 |  |  | 161,117 |
All Others |  | 108,271 |  |  | 121,954 |  |  | 77,174 |
Net revenue |  | 1,503,620 |  |  | 1,517,664 |  |  | 623,176 |
Income/(loss) from operations: |  |  |  |  |  |
Ball Bonding Equipment |  | 385,276 |  |  | $ | 401,450 |  |  | $ | 95,695 |
Wedge Bonding Equipment |  | 66,649 |  |  | 34,563 |  |  | 4,158 |
Advanced Solutions |  | (15,389) |  |  | (40,759) |  |  | (44,278) |
APS |  | 82,473 |  |  | 75,400 |  |  | 51,255 |
All Others |  | 25,732 |  |  | 20,565 |  |  | 7,632 |
Corporate Expenses |  | (74,669) |  |  | (78,772) |  |  | (55,953) |
Income from operations |  | 470,072 |  |  | 412,447 |  |  | 58,509 |

We have considered: (1) information that is regularly reviewed by our CODM in evaluating financial performance and how to allocate resources; and (2) other financial data, including information that we include in our earnings releases but which is not included in our financial statements, to disaggregate revenues by end markets served. The principal category we use to disaggregate revenues is by the end markets served.
The following table reflects net revenue by end markets served for fiscal 2022, 2021, and 2020

|  | Fiscal
(in thousands) |  | 2022 |  | 2021 |  | 2020
General Semiconductor |  | $ | 843,763 |  |  | $ | 928,259 |  |  | $ | 290,220 |
Automotive & Industrial |  | 198,138 |  |  | 129,817 |  |  | 60,169 |
LED |  | 137,077 |  |  | 187,568 |  |  | 76,574 |
Memory |  | 127,490 |  |  | 66,932 |  |  | 35,096 |
APS |  | $ | 197,152 |  |  | $ | 205,088 |  |  | $ | 161,117 |
Total revenue |  | $ | 1,503,620 |  |  | $ | 1,517,664 |  |  | $ | 623,176 |

The following tables reflect capital expenditures, depreciation and amortization expense by segment for fiscal 2022, 2021, and 2020.

|  | Fiscal
(in thousands) |  | 2022 |  | 2021 |  | 2020
Capital expenditures: |  |  |  |  |  |
Ball Bonding Equipment |  | $ | 978 |  |  | $ | 1,627 |  |  | $ | 1,586 |
Wedge Bonding Equipment |  | 1,450 |  |  | 387 |  |  | 607 |
Advanced Solutions |  | 19,036 |  |  | 6,090 |  |  | 214 |
APS |  | 4,964 |  |  | 5,286 |  |  | 8,131 |
All Others |  | 1,364 |  |  | 1,046 |  |  | 1,767 |
Corporate Expenses |  | 4,441 |  |  | 8,119 |  |  | 2,209 |
Capital expenditures |  | $ | 32,233 |  |  | $ | 22,555 |  |  | $ | 14,514 |

63

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

|  | Fiscal
(in thousands) |  | 2022 |  | 2021 |  | 2020
Depreciation expense: |  |  |  |  |  |
Ball Bonding Equipment |  | $ | 1,398 |  |  | $ | 1,153 |  |  | $ | 758 |
Wedge Bonding Equipment |  | 981 |  |  | 940 |  |  | 933 |
Advanced Solutions |  | 2,034 |  |  | 845 |  |  | 487 |
APS |  | 6,632 |  |  | 5,969 |  |  | 4,951 |
All Others |  | 1,047 |  |  | 1,179 |  |  | 1,252 |
Corporate Expenses |  | 4,284 |  |  | 3,750 |  |  | 3,987 |
Depreciation expense |  | $ | 16,376 |  |  | $ | 13,836 |  |  | $ | 12,368 |

|  | Fiscal
(in thousands) |  | 2022 |  | 2021 |  | 2020
Amortization expense: |  |  |  |  |  |
Ball Bonding Equipment |  | $ | — |  |  | $ | — |  |  | $ | — |
Wedge Bonding Equipment |  | — |  |  | — |  |  | — |
Advanced Solutions |  | — |  |  | — |  |  | — |
APS |  | 994 |  |  | 2,319 |  |  | 3,416 |
All Others |  | 3,557 |  |  | 3,369 |  |  | 3,955 |
Corporate Expenses |  | 366 |  |  | 286 |  |  | — |
Amortization expense |  | $ | 4,917 |  |  | $ | 5,974 |  |  | $ | 7,371 |

Geographical information
The following tables reflect destination sales to unaffiliated customers by country and long-lived assets by country for fiscal 2022, 2021, and 2020:

| Fiscal
(in thousands) | 2022 |  | 2021 |  | 2020
Destination sales to unaffiliated customers: |  |  |  |  |
China | $ | 855,345 |  |  | $ | 843,470 |  |  | $ | 321,294 |
Malaysia | 126,520 |  |  | 70,253 |  |  | 40,641 |
Taiwan | 123,995 |  |  | 275,251 |  |  | 64,373 |
Korea | 87,647 |  |  | 58,308 |  |  | 30,848 |
United States | 83,906 |  |  | 54,353 |  |  | 36,186 |
Hong Kong | 27,216 |  |  | 82,436 |  |  | 43,288 |
All other(1) | 198,991 |  |  | 133,593 |  |  | 86,546 |
Total destination sales to unaffiliated customers | $ | 1,503,620 |  |  | $ | 1,517,664 |  |  | $ | 623,176 |

(1) Certain balances in fiscal 2021 and 2020 have been reclassified to conform to the current period presentation. These reclassifications have no impact to the consolidated financial statements in fiscal 2021 and 2020.
64

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

| Fiscal
(in thousands) | 2022 |  | 2021 |  |
Long-lived assets: |  |  |  |  |
Singapore | $ | 59,672 |  |  | $ | 40,470 |  |  |
United States | 31,469 |  |  | 32,684 |  |  |
China | 19,548 |  |  | 25,386 |  |  |
Israel | 10,610 |  |  | 8,597 |  |  |
All other | 9,647 |  |  | 11,187 |  |  |
Total long-lived assets | $ | 130,946 |  |  | $ | 118,324 |  |  |

NOTE 17: COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS
Warranty Expense
The Company’s equipment is generally shipped with a one-year warranty against manufacturing defects. The Company establishes reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management’s estimate of future warranty costs, including product part replacement, freight charges and related labor costs expected to be incurred to correct product failures during the warranty period.
The following table reflects the reserve for product warranty activity for fiscal 2022, 2021, and 2020:

|  | Fiscal
(in thousands) |  | 2022 |  | 2021 |  | 2020
Reserve for warranty, beginning of period |  | $ | 16,961 |  |  | $ | 9,576 |  |  | $ | 14,185 |
Provision for warranty |  | 12,907 |  |  | 18,889 |  |  | 14,004 |
Changes in the estimation of warranty reserve |  | — |  |  | — |  |  | (5,417) |
Utilization of reserve |  | (16,425) |  |  | (11,504) |  |  | (13,196) |
Reserve for warranty, end of period |  | $ | 13,443 |  |  | $ | 16,961 |  |  | $ | 9,576 |

For the change in estimation of warranty reserve, see Note 1 for details.
O ther Commitments and Contingencies
The following table reflects obligations not reflected on the Consolidated Balance Sheets as of October 1, 2022:

|  |  |  | Payments due by fiscal year
(in thousands) |  | Total |  | 2023 |  | 2024 |  | 2025 |  | 2026 |  | Thereafter
Inventory purchase obligation (1) |  | $ | 316,123 |  |  | $ | 316,123 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |

(1) The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancelable and a portion may have varying penalties and charges in the event of cancellation.
From time to time, the Company is party to or the target of lawsuits, claims, investigations and proceedings, including for personal injury, intellectual property, commercial, contract, and employment matters, which are handled and defended in the ordinary course of business. The Company accrues a contingent loss liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When a single amount cannot be reasonably estimated but the cost can be estimated within a range, the Company accrues the minimum amount. The Company expenses legal costs, including those expected to be incurred in connection with a loss contingency, as incurred.
Unfunded Capital Commitments
As of October 1, 2022, the Company also has an obligation to fund uncalled capital commitments of approximately $9.6 million, as and when required, in relation to its investment in a private equity fund.
65

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Concentrations
The following tables reflect significant customer concentrations as a percentage of net revenue for fiscal 2022, 2021, and 2020:

|  | Fiscal
|  | 2022 |  | 2021 |  | 2020
ASE Technology Holding |  | * |  | 17.4 | % |  | *

* Represents less than 10% of total net revenue
The following table reflects significant customer concentrations as a percentage of total accounts receivable as of October 1, 2022 and October 2, 2021:

|  | As of
|  | October 1, 2022 |  | October 2, 2021
Tianshui Huatian Technology Co., Ltd. |  | 16.7 | % |  | 18.2 | %
Haoseng Industrial Co., Ltd. (1) |  | 12.6 | % |  | 14.3 | %

(1) Distributor of the Company's products
66

Table of Contents
Item 9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of October 1, 2022. At the time that the Original Form 10-K was filed on November 17, 2022, our Chief Executive Officer and Chief Financial Officer concluded that, as of October 1, 2022, our disclosure controls and procedures were effective in providing reasonable assurance that the information required to be disclosed by us in reports filed under the Securities Exchange Act of 1934, as amended, is (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (ii) accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure. Based on the identification of the material weakness described below, the Company, under the supervision of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, re-evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based on this re-evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of October 1, 2022.
Management’s Report on Internal Control Over Financial Reporting (As Restated)
The management of Kulicke and Soffa Industries, Inc. (the “Company”) is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934, as amended. The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America.
The Company’s internal control over financial reporting includes those policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles; provide reasonable assurance that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or future events, in each instance no matter how remote, or that the degree of compliance with the policies or procedures may deteriorate.
In Management's Report on Internal Control Over Financial Reporting included in the Original Form 10-K, our management had previously concluded that we maintained effective internal control over financial reporting as of October 1, 2022. Management has subsequently concluded that the material weakness described below existed as of October 1, 2022. As a result, management has concluded that the Company did not maintain effective internal control over financial reporting as of October 1, 2022, based on the criteria in Internal Control-Integrated Framework (2013) issued by the COSO. Accordingly, management has restated its report on internal control over financial reporting.
As described in the Explanatory Note, subsequent to the Original Form 10-K, the Company concluded that its prior determination that certain prior period conclusions about the Company’s operating and reportable segments were erroneous. As a result, the Company had incorrectly presented certain segment-related disclosures in the notes to our previously issued consolidated financial statements.
67

Table of Contents
In light of the foregoing, we have identified a material weakness in our internal control over financial reporting that existed as of October 1, 2022. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness is a result of a design gap in the existing review of the segment reporting process, which failed to (a) identify all of the key metrics used by the CODM to evaluate performance and allocate resources, (b) assess in totality the level of information provided to and utilized by the CODM to evaluate performance and allocate resources and (c) appropriately analyze every factor pertinent to whether operating segments share economic similarities that are required for aggregation under ASC 280. There were no material misstatements as a result of this material weakness; however, it could result in omitted disclosures within the segment reporting footnote disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected on a timely basis. Due to the material weakness, we have concluded that our internal control over financial reporting was not effective as of October 1, 2022.
The Company has evaluated the impact of the incorrect presentation of segment information, considering both quantitative and qualitative factors, and concluded that the errors were immaterial to the consolidated financial statements included in the Original Form 10-K and that there was no impact to the primary financial statements in the Original Form 10-K.
The effectiveness of the Company’s internal control over financial reporting as of October 1, 2022 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in its report, which appears in Part II, Item 8 of this Amendment.
Management’s Plans for Remediation of the Material Weakness
The Company is in the process of assessing and finalizing its plan for remediation of the material weakness, with the oversight of the Audit Committee of the Board of Directors, the Chief Executive Officer and the Chief Financial Officer. Specifically, we have improved our review process including the documentation of the evaluation of segment reporting under ASC 280. In addition, the Company has engaged an outside consultant to assist management in the development of a segment analysis framework to be used on a go forward basis to support the segment related disclosures, particularly when the Company has significant organizational structure or reporting structure changes that may impact the Company’s analysis under ASC 280.
While we believe the measures described above and others that may be identified and implemented in future periods will strengthen our internal control over financial reporting and remediate the identified material weakness, the material weakness will not be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.
Changes in Internal Control over Financial Reporting
There has been no change in the Company’s internal control over financial reporting during the three months ended October 1, 2022, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
68

Table of Contents
Part IV
Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) The following documents are filed as part of this report:

|  | Page
(1) | Financial Statements - Kulicke and Soffa Industries, Inc.: |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 1093) | 28
| Consolidated Balance Sheets as of October 1, 2022 and October 2, 2021 | 31
| Consolidated Statements of Operations for fiscal 2022, 2021 and 2020 | 32
| Consolidated Statements of Comprehensive Income for fiscal 2022, 2021 and 2020 | 33
| Consolidated Statements of Changes in Shareholders' Equity for fiscal 2022, 2021 and 2020 | 34
| Consolidated Statements of Cash Flows for fiscal 2022, 2021 and 2020 | 35
| Notes to Consolidated Financial Statements | 36
(2) | Financial Statement Schedule: |
| Schedule II - Valuation and Qualifying Accounts | 70
| All other schedules are omitted because they are not applicable or the required information is shown in the Consolidated Financial Statements or notes thereto. |
(3) | Exhibits: |
| See “Exhibit Index” within Item 15 below. | 71

69

Table of Contents
KULICKE AND SOFFA INDUSTRIES, INC.
Schedule II-Valuation and Qualifying Accounts
(in thousands

Fiscal 2022: | Beginning of period |  | Charged to Costs and Expenses |  | Other Additions |  | Other Deductions |  | End of period
Allowance for doubtful accounts | $ | 687 |  |  | $ | (245) |  |  | $ | — |  |  | $ | (442) |  | (1) | $ | — |
Inventory reserve | $ | 23,042 |  |  | $ | (2,171) |  |  | $ | — |  |  | $ | (1,633) |  | (2) | $ | 19,238 |
Valuation allowance for deferred taxes | $ | 34,095 |  |  | $ | — |  |  | $ | — |  |  | $ | (12,345) |  | (4) | $ | 21,750 |
Fiscal 2021: |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts | $ | 968 |  |  | $ | (248) |  |  | $ | — |  |  | $ | (33) |  | (1) | $ | 687 |
Inventory reserve | $ | 31,163 |  |  | $ | (2,965) |  |  | $ | — |  |  | $ | (5,156) |  | (2) | $ | 23,042 |
Valuation allowance for deferred taxes | $ | 46,561 |  |  | $ | — |  |  | $ | — |  |  | $ | (12,466) |  | (4) | $ | 34,095 |
Fiscal 2020: |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts | $ | 597 |  |  | $ | 371 |  |  | $ | — |  |  | $ | — |  | (1) | $ | 968 |
Inventory reserve | $ | 29,313 |  |  | $ | 4,170 |  |  | $ | — |  |  | $ | (2,320) |  | (2) | $ | 31,163 |
Valuation allowance for deferred taxes | $ | 58,411 |  |  | $ | 6,887 |  | (3) | $ | — |  |  | $ | (18,737) |  | (5) | $ | 46,561 |
(1) | Represents write-offs of specific accounts receivable.
(2) | Sale or scrap of previously reserved inventory.
(3) | Reflects the net increase in the valuation allowance primarily associated with the Company’s U.S. and foreign tax credits, U.S. and foreign net operating losses and other deferred tax assets.
(4) | Reflects the net decrease in the valuation allowance primarily associated with the Company’s utilization of certain foreign net operating losses for which a valuation allowance had previously been recorded, partially offset by an increase for U.S. and foreign tax credits, U.S. and foreign net operating losses and other deferred tax assets.
(5) | Reflects the balances relating to foreign tax credits on undistributed foreign earnings and related valuation allowances that have been reclassified in fiscal 2020.

70

Table of Contents
EXHIBIT INDEX

EXHIBIT NUMBER |  | ITEM
3.1 |  | The Company's Amended and Restated Articles of Incorporation, dated December 5, 2007, is incorporated herein by reference to Exhibit 3(i) to the Company's Annual Report on Form 10-K for the fiscal year ended September 29, 2007, SEC file number 000-00121.
3.2 |  | The Company's Amended and Restated By-Laws, dated October 22, 2015, is incorporated herein by reference to Exhibit 3(ii) to the Company's Current Report on Form 8-K dated October 22, 2015.
4.1 |  | Specimen Common Share Certificate of Kulicke and Soffa Industries Inc., is incorporated herein by reference to Exhibit 4 to the Company's Form-8A12G/A dated September 11, 1995, SEC file number 000-00121.
4.2 |  | Description of the Company's securities.
10.1 |  | Kulicke & Soffa Industries, Inc. Executive Severance Pay Plan, dated as of August 9, 2011, is incorporated herein by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on August 12, 2011.*
10.2 |  | Kulicke & Soffa Industries, Inc. Officer Severance Pay Plan, dated as of August 9, 2011, is incorporated herein by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on August 12, 2011.*
10.3 |  | Form of Change of Control Agreement, is incorporated herein by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed on August 12, 2011.*
10.4 |  | Form of Director Indemnification Agreement is incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 10, 2013.*
10.5 |  | Lease Agreement between DBS Trustee Limited, as trustee of Mapletree Industrial Trust, and the Kulicke & Soffa Pte. Ltd, dated December 1, 2013, is incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 5, 2013.
10.6 |  | Lease Agreement Variation Letter between DBS Trustee Limited, as trustee of Mapletree Industrial Trust, and the Kulicke & Soffa Pte. Ltd, dated December 1, 2013, is incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on December 5, 2013.
10.7 |  | Form of Officer Indemnification Agreement is incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 11, 2013.*
10.8 |  | Offer Letter between Kulicke and Soffa Industries, Inc. and Fusen Chen dated October 3, 2016, incorporated herein by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed on October 3, 2016.*
10.9 |  | 2017 Equity Plan is incorporated herein by reference to Appendix A to the Company's Proxy Statement on Schedule 14A for the annual meeting of shareholders on March 14, 2017.*
10.10 |  | Form of Performance Share Unit Award Agreement regarding the 2017 Equity Plan is incorporated herein by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed on November 6, 2017.
10.11 |  | Form of Restricted Share Unit Award Agreement regarding the 2017 Equity Plan is incorporated herein by reference to Exhibit 10.2 of the Company's Current Report on Form 8-K filed on November 6, 2017.
10.12 |  | The Company's 2021 Omnibus Incentive Plan is incorporated herein by reference to the Company's Proxy Statement on Schedule 14A for the annual meeting of shareholders on March 4, 2021
10.13 |  | Form of CEO Performance Share Unit Award Agreement (Growth PSUs) regarding the 2021 Omnibus Incentive Plan.
10.14 |  | Form of Executive Performance Share Unit Award Agreement (Growth PSUs) regarding the 2021 Omnibus Incentive Plan.
10.15 |  | Form of CEO Performance Share Unit Award Agreement (Relative TSR) regarding the 2021 Omnibus Incentive Plan.
10.16 |  | Form of Executive Performance Share Unit Award Agreement (Relative TSR) regarding the 2021 Omnibus Incentive Plan.
10.17 |  | Form of Restricted Stock Unit Award Agreement regarding the 2021 Omnibus Incentive Plan.
10.18 |  | Incentive Compensation Plan Fiscal Year 2022.

71

Table of Contents

21.1 |  | Subsidiaries of the Company.
23.1 |  | Consent of PricewaterhouseCoopers LLP (Independent Registered Public Accounting Firm).
31.1 |  | Certification of Fusen Chen, Chief Executive Officer of Kulicke and Soffa Industries, Inc., pursuant to Rule 13a-14(a) or Rule 15d-14(a).
31.2 |  | Certification of Lester Wong, Chief Financial Officer of Kulicke and Soffa Industries, Inc., pursuant to Rule 13a-14(a) or Rule 15d-14(a).
32.1 |  | Certification of Fusen Chen, Chief Executive Officer of Kulicke and Soffa Industries, Inc., pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 |  | Certification of Lester Wong, Chief Financial Officer of Kulicke and Soffa Industries, Inc., pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.SCH |  | Inline XBRL Taxonomy Extension Schema Document
101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104 |  | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).
* Indicates a management contract or compensatory plan or arrangement ** Copies of certain instruments defining the rights of holders of certain of our long-term debt are not filed herewith. We hereby agree to furnish a copy of any such instrument to the SEC upon request. |

72

Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

|  | KULICKE AND SOFFA INDUSTRIES, INC.
| By: | /s/ FUSEN CHEN
|  | Fusen Chen
|  | President and Chief Executive Officer
| Dated: | August 8, 2023

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

Signature | Title | Date
/s/ FUSEN CHEN | President and Chief Executive Officer | August 8, 2023
Fusen Chen | (Principal Executive Officer) |
/s/ LESTER WONG | Executive Vice President and Chief Financial Officer | August 8, 2023
Lester Wong | (Principal Financial Officer and Principal Accounting Officer) |
/s/ JON A. OLSON | Director | August 8, 2023
Jon A. Olson |  |
/s/ GREGORY F. MILZCIK | Director | August 8, 2023
Gregory F. Milzcik |  |
/s/ CHIN HU LIM | Director | August 8, 2023
Chin Hu Lim |  |
/s/ JEFF RICHARDSON | Director | August 8, 2023
David J. Richardson |  |
/s/ MUI SUNG YEO | Director | August 8, 2023
Mui Sung Yeo |  |
/s/ PETER T. KONG | Director | August 8, 2023
Peter T. Kong |  |

73